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Summary 
Actin dynamics are involved in a plethora of vital cellular processes, including cell division 
and motility, regulation of cell shape or endocytic trafficking, among others. At the 
synapse, actin is the most prominent cytoskeletal component, and hence a major player 
impacting on synaptic transmission by regulating synaptic shape, neurotransmitter vesicle 
release and post-synaptic receptor trafficking.  
Growing evidence suggests that the pathogenesis of depression involves structural neuronal 
changes and that the therapeutic benefit of antidepressants might be mediated by 
affecting neuronal plasticity. Moreover, the “disturbed cytoskeletal theory” of mood 
disorders has been proposed, and chronic stress is known to affect neuronal structure and 
synaptic transmission efficiency. While it is clear that these processes of adaptation and 
maladaptation to stress are brought about by alterations of actin structures, up to now, a 
profound mechanistic understanding of the pathway from stress to neuronal reorganization 
and cognitive performance remains elusive. 
As a contribution to elucidating the relevance of actin dynamics for synaptic function 
during the stress response, a two-sided approach was taken in this study by analyzing the 
actin-related effects of the stress-induced protein DRR1 (Down-regulated in renal cell 
carcinoma 1) and of antidepressants, respectively. 
The three antidepressants clomipramine, doxepin, and citalopram were tested in several 
in vitro assays of actin dynamics. Only clomipramine moderately slowed down overall 
actin polymerization; this was attributed to a potential reduction of the nucleation process 
required for the formation of actin filaments. High excess of clomipramine over actin was 
necessary in these experiments to produce the effect. In cells, the overall F-actin structure 
and two-dimensional migration remained unaffected by treatment with clomipramine, 
while spreading appeared to be reduced at high concentrations of clomipramine. However, 
unspecific cytotoxic effects of clomipramine at this concentration might be involved, as 
observed in cellular stainings with high concentrations. 
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Being previously known as potential tumor suppressor, DRR1 was recently characterized 
as a direct link between chronic stress, actin dynamics and improved cognition (Schmidt 
et al., 2011). In addition to the previously described actin bundling activity of DRR1, 
here, it was found to cap actin filaments, thereby inhibiting their elongation with a 
concomitant increase in nucleation of new filaments. This tripartite effect of DRR1 is 
accomplished by two actin binding regions separated by a central domain, which is 
presumably mediating homodimerization. Altogether, DRR1 shifts the actin filament 
structure towards more, shorter, and thicker actin bundles. 
DRR1 was furthermore found to increase the overall F-actin content in HeLa cells, 
resulting in the activation of the transcription factor serum response factor, which is 
dependent on the G-/F-actin equilibrium in the cell. Spreading of HeLa cells was inhibited 
by DRR1’s bundling and capping activities, and bundling appeared to reduce actin 
turnover in cells. In primary hippocampal neurons, ectopic DRR1 was located along 
dendrites with a strong accumulation in dendritic spines and particularly in enlarged spine 
heads. 
The findings in this work support the notion of DRR1 as an intriguingly multifunctional 
player in organizing the actin cytoskeleton at the synapse during stress response. Previous 
behavioral analysis of DRR1 proposed a function in promoting stress resilience, due to the 
improved cognition and sociability upon virus-mediated upregulation of DRR1 in the 
hippocampus and lateral septum, respectively (Masana et al., 2014; Schmidt et al., 2011). 
The results obtained in this study further reinforce this role in stress coping, as the 
molecular effect of DRR1 on actin dynamics is in line with a function in stabilizing mature 
dendritic spines, which are characterized by a branched, crosslinked and capped actin 
meshwork. 
Assuming that the effect of DRR1 on actin dynamics is not only significant for coping 
with chronic stress but also during tumor development and progression, the model of 
DRR1’s molecular mechanism presented in this work could contribute to several 
physiologically relevant processes. Altogether, this study adds to a more comprehensive 
understanding of actin dynamics in response to chronic stress and upon treatment with 
antidepressants. Eventually, this knowledge has the potential to open up novel therapeutic 
targets for psychiatric disorders. 
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1. Introduction 
1.1. Physiological and pathological mechanisms of 
stress 
All organisms face a constant exposure to changing environmental stimuli, while thriving 
towards stable physiological conditions. Therefore, in response to a challenging stressor, an 
adaptive response is initiated in order to return to a physiological equilibrium. The impact 
of stressors depends on their intensity and duration as well as on the vulnerability of 
individuals. In spite of these variations, a common response pattern with characteristic 
alterations in the behavioral, autonomic and neuroendocrine systems exists (Pacák and 
Palkovits, 2001). While the physiological stress response is an important process to 
maintain homeostasis, long-term exposure or trauma can lead to maladaptation and 
pathological consequences like anxiety, depression, schizophrenia or post-traumatic stress 
disorder (de Kloet et al., 2005). 
1.1.1. The HPA axis 
The hypothalamic-pituitary-adrenal (HPA) axis was described for the first time by the 
Canadian endocrinologist Hans Selye as the key effector of the stress response (Selye, 
1936, 1950). In addition to the immediate “fight-or-flight” response to a stressor via the 
autonomic nervous system, the HPA axis provides a slower neuroendocrine system 
facilitating adaptation, while also evoking rapid effects similar to the autonomic system 
(Ulrich-Lai and Herman, 2009). 
The synthesis and secretion of glucocorticoids as the effector hormone of the HPA axis 
involves a complex neuroendocrine cascade. Sensory information induced by an external or 
internal stressor is processed in the limbic structures of the brain, including the amygdala, 
hippocampus and prefrontal cortex. The secretion of corticotropin-releasing hormone 
(CRH) and vasopressin (AVP) from the hypothalamus governs HPA axis activity 
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stimulating production and secretion of adreno-corticotrophic hormone (ACTH) from the 
anterior pituitary gland. ACTH in turn activates secretion of glucocorticoids from the 
adrenal glands (Engelmann et al., 2004). In order to reinstate a homeostatic equilibrium, 
glucocorticoids inhibit the synthesis and release of CRH and ACTH, thus forming a 
negative-feedback loop balancing HPA axis activity (De Kloet and Reul, 1987). 
The effects of glucocorticoids – mainly cortisol in humans and corticosterone in rodents – 
are executed by two intracellular receptors, the glucocorticoid receptor (GR) and the 
mineralocorticoid receptor (MR). While the GR is restricted to neurons of the limbic 
system, the MR is widely expressed throughout neurons and glia in the whole brain and 
exhibits an about 10fold higher affinity to glucocorticoids than the GR (Reul and de 
Kloet, 1985). The MR is thus activated at low levels of stress mediating basal HPA 
activity. In contrast, the GR shows activity during high and prolonged glucocorticoid 
levels and is progressively activated during stress- and circadian-induced boosts (de Kloet 
et al., 1993). Being transcriptional regulators, the MR and the GR impact on numerous 
genes, and only roughly one third of the target genes respond to both receptors (Datson et 
al., 2001). Immediate effects of glucocorticoids implicate energy mobilization by affecting 
cell metabolism and increased arousal and excitability, while slower, gene-mediated effects 
involve suppression of immune function, and changes in synaptic transmission (de Kloet et 
al., 2005). 
1.1.2. Effects of stress on neurons and the brain 
The pathological effects of stress on brain structure and function have been acknowledged 
for more than 30 years, after chronic exposure to high levels of glucocorticoids was shown 
to reduce hippocampal volume and impair cognitive function (Landfield et al., 1981). 
Acute and chronic stress have been shown to evoke dramatic changes in the amygdala, 
prefrontal cortex and the hippocampus (Lupien et al., 2009; Roozendaal et al., 2009; Vyas 
et al., 2002). In addition, changes in neuronal architecture and network dynamics have 
been observed including a reduction of adult neurogenesis, remodeling of dendritic spines 
and a reduction in synapse number in CA3 hippocampal neurons (Fuchs et al., 2006). 
While imaging studies have provided evidence for a reduction in hippocampal volume of 
patients with depression, the exact mechanisms of this (reversible) volume loss remain 
unclear. Neither neuronal loss nor suppression of neurogenesis appear to be decisive, but a 
decrease in dendritic arborization, amount of synapses, and loss of glial cells were proposed 
as cause (Czéh and Lucassen, 2007). A reduction in dendritic spine number was shown 
both upon stress and during depression, supporting the causal role of chronic stress in the 
etiology of affective diseases (Chen et al., 2008; Soetanto et al., 2010). 
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Moreover, structural changes of neurons in response to stress impact on learning and 
memory formation. In particular, dynamics of dendritic spines have been shown to be 
implicated in these processes (Kasai et al., 2010). Acute and mild stress has been shown to 
facilitate memory formation. In contrast, chronic stress exposure or high levels of 
glucocorticoids can severely impair cognitive performance (Reagan et al., 2008). The 
molecular underpinnings linking stress to cognition are just beginning to be understood. 
For example, chronic social defeat stress caused a sustained reduction in the levels of the 
Rho-GTPase Rac1 in the nucleus accumbens (a part of the limbic system) via epigenetic 
repression of the promotor, which resulted in depressive like behavior of mice. Since Rac1 
is implicated in spine formation by impacting on actin dynamics, these findings indicate a 
tight regulatory network from stress, to the actin cytoskeleton and behavior (Golden et 
al., 2013). 
Although vast evidence supports the mechanisms of adaptation and maladaptation to 
stress on the structural and behavioral level, molecular players translating such stressful 
stimuli into changes in synaptic transmission and behavior remain largely unknown.  
1.1.3. Stress as a risk factor for psychiatric disorders 
In the beginning of the 20th century, the German psychiatrist Emil Kraepelin was the first 
to classify affective disorders thereby initiating the modern era of scientific psychiatry. 
Although up to now the etiology of affective disorders including major depression, PTSD, 
anxiety, and bipolar disorder, is not fully understood, a causative role of high and 
prolonged stress has become obvious, particularly in individuals with a history of 
childhood adversity (McLaughlin et al., 2010). Today, strong evidence from correlative 
pre-clinical and clinical studies, genetically modified animals, and pharmacological studies 
analyzing HPA function in affective disorders supports the concept of stress as a risk 
factor for psychiatric disorders in genetically predisposed individuals (Ising and Holsboer, 
2006; de Kloet et al., 2005). 
Malfunctions of the HPA axis during affective disorders have been acknowledged since the 
late 60s after the observation of increased levels of cortisol in patients suffering from 
severe depression (Butler and Besser, 1968). Years later, HPA hyperactivity caused by an 
aberrant negative-feedback loop of the GR and increased CRH activity were found as a 
pathological mechanism underlying depression (Holsboer, 2000; Parker et al., 2003; 
Steckler et al., 1999). In contrast, PTSD patients were characterized by reduced blood 
cortisol levels (Yehuda, 2002).  
Furthermore, genetic polymorphisms causing stress vulnerability have been identified, like 
an allele of the gene FKBP5, which correlated with increased recurrence of depressive 
episodes (Binder et al., 2004). This vulnerability was later associated with allele-specific 
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DNA demethylation in the functional GREs of the FKBP5 promotor, occurring upon 
childhood trauma and programming promotor reactivity to stress later in life (Klengel et 
al., 2013). Further evidence exists showing that pathological alterations in HPA axis 
activity are often induced by early life stress and, particularly, by epigenetic programming 
in response to environmental stressors (Halligan et al., 2007; Lupien et al., 2009; Weaver 
et al., 2004).  
1.2. Actin dynamics and actin binding proteins 
Actin, a 42 kDa big globular protein, is the major cytoskeletal and structural component 
at the synapse. Thus, it has to be rearranged to bring about the structural and functional 
alterations induced by stress surveyed above. In the following, the mechanisms of actin 
rearrangement are briefly reviewed. 
1.2.1. Actin polymerization  
Actin is the smallest fiber of the cellular cytoskeleton, which is composed of intermediate 
filaments, microtubules, and actin microfilaments. It is involved in a high variety of 
cellular functions including scaffolding, motility, cell division, and intracellular trafficking. 
This versatility is facilitated by its highly dynamic structure. 
Actin exists in two states: monomeric, globular (G-)actin and polymeric, filamentous  
(F-)actin. It is an ATPase that tightly binds ATP together with a divalent cation (Mg2+ 
or Ca2+). Under appropriate conditions, spontaneous assembly of actin filaments occurs in 
two phases. The first, energetically unfavorable step consists in the association of three 
ATP-bound actin subunits, a process termed nucleation. In the second step, the filament 
is rapidly elongated by the incorporation of additional actin monomers. Along the 
filament, the bound ATP is hydrolyzed to ADP, eventually causing the dissociation of 
monomers at the opposite end. In this way, the filament length eventually reaches a stable 
equilibrium of elongation and degradation (Pollard, 1986). Thus, actin filaments undergo a 
constant turnover of filaments referred to as treadmilling, in which new monomers are 
added at the barbed or “+” end, and depolymerization happens at the opposite pointed or 
“-“ end (Harris and Higgs, 2006). 
1.2.2. Regulation of actin structures and dynamics 
A plethora of actin binding proteins (ABPs) is involved in the regulation of actin 
polymerization dynamics and higher-order actin structures (Figure 1). Proteins influencing 
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on actin turnover can affect nucleation of G-actin or, by binding to the monomers or 
filament ends promote or prevent assembly and disassembly of F-actin (Figure 1A). 
Nucleation of actin can be initiated either de novo by association of monomers into dimers 
and trimers, or by branching from preexisting filaments. The most widely studied class of 
de novo actin nucleators are the formins, including the diaphanous-related formins mDia 
(Dominguez, 2010). In the resting state, formins are autoinhibited by the interaction 
between their diaphanous autoregulatory domain (DAD) and the N-terminal diaphanous 
inhibitory domain (DID). Upon activation by Rho GTPases, this autoinhibition is 
released, and the formin-homology (FH) domains within the central region are enabled to 
promote de novo nucleation and filament elongation, by remaining bound to the barbed 
end (Pruyne et al., 2002). In contrast, the Arp2/3 complex generates new actin filaments 
by nucleation from existing filaments, thus creating new and free barbed ends for 
elongation (Mullins et al., 1998).  
Elongation is terminated by capping proteins that bind to the barbed ends and inhibit the 
addition of further actin monomers, thereby limiting the length of the filament. In this 
way, they are essential for the regulation of actin turnover (Edwards et al., 2014).  
Disassembly and shortening of older filaments, processes called severing, are performed by 
ADF/cofilin, the most prominent severing protein (Bernstein and Bamburg, 2010). Cofilin 
enhances actin filament turnover by inducing depolymerization and creating new barbed 
ends by releasing actin oligomers (Carlier et al., 1997; Lappalainen and Drubin, 1997).  
At physiological concentration of Mg2+ within the cell in the millimolar range and at 
favorable pH conditions, ATP-actin should spontaneously associate to filaments leaving 
only a small fraction of monomers. Thus, the question arises how the high amount of 
unpolymerized actin is maintained in the cell. This effect can be attributed to another 
class of ABPs, the sequestering proteins. Such a sequestering protein, profilin, binds G-
actin and inhibits nucleation. In addition, it promotes the nucleotide exchange of ADP-
actin to ATP, thereby recycling old actin. Yet, profilin-actin monomers can associate to 
the barbed end, meaning that elongation is not inhibited by profilin (Pollard and Cooper, 
1984). 
Actin filaments can be arranged into higher-order structures like branched meshworks or 
thick actin bundles. Regulation of these structures is crucial for cell morphology and many 
cellular processes. 
Sheet-like membrane protrusions at the leading edge of motile cells are composed of 
Arp2/3-branched actin meshworks (Figure 1B). Upon activation by the Wiskott-Aldrich 
syndrome protein (WASP), Arp2/3 nucleates new filaments by creating branches from 
existing ones at a fixed 70° angle, thus generating the lamellar structure (Higgs et al., 
1999; Mullins et al., 1998). Furthermore, crosslinking proteins like filamin can stabilize 
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such an orthogonal meshwork structure by binding to two filaments (Figure 1C) 
(Nakamura et al., 2011).  
Other crosslinking proteins create tight actin bundles which for example produce finger-
like protrusions in the cell (Figure 1D). Due to the polarity of actin filaments, bundles can 
be either parallel or antiparallel, a parameter which is controlled by the respective 
bundling factor. For example, α-actinin generates both, parallel and anti-parallel actin 
bundles, while fascin generates a parallel organization (Jayo and Parsons, 2010; Sjöblom et 
al., 2008). Crosslinking proteins either feature two actin binding sites or one actin binding 
site and a dimerization region, thereby crosslinking filaments as monomers or dimers, 
respectively. 
 
Figure 1. Overview of actin dynamics and actin binding proteins. (A) Actin 
filaments are polymerized at the barbed (+) end and depolymerized at the pointed (-) end, 
thereby undergoing a constant turnover (treadmilling). This basic polymerization kinetic is 
regulated by a variety of ABPs. Profilin helps to keep a pool of unpolymerized actin within the 
cell by sequestering G-actin, formins promote nucleation, capping proteins inhibit elongation at 
the barbed end, and severing proteins depolymerize and shorten the filaments. (B) A branched 
network of F-actin is created by the Arp2/3 complex by nucleation from preexisting filaments. 
(C) Orthogonal crosslinking of F-actin generates a meshwork structure (e.g. with filamin). (D) 
Bundling of actin filaments is performed by crosslinkers exhibiting either two actin-binding sites 
(e.g. fascin) or one actin-binding site concomitant with dimerization (e.g. α-actinin). 
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1.3. Actin-dependent processes in cells 
1.3.1. Basic cellular functions of actin dynamics 
Many basic cellular processes depend on proper regulation of actin dynamics. These 
include, among others, cell adhesion, morphogenesis, endo-/exocytosis, motility and 
cytokinesis. 
Directional motility is a fundamental process for all organisms, for example during 
development, wound healing, or immune response; but is also used by cancer cells to 
invade neighboring tissue. While microtubules play an important role for cell polarization, 
it is commonly accepted that actin is the driver of cell locomotion (Euteneuer and 
Schliwa, 1984; Pletjushkina et al., 1994). Cell migration relies on three basic actin 
structures: a branched filamentous network termed lamellipodia comprising the sheet-
structure of the leading edge, finger-like filopodial bundles at the plasma membrane, and 
contractile stress fibers in the cytoplasm (Pollard and Borisy, 2003). Actin bundles in 
filopodia are parallel-oriented, while stress fibers contain antiparallel actin fibers bundled 
with myosin (Cramer et al., 1997). Actin polymerization drives forward the leading edge of 
motile cells, and rapid depolymerization is necessary at the rear part of the cell to enable 
retraction and locomotion (Rohatgi et al., 1999; Zigmond, 1993). Lamellipodia at the 
leading edge consist of a highly structured meshwork of short actin filaments with the 
rapidly growing ends pointed towards the membrane. The filaments are branched by 
Arp2/3, are highly crosslinked, and reach a density of above 1000 µm F-actin/µm³ with a 
G-actin concentration of about 8.5 µM (Abraham et al., 1999). In contrast, filopodial 
protrusions are promoted by barbed-end nucleators like formins (Dominguez, 2010). Thus, 
the shape of the protrusion – lamellar or filopodial – is controlled by the balance of 
capping proteins and nucleators (Mejillano et al., 2004).  
Furthermore, coordination of these actin-dependent processes with cycles of adhesion at 
the front and destabilization of adhesion at the rear via formation and disassembly of focal 
adhesions is essential for cell movement (Mitchison and Cramer, 1996). The focal 
adhesions in turn, are anchored to stress fibers and thereby mechanically interlinked with 
the actin machinery (Patla et al., 2010). 
Tumor cells were shown to use the same basic strategies as non-neoplastic cells for 
metastatic migration (Friedl and Wolf, 2003). Meanwhile, a role for actin-bundling 
proteins has been described in cancer metastasis (Stevenson et al., 2012). Mechanical 
stiffness of the cell was inversely correlated with migratory and invasive potential of tumor 
cells, although this does not seem to be a general rule (Narumiya et al., 2009; 
Swaminathan et al., 2011).  
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Interestingly, nuclear shape was shown to be linked to cell shape and cell adhesion via an 
“actin-cap” on top of the nucleus, comprised of actin-myosin bundles. Defects in this actin 
cap were associated with diseases like progeria (accelerated aging), in which the nuclear 
shape is distorted (Khatau et al., 2009). 
During cell division, extensive rearrangements of the actin and microtubule cytoskeleton 
take place. Upon entering mitosis, cells acquire their characteristic round shape. The 
separation of the centrosomes and subsequent spindle assembly is coordinated by actin 
and myosin (Uzbekov et al., 2002). At the end of mitosis, actin forms a contractile ring 
with myosin at the cleavage furrows to direct cytokinesis (Lee et al., 2012; Mabuchi, 
1994). The importance of actin for cell cycle progression became obvious from studies 
using drugs impacting on actin polymerization or by overexpression of ABPs. For 
example, overexpression of the depolymerizing ADF/cofilin resulted in cell cycle arrest in 
G1 for more than 90% of the cells (Lee and Keng, 2005). An excess of F-actin induced by 
treatment with the drug Jasplakinolide, which stabilizes filaments, or overexpression of the 
WASP protein resulting in excessive Arp2/3 activation, generated polynucleated cells, 
suggesting defects in mitosis and cytokinesis (Moulding et al., 2007). 
In neuronal cells, several fundamental aspects are regulated by actin dynamics, including 
proliferation, migration, axonal vesicle trafficking, and synaptic transmission. While the 
majority of migratory events take place during embryonic development, there is still 
migration in the postnatal and even in the mature, adult brain (Ghashghaei et al., 2007). 
The significance of actin in neuronal migration becomes evident by the association of 
mutations in the cytoplasmic β- and γ-actin genes with a neuronal defect causing 
structural brain abnormalities (Rivière et al., 2012). In mature neurons, actin is the most 
prominent cytoskeletal component at the synapse. Its functional significance goes beyond 
merely regulating the morphology of the synapse. The efficacy of synaptic transmission is 
modulated in a use-dependent manner and is believed to be the basis of learning and 
memory (Neves et al., 2008). Actin is a key regulator in both, pre- and post-synaptic 
mechanisms impacting on synaptic transmission (Dillon and Goda, 2005).  
1.3.2. Effects of nuclear actin 
Although during the last decade increasing evidence supports not only the presence, but 
also the crucial role of actin in the nucleus, its exact functional implications are still 
enigmatic. To begin with, controversial findings argue that nuclear actin is exclusively 
monomeric, or exists as filamentous F-actin stretches as well (McDonald et al., 2006; 
Pederson, 2008; Vartiainen et al., 2007). Suggested functions of actin-including complexes 
in the nucleus range from chromatin-remodeling during DNA replication and repair, to 
transcriptional regulation and to structural scaffolding (Castano et al., 2010).  
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DNA transcription was shown to be induced by association of Arp2/3 with 
RNA polymerase II. In a manner similar to its cytoplasmic function, Arp2/3 promotes 
actin assembly upon activation by N-WASP, resulting in increased RNA polymerase II-
dependent transcription (Yoo et al., 2007). In fact, RNA pol II-dependent transcription 
was proposed to be regulated by a general actin-based mechanism during the initial phase, 
mediated by interactions with ribonucleoproteins (Kukalev et al., 2005; Percipalle et al., 
2003).  
Many nuclear hormone receptors are activated or repressed by ABPs. For example, the 
actin bundling protein supervillin acts as the primary coactivator of the androgen receptor 
(Ting et al., 2002). Furthermore, ADF/cofilin was found to inhibit the glucocorticoid 
receptor presumably via its actin severing and depolymerization activity (Rüegg et al., 
2004).  
1.3.3. Signal transduction of actin dynamics 
Reorganization of the actin cytoskeleton is tightly regulated by complex signaling 
pathways in order to accomplish the high variety of cellular functions. Members of the Ras 
superfamily of small GTPases, in particular RhoA, Cdc42, and Rac1, have emerged as key 
players in linking surface receptors to the actin cytoskeleton. They function as molecular 
relay in response to extracellular signals by cycling between their inactive GDP-bound 
state and active GTP-bound state (Hall, 1998). 
Constitutively active and dominant-negative mutants of the Rho GTPases have shed light 
on their effects. RhoA leads to the assembly of stress fibers (i.e. contractile actin-myosin 
filaments) and focal adhesions. While both Rac1 and Cdc42 promote actin polymerization, 
Rac1 leads to the formation of an F-actin meshwork at the cellular edge, generating 
lamellipodia and membrane ruffles; Cdc42 induces finger-like cell surface protrusions called 
filopodia (Burridge and Wennerberg, 2004). 
Various aspects of neuronal development are regulated by Rho GTPases including 
neuronal outgrowth, axonal pathfinding, and dendritic spine formation (Govek et al., 
2005). Formation of neurites depends on Rac1 and Cdc42 activity, concomitant with 
RhoA inactivation (Aoki et al., 2004; Jeon et al., 2011; Sarner et al., 2000). Moreover, 
Rac1 and RhoA play distinct roles during dendrite formation. While RhoA and its effector 
kinase ROCK shape neuronal morphology by inhibiting dendritic pruning, Rac1 activity is 
necessary for the formation of dendritic spines (Nakayama et al., 2000). Cdc42 also 
promotes the complexity of dendrites, although to a lesser extent than Rac1 (Kuhn et al., 
2000; Ruchhoeft et al., 1999). 
Furthermore, actin dynamics is not only regulated by upstream pathways, but also 
impacts on downstream processes, not only by directly affecting RNA pol II-dependent 
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transcription as described above, but also by regulating the activity of the serum response 
factor (SRF). The transcription factor SRF was found to be regulated in response to 
changes in the G-/F-actin equilibrium via its coactivator MAL (also known as MKL-1 or 
MRTF-A), which shuttles from the cytosol to the nucleus (Figure 2). Under normal 
conditions and bound to G-actin, MAL is rapidly exported from the nucleus. Triggered by 
serum-stimulated activation of the GTPase RhoA leading to actin polymerization, 
however, it is released from G-actin and translocated to the nucleus, where it activates 
SRF resulting in the transcription of genes with serum responsive elements (SREs) 
(Posern and Treisman, 2006; Vartiainen et al., 2007). ABPs influencing actin dynamics in 
the cytosol or the nucleus have also been linked to SRF activity. For example, nuclear 
formins were revealed as potent activators of SRF (Baarlink et al., 2013). SRF-responsive 
genes encode regulators of the actin and microtubule cytoskeleton, cell growth and 
motility, adhesion, extracellular matrix synthesis and processing, and transcription 
(Esnault et al., 2014).  
 
Figure 2. The pathway of the serum response factor (SRF). Serum activates the 
small Rho GTPase RhoA, which shifts the G-/F-actin equilibrium towards F-actin. In the 
resting state, the SRF cofactor MAL is inhibited by binding to G-actin. With increasing actin 
polymerization, MAL is released from G-actin and translocated to the nucleus, where it 
activates SRF. SRF activity leads to the transcription of genes with serum responsive elements 
(SREs) in their regulatory regions. 
In neurons, MAL and SRF regulate migration, axonal outgrowth and guidance, dendritic 
branching, spine morphogenesis, and learning behavior (Kalita et al., 2012). MAL is 
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particularly highly expressed in the hippocampus, and to a lesser extend in the olfactory 
bulb, caudate putamen, and cerebral cortex (Shiota et al., 2006). RNAi-mediated 
inhibition of MAL in hippocampal or cortical neurons led to a decrease of neurite length 
and dendritic processes suggesting that SRF control the formation of neural circuits (Knöll 
et al., 2006; Shiota et al., 2006). Evidence from SRF knockout mice showing less dendritic 
spines and learning deficits further supports the idea of the MAL-SRF pathway playing a 
significant role in memory formation (Etkin et al., 2006; Ramanan et al., 2005; Stritt and 
Knöll, 2010). 
1.3.4. Synaptic plasticity, learning and memory 
Actin functions as a key player impacting on synaptic transmission. Actin dynamics 
regulated by a variety of ABPs are crucial in shaping synaptic morphology, but 
furthermore affect neurotransmitter vesicle release and receptor distribution at the post-
synaptic spine, thereby impacting on synaptic transmission (Cingolani and Goda, 2008; 
Dillon and Goda, 2005). 
In presynaptic terminals, actin is implicated in all steps of the synaptic vesicle cycle, 
which includes docking, priming, fusion (leading to neurotransmitter release) and recycling 
(i.e. endocytosis). While it serves as a guide for neurotransmitter vesicles, it might also act 
as a physical barrier for the priming step (Cingolani and Goda, 2008; Lee et al., 2013). 
Mobility of synaptic vesicles was shown to increase upon treatment with actin 
depolymerizing agents (cytochalasin and latrunculin), providing evidence for the dual 
function of actin at the presynapse (Jordan et al., 2005; Shtrahman et al., 2005). The 
release of neurotransmitter is directly affected by alterations in actin dynamics as shown 
by experiments with latrunculin A. Moreover, an increase in paired-pulse facilitation was 
found, supporting an increased release probability of neurotransmitter vesicles upon actin 
depolymerization (Morales et al., 2000). 
At the postsynaptic-site, which is composed of a dendritic spine in most excitatory 
synapses, actin is involved in shape, receptor anchoring and trafficking. It has become 
evident, that synapse morphology is intimately linked with synaptic function: smaller 
spines are less stable, exhibit less neurotransmitter receptors, and consequently show a 
lower synaptic strength (Hotulainen and Hoogenraad, 2010). During long-term 
potentiation (LTP), the G-/F-actin ratio is shifted towards F-actin and the spine volume 
increases, while the opposite was found for long-term depression (LTD) (Fukazawa et al., 
2003; Okamoto et al., 2004). Different shapes of spines have been identified and, being a 
highly dynamic structure, these shapes are not static, but undergo constant turnover and 
remodeling (Bourne and Harris, 2008). Neuronal activity modulates dendritic spine 
maturation from a filopodia-like shape (thin spines), to shorter and thicker spines lacking 
a well-defined neck (stubby spines), and finally to larger spines with a pronounced head 
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and neck structure (mushroom spines) (Calabrese et al., 2006). These findings suggest 
dendritic spine plasticity to be a crucial process of learning and memory (Yuste and 
Bonhoeffer, 2001). Moreover, the glutamate receptors AMPA (α-amino-3-hydroxy-5-
methyl-4-isoxazole-propionic acid receptor) and NMDA (N-Methyl-D-aspartic acid 
receptor) have been shown to disperse from the post-synaptic density upon actin 
depolymerization (Allison et al., 1998). Yet, distinct specialized actin populations appear 
to exist within the dendritic spine, as suggested by many studies (Osterweil et al., 2005; 
Zhou et al., 1994).  
A study using superresolution microscopy and photoactivatable GFP-labeled actin 
revealed distinct sites of actin polymerization at the tip of the spines but also away from 
the synapse to some extent. Within dynamic subregions, a structure comprised of dense F-
actin with heterogeneous distribution was proposed due to slower movement of 
photoactivated GFP-actin. Actin filaments in the neck were often oriented with the 
(growing) barbed end towards the dendritic shaft (Frost et al., 2010). In addition to actin, 
dynamic microtubules have been shown to transiently enter dendritic spines to influence 
on the actin cytoskeleton and spine dynamics (Jaworski et al., 2009). 
Altogether, an active contribution of actin dynamics to synaptic transmission at pre- and 
post-synaptic sites is well recognized. With dendritic spines being a key parameter in 
synaptic transmission, it is not surprising that many stress-dependent psychiatric and 
neurologic diseases – including amongst others schizophrenia, compulsive behavior, autism, 
and Alzheimer’s disease – have been associated with anomalies in spine number and 
morphology (Newey et al., 2005; Spronsen and Hoogenraad, 2010). These findings also 
provide the basis for a central role of actin dynamics during stress response and upon 
maladaptation in affective disorders. 
1.4. Effects of antidepressants on cytoskeletal 
dynamics 
Mood disorders like depression, anxiety or bipolar disorder are a major disability 
worldwide. The discovery of tricyclic antidepressants (TCAs) led to the development of 
the monoamine deficiency hypothesis of depression, stating an imbalance of serotonergic 
and noradrenergic function (Lanni et al., 2009). This hypothesis was strengthened when 
the first selective serotonin reuptake inhibitor (SSRI) – fluoxetine – was developed 
showing a comparable therapeutic outcome with concomitant reduction of side effects 
(Montgomery, 1989).  
Yet, nowadays evidence is accumulating that all classes of antidepressants might affect 
further cellular pathways besides the monoamines resulting in their therapeutic benefit. 
1. INTRODUCTION 
13 
 
While the knowledge about the etiology of mood disorders is expanding, limits of the 
monoamine hypothesis have been identified. Currently available therapies are far from 
being satisfactory: antidepressants are not effective for some patients, the onset of 
therapeutic benefits can take up four to six weeks and there are still major side effect 
(Chang and Fava, 2010). 
Another proposed model is the “disturbed cytoskeletal theory” of mood disorders. Nakatani 
et al. analyzed gene expression of mice either vulnerable or resilient to depression-like 
behavior and found that an altered balance towards actin depolymerization might 
contribute to the disease. They identified a reduction in Cap1, an important mediator of 
rapid actin turnover, as a quantitative trait in mice vulnerable to depression as well as a 
trend to its reduction in postmortem brains of bipolar patients. Other regulated actin-
related proteins in the vulnerable animal model included cofilin1 and profilin1 
(upregulated) and the Rho family GTPase member Pak1 (downregulated) (Nakatani et 
al., 2007).  
Moreover, several antidepressants have been shown to impact on cytoskeletal-dependent 
processes. The TCA desipramine enhanced mictrotubule assembly via upregulation of 
MAP-4 in chronically stressed mice, while fluoxetine upregulated Drebrin A, an actin-
associated protein promoting neuronal growth (Yang et al., 2003). Amitriptyline, another 
TCA, reduced neurite outgrowth in chick cerebral neurons by reducing the activity of 
adenylate cyclase and therefore cAMP levels, which promotes outgrowth (Wong et al., 
1991). A proteomic analysis of prefrontal cortex and hippocampus of a rat model of 
depression-like behavior revealed escitalopram and nortryptiline to affect actin-related 
proteins and actin itself in the depression-like behavior sensitive rat line (Piubelli et al., 
2011a, 2011b). 
1.5. The stress-induced protein DRR1 
1.5.1. Identification of a novel, stress-induced protein 
A microarray study of the neonatal mouse brain on genes induced upon maternal 
separation identified downregulated in renal cell carcinoma gene 1 (DRR1) as one of the 
most strongly upregulated genes (Liebl et al., 2009). Maternal separation is a robust 
stressor resulting in profound activation of the HPA axis and is being used as a model of 
early trauma (Levine, 2001). In the PVN and the CA3 hippocampal region, DRR1 levels 
were also increased by 24 h of food deprivation in adult mice. The highest mRNA 
expression of DRR1 in response to stress was found in the hypothalamic paraventricular 
nucleus (PVN) and the CA3 region of the hippocampus. Basal levels were highest in the 
septum, the neocortex, the CA3 region of the hippocampus, and the cerebellum. DRR1’s 
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upregulation was moreover shown to be dependent on the GR, as it was induced in 
response to the synthetic GR agonist dexamethasone and this induction was blocked by 
treatment with the GR antagonist RU486. Three conserved glucocorticoid responsive 
elements (GREs) were identified in the gene regulatory regions of DRR1, although an 
indirect effect mediated by other transcription factors could not be excluded (Schmidt et 
al., 2011). The stress-induction of DRR1 was recently validated by a proteomic study 
measuring gene expression in mice in response to acute stress, where DRR1 was 
significantly upregulated in the prefrontal cortex (Stankiewicz et al., 2014). 
Previously, DRR1 was described as a potential tumor suppressor gene, as it was found to 
be downregulated in renal cell carcinoma and various cancer cell lines including renal cell, 
ovarian, cervical, gastric, prostate, and non-small cell lung cancer (Kholodnyuk et al., 
2006; Liu et al., 2009; Vanaja et al., 2006; Wang et al., 2000; Yamato et al., 1999). 
Furthermore, it was downregulated with progression of neuroblastoma, meningioma and 
malignant glioma. It was expressed at lower levels in malignant gliomas (WHO grade IV), 
than in diffuse astrocytomas (grade II) (Asano et al., 2010; van den Boom et al., 2006; 
Fèvre-Montange, 2009). Awakura et al. described promotor hypermethylation as the 
silencing mechanism in cancer, indicating that its function might be under epigenetic 
control (Awakura et al., 2008). However, DRR1 was also suggested as a tumor invasive 
factor in human glioma due to its increasing expression with malignant astrocytoma 
progression (Le et al., 2010). Moreover, the analysis of shared gene expression patterns in 
bipolar disorder and schizophrenia provided evidence for a strong increase of DRR1 in 
dorsolateral prefrontal cortex of patients suffering from either of the diseases, presumably 
indicating an aberrant adaptation to chronic stress (Shao and Vawter, 2008). 
Interestingly, DRR1 was also proposed as a candidate biomarker in ulcerative colitis for 
differential diagnosis with Crohn’s disease (Lin et al., 2014). 
The protein consists of 144 amino acids (in mammals) and is strongly conserved across 
most species, including mammals, Xenopus, fish, and Drosophila (Nakajima and Koizumi, 
2014; Zhao et al., 2007). DRR1 is also referred to as family of sequence similarity 107 
member A (FAM107A) or Tohoku University cDNA clone A on chromosome 3 (TU3A). 
Fam107B is the unique paralog of DRR1 consisting of 131 amino acids (in mammals). The 
sequences of FAM107A and B are highly conserved, except for the 15 N-terminal amino 
acids of FAM107A (Masana et al., 2015). Due to its induction in response to 
hyperthermia, FAM107B is also termed heat-shock-inducible tumor small protein (HITS). 
Although it shares GREs with DRR1, it is not stress-inducible in the adult mouse, but it 
has been proposed to exert a tumor suppressive function as well (Nakajima et al., 2010, 
2012). Basal expression of DRR1 in adult mice is highest in limbic areas of the brain, 
while FAM107B expression was predominantly found in the forming telencephalon during 
embryogenesis and neurogenic niches like the dentate gyrus (Masana et al., 2015; Schmidt 
et al., 2011; Su et al., 2004). 
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DRR1 was found to strongly colocalize with F-actin structures in the cell like membrane 
ruffles, filopodia and stress fibers (Schmidt et al., 2011; Wang et al., 2000). Its direct 
interaction with F-actin was confirmed in F-actin co-sedimentation assays with purified 
proteins. Additionally, it was suggested to stabilize F-actin by crosslinking filaments into 
bundles (Schmidt et al., 2011). With its molecular and cellular function being not yet fully 
unraveled, considering its interaction partners provides interesting insights into its 
potential impact during stress. 
1.5.2. Interaction partners of DRR1 
In addition to β-actin, Schmidt et al. identified peroxiredoxin 1 (Prdx1) and protein 
arginine methyltransferase 5 (Prmt5) as direct or indirect interaction partners of DRR1 
via co-immunoprecipitation and mass spectrometry (Schmidt et al., 2011). Moreover, 
DRR1 was suggested to act as a bridge between actin and microtubule cytoskeletal 
components, by binding to the microtubule-associated protein 1A (MAP1A) and to have 
an impact on gene transcription via the transcription factor Tada2α (Frijters et al., 2010; 
Le et al., 2010). A short summary of the interactors’ functions are provided in the 
following. 
Peroxiredoxins protect thiols against oxidation and have been proposed as important 
players in the peroxide detoxification of the cell due to their high abundance (Wood et al., 
2003). This mechanism is of relevance in removing peroxides produced at basal levels as 
normal cell metabolites, but furthermore to avoid damage of cellular components by H2O2 
transiently produced as intracellular messenger. Increasing evidence supports the notion of 
H2O2 as a relevant intracellular messenger modifying protein function through oxidation of 
crucial cysteines, for example of protein tyrosine phosphatases (Sies, 2014).  
The second interactor of DRR1, Prmt5, mediates methylation of a variety of proteins 
including histones, many RNA-binding proteins, signal transducers, DNA-binding 
transcriptional regulators, and transcriptional coregulators (Lee and Stallcup, 2009). 
Although protein phosphorylation is likely to be the most studied post-translational 
modification, protein methylation is also quite relevant, as about 2% of the nuclear 
proteins are methylated (Boffa et al., 1977).  
Le et al. identified the light chain 2 (LC2) subunit of MAP1A as a candidate DRR1-
binding protein. This interaction is presumably relevant for the disassembly of focal 
adhesions and malignant glioma invasion (Le et al., 2010). MAP1-family members bind 
along and stabilize the microtubule lattice (Halpain and Dehmelt, 2006). They exhibit a 
temporal and regional expression pattern in the nervous system, with MAP1A 
preferentially localizing to dendrites and post-synaptic densities in adult neurons, 
indicating that the interaction with DRR1 might be significant mature neurons 
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(Schoenfeld et al., 1989). Interestingly, MAP1A was identified as an interaction partner of 
DISC-1, a candidate gene for schizophrenia and bipolar disorder, suggesting a potential 
relationship between DRR1 and DISC-1 in addition to the described increase of DRR1 in 
schizophrenia patients (Morris et al., 2003; Shao and Vawter, 2008). 
A further study suggested the transcription factor Tada2α as an interaction partner of 
DRR1. Being a core protein of the histone acetyltransferase complex, this interaction 
suggests an involvement of DRR1 in epigenetic gene regulation (Frijters et al., 2010). 
1.5.3. Cellular effects of DRR1 
As mentioned above, DRR1 was suggested as a promotor of tumor invasion, as it 
significantly enhanced the invasiveness of the U251 glioma cell line. This effect was 
attributed to its ability to bind to F-actin and the LC2 chain of MAP1A, thereby 
promoting the disassembly of focal adhesions. While RNAi-mediated downregulation of 
DRR1 yielded round-shaped glioma cells, DRR1 overexpression altered cell morphology 
towards an elongated spindle shape promoting motility (Le et al., 2010). Meanwhile, an 
apparent increase in F-actin correlating with DRR1 expression level was also described 
(Schmidt et al., 2011). 
DRR1’s novel mechanism of tumor invasion was attributed to its recruitment of the kinase 
AKT to focal adhesions. Dependent on adhesion and the activity of SRC-family kinases, it 
increases phosphorylation of AKT (at both phosphorylation sites T308 and S473) leading 
to its activation and thereby promoting downstream effectors of AKT involved in cell 
proliferation, survival, metabolism, and invasion (Dudley et al., 2013). 
1.5.4. Effects of DRR1 on neuronal cells 
DRR1 is highly expressed during embryogenesis in the brain the spinal cord. In particular, 
its expression was found in the axonal projections of central and peripheral neural cells of 
mice during embryonic day E10.5 to 16.5. There, it was proposed to promote cell survival, 
as an RNAi-mediated knock down of DRR1 caused cell death in comparison to the control 
RNAi (Asano et al., 2010). 
Moreover, in 3-4 weeks old primary rat hippocampal neurons, endogenous DRR1 was 
visualized as a punctuate pattern along the neurites. Neurite outgrowth was inhibited with 
heterologous expression of DRR1 in hippocampal neurons and the Neuro2a cell line, but it 
did not affect already developed neurites. Staining signals overlapping with synaptophysin 
and synapsin indicated localization to the pre-synaptic site, while it was also partially 
found at post-synaptic boutons. Stable virus-mediated increase of DRR1 in mice 
hippocampi indicated a reduction of spine density on apical dendrites. Interestingly, it 
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affected efficacy of synaptic transmission by increasing paired-pulse facilitation but 
reducing LTP magnitude (Schmidt et al., 2011). 
1.5.5. DRR1 shapes cognition and social behavior 
Upregulation of DRR1 using adeno-associated virus in the CA3 region of the hippocampus 
had no negative impact on normal locomotor activity of mice in homecage or open field. 
With a virus-mediated increase similar to the one observed by stress, DRR1 enhanced 
hippocampal-dependent memory in a Y-maze and the object relocation test, and cognitive 
flexibility in the reversal learning task (Schmidt et al., 2011). 
To assess regional specificity of the behavioral effect of increased DRR1, it was 
overexpressed in the lateral septum, again using an adeno-associated virus. DRR1 was 
expressed in neurons and astrocytes of the lateral septum, it increased social behavior of 
the mice but did not impact on cognitive, anxiety-like or anhedonic behavior. These 
findings support the idea of DRR1 as a protective buffer counterbalancing aversive stress 
effects on social behavior (Masana et al., 2014). It is likely that timing and degree of 
DRR1 upregulation upon stress are crucial, but maladaptive consequences, e.g. due to 
long-term stress exposure, cannot be excluded. 
1.6. Objective 
The link between stress and actin dynamics appears to be a critical component of the 
general adaptation mechanism (Masana et al., 2014; Schmidt et al., 2011). However, up to 
now, a profound mechanistic understanding of the pathway from stress to neuronal 
reorganization and cognitive performance remains elusive. Assuming that the mechanism 
of DRR1 is not only relevant for coping with stress but also during tumor development 
and progression, elucidating DRR1’s mechanism of action could contribute to several 
physiologically relevant processes. For the present work, the aim was to dissect the 
molecular mechanism of DRR1 and its significance in actin-dependent cell function. As a 
second approach the effects of certain antidepressants on actin dynamics were to be 
analyzed. 
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2. Material 
2.1. Consumable supplies 
NAME MANUFACTURER 
Cell culture dishes, multi-well plates TPP (Trasadingen, Switzerland) 
Cell scrapers sterile Peske (Aindlingen-Arnhofen) 
Centrifugation tubes 50 mL, 15 mL  TPP (Trasadingen, Switzerland) 
Centrifugation tubes for the UZ  Beckman (Krefeld) 
Coverslips  Carl Roth (Karlsruhe) 
Cryotubes 2 mL TPP (Trasadingen, Switzerland) 
Electroporation cuvettes Bio-Rad Laboratories (München) 
Eppendorf reaction tubes 1.5 mL, 2 mL  TPP (Trasadingen, Switzerland) 
Eppendorf reaction tubes 1.5 mL, low-binding Eppendorf (Wesseling-Berzdorf) 
Eppendorf reaction tubes 1.5 mL, safe-lock  Eppendorf (Wesseling-Berzdorf) 
Filter paper 3 MM Whatman  Carl Roth (Karlsruhe) 
Folded filter Carl Roth (Karlsruhe) 
Glass slides  Carl Roth (Karlsruhe) 
Luminometer plate 96 well (white) Nalgene Nunc International (USA) 
Nitrocellulose membrane  GE Healthcare (Freiburg) 
Pasteur pipettes 230 mm Carl Roth (Karlsruhe) 
Petri dishes unsterile TPP (Trasadingen, Switzerland) 
Pipette Stripette 1, 5, 10, 25 mL Corning Inc. (Acton, USA) 
Pipette tips 0.5-10 µL, 5-200 µL, 100-1000 µL Corning Inc. (Acton, USA) 
Plastic supplies for tissue culture  TPP (Trasadingen, Switzerland) 
Serological pipettes 2, 5, 10, 25 mL Peske (Aindlingen-Arnhofen) 
Sterile filter units Nalgene Nunc International (USA) 
Vivaspin 20 filter columns (30 kDa MWCO)  GE Healthcare (Freiburg) 
Table 1. List of consumable supplies. 
2. MATERIAL 
19 
 
2.2. Chemicals 
NAME MANUFACTURER 
3-(N-morpholino)propanesulfonic acid (MOPS) Carl Roth (Karlsruhe) 
Acetic acid (CH3COOH) Sigma-Aldrich (St. Louis, USA) 
Acrylamide/Bis Solution, 37.5:1 (30% w/v) Serva (Heidelberg) 
Adenosine 5‘-triphosphate (ATP) Sigma-Aldrich (St. Louis, USA) 
Agar agar Carl Roth (Karlsruhe) 
Agarose Biozym (Oldenburg) 
Ammonium sulfate Carl Roth (Karlsruhe) 
Ammonium persulfate (APS)  Carl Roth (Karlsruhe) 
Ampicillin Sigma-Aldrich (St. Louis, USA) 
AMPUWA ddH2O Fresenius Kabi (Bad Homburg) 
BES Carl Roth (Karlsruhe) 
Boric acid Sigma-Aldrich (St. Louis, USA) 
Bovine Serum Albumin (BSA)  Sigma-Aldrich (St. Louis, USA) 
Brilliant blue G Sigma-Aldrich (St. Louis, USA) 
Bromophenol blue  Sigma-Aldrich (St. Louis, USA) 
Calcium chloride (CaCl2 · 2 H2O) Carl Roth (Karlsruhe) 
Casein Carl Roth (Karlsruhe) 
Chloroform (CHCl3) Sigma-Aldrich (St. Louis, USA) 
Citalopram hydrobromide Sigma-Aldrich (St. Louis, USA) 
Clomipramine hydrochloride Sigma-Aldrich (St. Louis, USA) 
Coomassie Brillant Blue G  Sigma-Aldrich (St. Louis, USA) 
Crosslinker DSS, DSG, BMB Thermo Fisher (Rockford, USA) 
Cytochalasin D (Cyto D) Sigma-Aldrich (St. Louis, USA) 
DAPI (4’,6-diamidino-2-phenylindole)  Sigma-Aldrich (St. Louis, USA) 
Deoxynucleotide triphosphates (dNTPs)  Peqlab (Erlangen) 
Dipotassium phosphate (K2HPO4 · 3 H2O) Carl Roth (Karlsruhe) 
Disodium phosphate (Na2HPO4) Carl Roth (Karlsruhe) 
DMSO (dimethyl sulfoxide)  Sigma-Aldrich (St. Louis, USA) 
Doxepin hydrochloride Sigma-Aldrich (St. Louis, USA) 
DTT (1,4-Dithiothreitol)  Carl Roth (Karlsruhe) 
Ethanol absolute p.a. Sigma-Aldrich (St. Louis, USA) 
Ethidium bromide Sigma-Aldrich (St. Louis, USA) 
Ethylene glycol tetraacetic acid (EGTA) Carl Roth (Karlsruhe) 
Fibronectin (bovine) Merck Millipore (Darmstadt) 
Gelatin Sigma-Aldrich (St. Louis, USA) 
Glucose Carl Roth (Karlsruhe) 
Glycerol Merck Millipore (Darmstadt) 
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Glycin Sigma-Aldrich (St. Louis, USA) 
Hydrochloric acid (HCl) Merck Millipore (Darmstadt) 
IGEPAL Sigma-Aldrich (St. Louis, USA) 
Isopropyl alcohol Sigma-Aldrich (St. Louis, USA) 
Isopropyl-β-D-1-thiogalactopyranoside (IPTG)  Peqlab (Erlangen) 
Laminin Sigma-Aldrich (St. Louis, USA) 
Magnesium chloride (MgCl2) Carl Roth (Karlsruhe) 
Magnesium sulfate (MgSO4) Merck Millipore (Darmstadt) 
Maltose Carl Roth (Karlsruhe) 
Manganese(II) chloride (MnCl2 · 4 H2O) Carl Roth (Karlsruhe) 
Methanol Sigma-Aldrich (St. Louis, USA) 
Milk powder Carl Roth (Karlsruhe) 
Paraformaldehyde (PFA) Carl Roth (Karlsruhe) 
Phalloidin Alexa Fluor 488 Life Technologies (Frankfurt) 
Phalloidin Alexa Fluor 546 Life Technologies (Frankfurt) 
Phosphoric Acid, 85% Sigma-Aldrich (St. Louis, USA) 
PMSF (Phenylmethylsulfonyl fluoride) Sigma-Aldrich (St. Louis, USA) 
Poly-D-lysine  Sigma-Aldrich (St. Louis, USA) 
Potassium acetate (CH3COOH) Carl Roth (Karlsruhe) 
Potassium chloride (KCl) Carl Roth (Karlsruhe) 
Potassium hydroxide (KOH) Carl Roth (Karlsruhe) 
Ribonuclease A Sigma-Aldrich (St. Louis, USA) 
Rubidium dichloride (RbCl2) Carl Roth (Karlsruhe) 
Sodium chloride (NaCl) Carl Roth (Karlsruhe) 
Sodium dodecyl sulfate (SDS)  Fluka (USA) 
Sodium hydroxide (NaOH) Merck Millipore (Darmstadt) 
Sucrose Carl Roth (Karlsruhe) 
TEMED (Tetramethylethylenediamine)  Carl Roth (Karlsruhe) 
Tris-(hydroxymethyl)-aminomethane (Tris)  Riedel-de Haen (Seelze) 
Triton X-100  Carl Roth (Karlsruhe) 
Tween 20  Sigma-Aldrich (St. Louis, USA) 
β-Mercaptoethanol Sigma-Aldrich (St. Louis, USA) 
Table 2. List of chemicals. 
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2.3. Solutions and media 
NAME MANUFACTURER 
Antibiotic-Antimycotic (100x) Life Technologies (Frankfurt) 
B-27 Supplement (50x) serum free Life Technologies (Frankfurt) 
Dulbecco´s Modified Eagle Medium (DMEM),  
High Glucose w/o Phenol red 
Life Technologies (Frankfurt) 
Fetal bovine serum (FBS)  Life Technologies (Frankfurt) 
GlutaMAX Supplement Life Technologies (Frankfurt) 
HBSS Life Technologies (Frankfurt) 
HEPES (1M) Life Technologies (Frankfurt) 
LB broth Sigma-Aldrich (St. Louis, USA) 
Neurobasal A-Medium Life Technologies (Frankfurt) 
PBS (10x) Life Technologies (Frankfurt) 
S.O.C. Medium  Life Technologies (Frankfurt) 
Sodium pyruvate solution (100x) Life Technologies (Frankfurt) 
Trypan blue Carl Roth (Karlsruhe) 
Trypsin-EDTA Solution (10x)  Life Technologies (Frankfurt) 
Table 3. List of solutions and media. 
2.4. Kits and ready-to-use materials 
NAME MANUFACTURER 
Albumin Standard Thermo Scientific (Rockford, USA) 
BCA Protein Assay Thermo Scientific (Rockford, USA) 
β-actin Cytoskeleton, Inc. (Denver, USA) 
BSA (100x) for restriction of DNA NEB (Frankfurt) 
Dynabeads Protein G Life Technologies (Frankfurt) 
EndoFree Plasmid Maxi Kit Qiagen (Hilden) 
EZ-PCR Mycoplasma Test Kit Biological Industries (Frankfurt) 
GeneArt Site-Directed Mutagenesis System Life Technologies (Frankfurt) 
GFP-Trap (with agarose beads) Chromotek (München) 
Immobilon Western Chemiluminescent HRP 
Substrate 
Merck Millipore (Darmstadt) 
Lipofectamine 2000 Life Technologies (Frankfurt) 
NEBuffers 1-4 for restriction of DNA NEB (Frankfurt) 
NucleoBond AX100 Columns Macherey-Nagel (Düren) 
peqGOLD DNA ladder mix Peqlab (Erlangen) 
peqGOLD Prestained Protein-Marker IV  Peqlab (Erlangen) 
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ProLong Gold Antifade Life Technologies (Frankfurt) 
Protease inhibitor cocktail (PI) containing 
2 mM AEBSF, 0.3 µM Aprotinin, 
130 µM Bestatin, 14 mM E-64, 1 mM Leupeptin, 
and 1 mM EDTA 
Sigma-Aldrich (St. Louis, USA) 
QIAquick Gel Extraction Kit  Qiagen (Hilden) 
TurboFect Transfection Reagent Thermo Scientific (Rockford, USA) 
Table 4. List of kits and ready-to-use materials. 
2.5. Enzymes 
2.5.1. Restriction endonucleases 
All restriction endonucleases were purchased from NEB (Frankfurt). 
2.5.2. DNA polymerases and ligases 
Herculase II Fusion DNA Polymerase 
(and 5x buffer and DMSO)  
Agilent Technologies (Santa Clara, 
USA) 
Pwo Polymerase 
(and 10x buffer)  
Peqlab (Erlangen) 
T4-DNA Ligase 
(and 10x buffer)  
NEB (Frankfurt) 
Taq DNA Polymerase 
(and 10x buffer and MgCl2)  
Life Technologies (Frankfurt) 
2.6. Antibodies 
2.6.1. Primary antibodies 
NAME HOST MANUFACTURER 
anti –Prx1 (N-19) goat Santa Cruz Biotech. (Heidelberg) 
anti-acetyl-Histone H4 rabbit Upstate (Schwalbach) 
anti-Synaptophysin mouse Cell Signaling (Frankfurt) 
anti-Actin (I-19) goat Santa Cruz Biotech. (Heidelberg) 
anti-AKT rabbit Cell Signaling (Frankfurt) 
anti-DRR1 rabbit Biogenes (Berlin) 
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anti-FLAG-M2-HRP mouse Sigma-Aldrich (St. Louis, USA) 
anti-GFP (B-2) mouse Santa Cruz Biotech. (Heidelberg) 
anti-Histone Core sheep Abcam (Cambridge, UK) 
anti-MBP-HRP mouse NEB (Frankfurt) 
anti-Prmt5 mouse Santa Cruz Biotech. (Heidelberg) 
anti-PSD95 mouse Thermo Scientific (Rockford, USA) 
Table 5. List of primary antibodies. 
2.6.2. Secondary antibodies 
NAME HOST MANUFACTURER 
anti-goat Alexa Fluor 488 donkey Life Technologies (Frankfurt) 
anti-goat Alexa Fluor 594 donkey Life Technologies (Frankfurt) 
anti-goat HRP donkey Santa Cruz Biotech. (Heidelberg) 
anti-mouse Alexa Fluor 488 donkey Life Technologies (Frankfurt) 
anti-mouse Alexa Fluor 546 goat Life Technologies (Frankfurt) 
anti-mouse HRP goat Cell Signaling (Frankfurt) 
anti-rabbit Alexa Fluor 488 goat Life Technologies (Frankfurt) 
anti-rabbit Alexa Fluor 488 donkey Life Technologies (Frankfurt) 
anti-rabbit Alexa Fluor 647 goat  Life Technologies (Frankfurt) 
anti-rabbit HRP goat Cell Signaling (Frankfurt) 
anti-sheep HRP rabbit Santa Cruz Biotech. (Heidelberg) 
Table 6. List of secondary antibodies. 
2.7. Bacterial clades 
CLADE GENOTYPE 
E. coli BL21(DE3)pLysS B F- dcm ompT hsdS(r B-;m B-) galß(DE3)[pLysS Cam`] 
E. coli DH5α F-Ф80LacZΔM15Δ(lacZYA-argF)U169 deoR recA1 endA1 
hsdR17 (r k-;m r+) phoA supE44 thi-1gyrA96relA1 
Table 7. List of bacterial clades. 
2.8. Cell lines 
NAME CELL TYPE ATCC CATALOG # 
HEK-293 human kidney cells CRL-1573 
HeLa human cervix carcinoma cells CCL-2 
Table 8. List of cell lines. 
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2.9. Oligonucleotides 
NAME SEQUENCE (5’ – 3’) APPLICATION 
3‘-HindIII-DRR1m GGC AGA AGC TTG ATG GAG GGA GCT 
CTA CAG 
Cloning 
3‘-HindIII-DRR1m-
FLAG 
GCA GAA GCT TGC TCA CTT GTC ATC 
GTC GTC CTT GTA GTC CAG TGC TCT 
TTC CTC GCT GGT 
Cloning 
5’-XhoI-DRR1m TGC CTC CTC GAG CCT CCA TGT ACT 
CAG AGA 
Cloning 
C94A-F GCC AAG CGG ATG CAG GCC CCC TTC 
AAG CAG GAG 
Cloning 
C94A-R CTC CTG CTT GAA GGG GGC CTG CAT 
CCG CTT GGC 
Cloning 
C94S-F GCC AAG CGG ATG CAG AGC CCC TTC 
AAG CAG G 
Cloning 
C94S-R CCT GCT TGA AGG GGC TCT GCA TCC 
GCT TGG C 
Cloning 
dN2-XhoI-16_F CAT CCT CGA GAC ATG GCC AGA CCA 
GAG TAC 
Cloning 
DRR1m-∆M-fw AGG GGC TTG GGT ATG GAC AGC CCC 
TTC AAG CAG GAG CTG CT 
Cloning 
DRR1m-∆M-rv AGC AGC TCC TGC TTG AAG GGG CTG 
TCC ATA CCC AAG CCC CT 
Cloning 
DRR1m-HindIII-112-
rev 
ATA GAA GCT TCA TCA GTT TTC CAG 
CTG GTT CAG TC 
Cloning 
DRR1m-HindIII-
FLAG-112-rev 
ATA GAA GCT TGC TCA CTT GTC ATC 
GTC GTC CTT GTA GTC GTT TTC CAG 
CTG GTT CAG TC 
Cloning 
DRR1m-XhoI-61-fw TGA TCT CGA GGT ATG GAC AGC AAG 
CCT GAG 
Cloning 
L15M-F ATC GAG GGA ATG ATG GCC AGA CCA 
GAG TAC AG 
Cloning 
L15M-R TCT GGC CAT CAT TCC CTC GAT GTC 
AGC CCG CTC 
Cloning 
M13 TGT AAA ACG ACG GCC AG Sequencing 
N-HindIII-60_R CTA TAA GCT TGC CTA ACC CAA GCC 
CCT TTT G 
Cloning 
P19L-F CTC ATG GCC AGA CTA GAG TAC AGA 
GAG TGG AAC 
Cloning 
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P19L-R CTC TCT GTA CTC TAG TCT GGC CAT 
GAG TCC CTC 
Cloning 
PE122AA-F AGA GAC GAG GAC CAC GCC GCC GCC 
TTC ATC AAA GTC CGG GAA 
Cloning 
PE122AA-R TTC CCG GAC TTT GAT GAA GGC GGC 
GGC GTG GTC CTC GTC TCT 
Cloning 
PE65AA-F TTG GGT ATG GAC AGC AAG GCC GCC 
CTG CAG CGA GTT CTA GAG 
Cloning 
PE65AA-R CTC TAG AAC TCG CTG CAG GGC GGC 
CTT GCT GTC CAT ACC CAA 
Cloning 
pRK5SV40.1 CTA TAG AAT AAC ATC CAC Sequencing 
Table 9. List of oligonucleotides. 
2.10. Plasmids 
NAME FEATURES SOURCE VECTOR 
pMAL-cR1 Cloning vector for protein expression in 
prokaryotic cells with N-terminal MBP-
Fusion. 
NEB (Frankfurt) pMAL-cR1 
pRK5-SV40-Pur-MCS 
(pRK5) 
Cloning vector for protein expression in 
mammalian cells. 
Plasmid obtained from G. 
Wochnik 
pRK5 
pEGFP-C1 Cloning vector for protein expression with N-
terminal EGFP in mammalian cells. 
Clontech (Saint-Germain-en-
Laye, France) 
pEGFP-C1 
pMAL-DRR1 Recombinant protein expression of DRR1 in 
E.coli with N-terminal MBP. 
Plasmid obtained from J. 
Schülke 
pMAL-cR1 
pMAL-N Recombinant protein expression of DRR1-N 
in E.coli with N-terminal MBP. 
Subcloned from pRK5-N with 
XhoI and HindIII 
pMAL-cR1 
pMAL-dN2 Recombinant protein expression of DRR1-
ΔN2 in E.coli with N-terminal MBP. 
Subcloned from pRK5-ΔN2 
with XhoI and HindIII 
pMAL-cR1 
pMAL-dN Recombinant protein expression of DRR1-ΔN 
in E.coli with N-terminal MBP. 
Subcloned from pRK5-ΔN 
with XhoI and HindIII 
pMAL-cR1 
pMAL-dC Recombinant protein expression of DRR1-ΔC 
in E.coli with N-terminal MBP. 
Subcloned from pRK5-ΔC 
with XhoI and HindIII 
pMAL-cR1 
pMAL-dM Recombinant protein expression of DRR1- 
ΔM in E.coli with N-terminal MBP. 
Subcloned from pRK5-ΔM 
with XhoI and HindIII 
pMAL-cR1 
pMAL-M Recombinant protein expression of DRR1-M 
in E.coli with N-terminal MBP. 
Subcloned from pRK5-M with 
XhoI and HindIII 
pMAL-cR1 
pMAL-C94A Recombinant protein expression of DRR1-
C94A in E.coli with N-terminal MBP. 
Cloned with Site-Directed 
Mutagenesis 
pMAL-cR1 
pMAL-C94S Recombinant protein expression of DRR1-
C94S in E.coli with N-terminal MBP. 
Cloned with Site-Directed 
Mutagenesis 
pMAL-cR1 
pMAL-dPEPE Recombinant protein expression of DRR1-
PEPE in E.coli with N-terminal MBP. 
Subcloned from pRK5-PEPE 
with XhoI and HindIII 
pMAL-cR1 
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pMAL-L15M Recombinant protein expression of DRR1-
L15M in E.coli with N-terminal MBP. 
Subcloned from pRK5-L15M 
with XhoI and HindIII 
pMAL-cR1 
pMAL-P19L Recombinant protein expression of DRR1-
L15M in E.coli with N-terminal MBP. 
Subcloned from pRK5-P19L 
with XhoI and HindIII 
pMAL-cR1 
pRK5-DRR1 Expression of murine DRR1 in mammalian 
cells. 
Plasmid obtained from J. 
Schülke 
pRK5 
pRK5-DRR1-F Expression of murine DRR1-FLAG in 
mammalian cells. 
Plasmid obtained from J. 
Schülke 
pRK5 
pRK5-N Expression of murine DRR1-N in mammalian 
cells. 
Cloned with PCR and 
mutation primers 
pRK5 
pRK5-dN2 Expression of murine DRR1-ΔN2 in 
mammalian cells. 
Cloned with PCR and 
mutation primers 
pRK5 
pRK5-dN Expression of murine DRR1-ΔN in 
mammalian cells. 
Cloned with PCR and 
mutation primers 
pRK5 
pRK5-dN-F Expression of murine DRR1-ΔN-FLAG in 
mammalian cells. 
Cloned with PCR and 
mutation primers 
pRK5 
pRK5-dC Expression of murine DRR1-ΔC in 
mammalian cells. 
Cloned with PCR and 
mutation primers 
pRK5 
pRK5-dC-F Expression of murine DRR1-ΔC-FLAG in 
mammalian cells. 
Cloned with PCR and 
mutation primers 
pRK5 
pRK5-dM Expression of murine DRR1-ΔM in 
mammalian cells. 
Cloned with PCR and 
mutation primers 
pRK5 
pRK5-dM-F Expression of murine DRR1-ΔM-FLAG in 
mammalian cells. 
Cloned with PCR and 
mutation primers 
pRK5 
pRK5-M Expression of murine DRR1-M in mammalian 
cells. 
Cloned with PCR and 
mutation primers 
pRK5 
pRK5-M-F Expression of murine DRR1-M-FLAG in 
mammalian cells. 
Cloned with PCR and 
mutation primers 
pRK5 
pRK5-C94A Expression of murine DRR1-C94A in 
mammalian cells 
Subcloned from pRK5-C94A 
with XhoI and HindIII 
pRK5 
pRK5-C94A-F Expression of murine DRR1-C94A-FLAG in 
mammalian cells 
Subcloned from pRK5-C94A 
with XhoI and HindIII 
pRK5 
pRK5-C94S Expression of murine DRR1-C94S in 
mammalian cells 
Subcloned from pRK5-C94A 
with XhoI and HindIII 
pRK5 
pRK5-C95S-F Expression of murine DRR1-C94S-FLAG in 
mammalian cells 
Subcloned from pRK5-C94A 
with XhoI and HindIII 
pRK5 
pRK5-PE65AA Expression of murine DRR1-PE65AA in 
mammalian cells 
Cloned with PCR and 
mutation primers 
pRK5 
pRK5-PE65AA-F Expression of murine DRR1-PE65AA-FLAG 
in mammalian cells 
Cloned with PCR and 
mutation primers 
pRK5 
pRK5-PE122AA Expression of murine DRR1-PE122AA in 
mammalian cells 
Cloned with PCR and 
mutation primers 
pRK5 
pRK5-dPEPE Expression of murine DRR1-PEPE in 
mammalian cells 
Cloned with PCR and 
mutation primers 
pRK5 
2. MATERIAL 
27 
 
pRK5-dPEPE-F Expression of murine DRR1-PEPE-FLAG in 
mammalian cells 
Cloned with PCR and 
mutation primers 
pRK5 
pRK5-L15M Expression of murine DRR1-L15M in 
mammalian cells 
Cloned with PCR and 
mutation primers 
pRK5 
pRK5-P19L Expression of murine DRR1-P19L in 
mammalian cells 
Cloned with PCR and 
mutation primers 
pRK5 
pRK5-DRR1- EGFP Expression of murine DRR1-EGFP in 
mammalian cells. 
Plasmid obtained from J. 
Schülke 
pEGFP-C1 
pRK5-N-EGFP Expression of murine ΔN-EGFP in 
mammalian cells. 
Subcloned from pRK5-ΔN 
with XhoI and HindIII 
pEGFP-C1 
pRK5-dN2-EGFP Expression of murine ΔN-EGFP in 
mammalian cells. 
Subcloned from pRK5-ΔN 
with XhoI and HindIII 
pEGFP-C1 
pRK5-dN-EGFP Expression of murine ΔN-EGFP in 
mammalian cells. 
Subcloned from pRK5-ΔN 
with XhoI and HindIII 
pEGFP-C1 
pRK5-dC-EGFP Expression of murine ΔC-EGFP in 
mammalian cells. 
Subcloned from pRK5-ΔC 
with XhoI and HindIII 
pEGFP-C1 
pRK5-dM-EGFP Expression of murine ΔM-EGFP in 
mammalian cells. 
Subcloned from pRK5-ΔM 
with XhoI and HindIII 
pEGFP-C1 
pRK5-M-EGFP Expression of murine M-EGFP in mammalian 
cells. 
Subcloned from pRK5-M with 
XhoI and HindIII 
pEGFP-C1 
pRK5-C94A-EGFP Expression of murine C94A-EGFP in 
mammalian cells. 
Subcloned from pRK5-C94A 
with XhoI and HindIII 
pEGFP-C1 
pRK5-dPEPE-EGFP Expression of murine PEPE-EGFP in 
mammalian cells. 
Subcloned from pRK5-PEPE 
with XhoI and HindIII 
pEGFP-C1 
pRK5-L15M-EGFP Expression of murine L15M-EGFP in 
mammalian cells. 
Subcloned from pRK5-L15M 
with XhoI and HindIII 
pEGFP-C1 
pRK5-P19L-EGFP Expression of murine P19L-EGFP in 
mammalian cells. 
Subcloned from pRK5-P19L 
with XhoI and HindIII 
pEGFP-C1 
3DA.luc SRF-driven firefly reporter plasmid Robert Grosse (Universität 
Marburg, Germany) 
 
mDia1-dDAD Control plasmid for SRF activity expressing 
mDia1-dDAD (inhibitory domain) 
Robert Grosse (Universität 
Marburg, Germany) 
 
Gaussia-KDEL SV40-driven gaussia luciferase reporter 
plasmid (C-terminal ER retention signal) 
Project Group Rein pRK5 
Table 10. List of plasmids. 
2.11. Instruments 
NAME MANUFACTURER 
Balance Voyager 50187  Ohaus (Giessen) 
ChemiDoc Imaging System Bio-Rad Laboratories (München) 
Electroporation System, Gene Pulser II  Bio-Rad Laboratories (München) 
High-voltage power supply PowerPac 400  Bio-Rad Laboratories (München) 
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Incubator CB210 Binder (Tuttlingen) 
Magnetic stirrer RCT basic IKAMAG  Labortechnik (Staufen) 
Microplate reader MR 7000  Dynatech (Denkendorf) 
Mini Trans-Blot Cell Bio-Rad Laboratories (München) 
Mini-PROTEAN Electrophoresis system Bio-Rad Laboratories (München) 
Overhead stirrer Rotamix  ELMI (Latvia) 
pH meter pH538 WTW (Weilheim) 
Pipettes PIPETMAN Gilson (Middletown, USA) 
Sonicator, Cell Disruptor B15  Branson (USA) 
Spectrophotometer DU 640  Beckman (Krefeld) 
Stirrer DUOMAX 1030/POLYMAX1040 Heidolph (Schwabach) 
Supplies for agarose gels Bio-Rad Laboratories (München) 
Thermocycler Primus 25  Peqlab (Erlangen) 
Thermocycler Tgradient  Biometra (Göttingen) 
Thermomixer comfort  Eppendorf (Wesseling-Berzdorf) 
TriStar LB941 Luminometer Berthold Tech. (Bad Wildbad) 
UV-Transilluminator  Stratagene (La Jolla, USA) 
UV-Transilluminator GelDoc  Bio-Rad Laboratories (München) 
Vortexer MS2 IKA  Labortechnik (Staufen) 
Voyager 50228 (Precision balance) Ohaus (Giessen) 
Water bath type 1008 Gesellschaft für Labortechnik 
(Burgwedel) 
Microscopes: 
 
Axioplan 2  Carl Zeiss (Jena) 
CK30  Olympus (Hamburg) 
IX50  Olympus (Hamburg) 
LSM FV1000  Olympus (Hamburg) 
TSC SP5 Leica (Solms) 
Centrifuges: 
 
Allegra 21  Beckman (Krefeld) 
Allegra X-22R  Beckman (Krefeld) 
Biofuge pico  Heraeus (Mannheim) 
J2 MC (Rotor JA-14)  Beckman (Krefeld) 
Refrigerated centrifuge (5417 R)  Eppendorf (Wesseling-Berzdorf) 
Refrigerated centrifuge (5804 R)  Eppendorf (Wesseling-Berzdorf) 
Ultracentrifuge LB-70M (Rotor: SW 60 Ti)  Beckman (Krefeld) 
Varifuge 3.0R  Heraeus (Mannheim) 
Table 11. List of instruments. 
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2.12. Software 
NAME APPLICATION 
Adobe Acrobat 8.0 Creating and editing pdf-files 
Adobe Illustrator CS3 Editing of figures 
Adobe Photoshop CS3 Image processing 
FluoView FV1000 (Olympus, Hamburg) Image acquisition, processing and analysis 
of confocal microscopy 
Image Lab 5.0 (Bio-Rad, München) Analysis of SDS-PAGE and Western Blot 
ImageJ / Fiji Image processing and analysis 
MS Office Home and Student 2010 Office suite for desktop application 
Vector NTI 10 (Invitrogen, Karlsruhe) Sequence analysis of DNA and proteins 
Table 12. List of software. 
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3. Methods 
3.1. Bacterial culture 
3.1.1. Culturing bacteria 
Escherichia coli (E. coli) bacteria of the clades DH5α and BL21 were cultured in LB 
medium at 37°C. The antibiotics ampicillin (100 μg/mL) or kanamycin (50 µg/mL) were 
added to the medium to select for resistant cells. Bacteria were streaked on agar plates 
with semi-solid medium to generate discrete colonies. Liquid cultures were inoculated with 
a single colony or directly from glycerol stocks and cultured overnight on a shaker at 
200 rpm. Pellets of fresh 5 mL overnight cultures (centrifuged at 4,000 rpm and 4°C for 
10 min) were resuspended in 1 mL freezing medium (50% glycerol, 50% LB) for storage of 
bacteria at -80°C. 
3.1.2. Preparation of competent cells 
To make competent cells E. coli were inoculated in 10 mL LB medium and incubated 
overnight. The overnight culture was transferred to 150 mL of fresh medium and grown to 
an OD595 nm of 0.6. The suspension was cooled down on ice for 5 min. All following steps 
were performed on ice. After centrifugation (4,500 rpm, 10 min, 4°C) the pellet was 
resuspended in 45 mL of TFB1 buffer and incubated on ice for 90 min. Subsequently, the 
suspension was centrifuged again and the pellet was resuspended in 6 mL of TFB2 buffer. 
The bacterial suspension was aliquoted into 200 μL and frozen in liquid nitrogen bath. The 
competent cells were stored at -80°C. 
TFB1 buffer:  30 mM potassium acetate pH 8.5, 100 mM RbCl, 
50 mM MnCl2, 10 mM CaCl2, 15% glycerol, sterile filtered. 
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TFB2 buffer:   10 mM MOPS (3-N-morpholino-propansulfonic acid)-KOH 
pH 6.8, 10 mM RbCl, 75 mM CaCl2, 15% glycerol, sterile 
filtered. 
3.1.3. Transformation 
Bacteria were transformed with the heat shock method. For this, 100 μL of competent 
bacteria were thawed on ice and 10 μL of a ligation or 10-50 ng plasmid-DNA were added. 
After an incubation of 30 min on ice, the heat shock was performed at 42°C for 45 s, then 
the cells were cooled down on ice for two minutes and 900 μL of S.O.C. medium was 
added. The bacteria were then incubated on 37°C for 1 h on a shaker at 400 rpm to enable 
the expression of antibiotic resistance. Finally the bacteria were streaked on agar plates 
and incubated at 37°C overnight. 
3.1.4. Isolation of DNA from bacteria (Mini/Midi/Maxi) 
For Minipreps the pellets (centrifuged for 5 min, 5,000 rpm) of 2/10 mL (high-/low-copy 
plasmid) of fresh overnight cultures were resuspended in 200/400 μL resuspension 
buffer S1. The cells were lysed by addition of 200/400 μL lysis buffer S2, inverting the 
tube 6x and incubation at RT for 5 min. Then 200/400 μL of neutralization buffer S3 were 
added, the tube was mixed by inverting it 6x, and incubated on ice for 5 min. 
Subsequently, the cell debris was removed by centrifugation for 30 min at 13,000 rpm. The 
supernatant containing the plasmid was transferred to a new tube, 500/800 μL of 
isopropanol was added to precipitate the DNA. After centrifugation (5 min, 13,000 rpm) 
the DNA was washed with 1 mL 70% ethanol and centrifugation (5 min, 13,000 rpm). The 
ethanol was removed and the pellet was air-dried for about 30 min. Finally, DNA was 
resuspended in 50/30 μL ddH2O. The average yield for Minipreps with this protocol was 2-
10 μg plasmid-DNA. 
Midipreps were performed with anion-exchange columns AX-100 (Macherey-Nagel, Düren) 
following the manufacturer’s instructions with homemade buffers. The average DNA yield 
was 20-100 μg. The DNA pellet was resuspended in about 200-400 μL ddH2O. 
For transfection of primary neurons, plasmids were purified free of endotoxins with the 
EndoFree Plasmid Maxi Kit (Qiagen, Hilden) according to the manufacturer’s protocol. 
Plasmids were resuspended in 200 µL endotoxin-free TE buffer or water included in the 
kit and subsequently adjusted to a concentration of 1 µg/µL. Plasmid-DNA was stored at 
-20°C. 
S1 buffer:    50 mM Tris-HCl, 10 mM EDTA, pH 8.0, autoclave,  
    store at 4°C, add 100 μg/mL RNase A prior to use. 
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S2 buffer:    200 mM NaOH, 1% SDS. 
S3 buffer:    2.8 M KAc, pH 5.1. 
N2 buffer:    100 mM Tris, 15% ethanol, 900 mM KCl,   
    0.15% Triton X-100, adjust to pH 6.3 with H3PO4. 
N3 buffer:    100 mM Tris, 15% ethanol, 1.15 M KCl,  
    adjust to pH 6.3 with H3PO4. 
N5 buffer:  100 mM Tris, 15% ethanol, 1 M KCl,  
adjust to pH 8.5 with H3PO4. 
3.2. Cloning 
In order to analyze the functional domains of DRR1, several mutants (dN, dC, dM, and 
M) had been cloned during previous work (Kretzschmar, 2010). During the present work, 
all point mutants were cloned as well as the mutants N, dN2, and dPEPE. Shortly, the 
point mutants C94A, C94S, and PE65AA were generated with the GeneArt Site-directed 
Mutagenesis System (Life Technologies, Frankfurt) while N, dN2, L15M, P19L, PE122AA, 
and dPEPE were generated with mutational primers and linker PCR. Mutants were 
subcloned into different vectors for specific applications as described in the following 
chapters. The coding sequence of all constructs was verified by sequencing. 
3.2.1. Polymerase chain reaction (PCR) 
In vitro amplification of DNA fragments and mutations of DRR1 were performed with the 
polymerase chain reaction (PCR). All fragments subsequently needed for cloning were 
amplified with polymerases containing 3´ - 5´ proofreading exonuclease activity. The PCR 
reaction was prepared in a total reaction volume of 50 μl with the following components: 
20 ng DNA template, 10-30 pmol of each primer, 200 μM dNTPs (10 mM stock), 1-2.5 U 
polymerase, 1x reaction buffer, and ddH2O. The plasmid pRK5-DRR1 was used as a 
template for most mutants. PE65AA was used as a template for dPEPE using mutational 
primers of PE122AA. 
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The sequences of all primers used in this work are listed in chapter 2.9. 
MUTANT FORWARD PRIMER REVERSE PRIMER 
C94A C94A-F C94A-R 
C94A C94S-F C95S-R 
L15M (A1) 5‘-XhoI-DRR1m L15M_R 
 (A2) L15M_F 3‘-HindIII-DRR1m 
 (B) 5‘-XhoI-DRR1m 3‘-HindIII-DRR1m 
P19L (A1) 5‘-XhoI-DRR1m P19L_R 
 (A2) P19L_F 3‘-HindIII-DRR1m 
 (B) 5‘-XhoI-DRR1m 3‘-HindIII-DRR1m 
N 5‘-XhoI-DRR1m N-HindIII-60_R 
dN2 dN2-XhoI-16_F 3‘-HindIII-DRR1m 
PE65AA PE64AA-F PE65AA-R 
PE122AA (A1) 5‘-XhoI-DRR1m PE122AA_R 
 (A2) PE122AA_F 3‘-HindIII-DRR1m 
 (B) 5‘-XhoI-DRR1m 3‘-HindIII-DRR1m 
dPEPE (A1) 5‘-XhoI-DRR1m PE122AA_R 
 (A2) PE122AA_F 3‘-HindIII-DRR1m 
 (B) 5‘-XhoI-DRR1m 3‘-HindIII-DRR1m 
Table 13. Cloned mutants and respective primers used. 
The temperature program for the PCR was usually performed as follows: 
Initial Denaturation 95°C 5 min  
Denaturation 95°C 30 s  
Annealing 56°C 45 s 25 cycles 
Elongation 68°C 30 s  
Final Elongation 68°C 5 min  
Table 14. Standard program for PCR. 
If Herculase II Fusion polymerase was used the elongation time was decreased to 20 s, the 
denaturation temperature was increased to 98°C and the elongation temperature increased 
to 72°C. PCR products were analyzed on agarose gels loading 5 µL of each reaction. 
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3.2.2. Site-directed mutagenesis 
Site-directed mutagenesis was performed to generate the point mutants C94A, C94S, and 
PE65AA using the GeneArt Site-directed Mutagenesis System (Life Technologies, 
Frankfurt) according to the manufacturer. Shortly, the PCR was performed using 
Herculase II Fusion polymerase and the plasmid pMAL-DRR1 as a template with the 
following program: 
Plasmid methylation 37°C 20 min  
Initial Denaturation 94°C 2 min  
Denaturation 94°C 20 s  
Annealing 57°C 30 s 18 cycles 
Elongation 72°C 3.5 min  
Final Elongation 72°C 5 min  
Table 15. PCR program for site-directed mutagenesis. 
After the PCR, the mutated plasmids were transformed into DH5α-T1 E. coli cells 
included in the kit and selected clones were analyzed for successful mutations. 
3.2.3. Agarose gel electrophoresis 
Agarose gel electrophoresis was performed in order to analyze restricted plasmid-DNA or 
linear DNA fragments, quantify the amount of DNA or isolate a particular band. The size 
of the fragments was determined by loading the size marker peqGOLD DNA ladder mix 
(Peqlab, Erlangen) on the gel. Depending on the size of the DNA fragments, the gels were 
prepared with 0.8-2% (w/v) agarose. The agarose was added to 60 or 150 mL of 1x TBE 
buffer in a conical flask and dissolved by heating. After cooling down to at least ~60°C, 
ethidium bromide was added to a final concentration of 0.5 μg/mL, swirled to mix and 
poured into the gel tank. The comb was inserted and any bubbles were removed, then the 
gel was left to dry for at least 30 min. To run the electrophoresis, the gel was transferred 
to the electrophoresis tank filled with running buffer (1x TBE) and the comb was carefully 
removed. The DNA samples were prepared with 1:5 volume of DNA loading buffer and 
carefully loaded on the gel. The electrophoresis was performed at 100 V for 40-60 min. 
After the run the gels were analyzed with UV light of 302 nm in the UV-Transilluminator 
(Stratagene, La Jolla, USA). 
TBE buffer (10x):  90 mM boric acid, 2.5 mM EDTA, 90 mM Tris-HCl, pH 8.3. 
DNA loading buffer (5x):  5% glycerol, 0.5% SDS, 10 mM EDTA, 0.025% bromophenol 
blue, 0.025% xylene cyanol. 
Ethidium bromide:   10 mg/mL 
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3.2.4. Purification of DNA from agarose gels 
Particular DNA fragments, e.g. PCR products or specific restriction bands, were isolated 
from agarose gels by cutting out the band from the gel with a sterile scalpel. 
Subsequently, the DNA was purified from the gel with the QIAquick Gel Extraction Kit 
(Qiagen, Hilden), eluted in 30-50 μL ddH2O and stored at -20°C. 
3.2.5. Restriction of DNA 
Restriction of DNA or PCR products with restriction endonucleases was performed in the 
appropriate buffer following the manufacturer’s instructions and BSA was added if 
needed. Different amounts of DNA were used for the digestion: the whole volume of PCR 
products for cloning, 5-10 μL of minipreps for control digestions, and 2-10 μg of DNA for 
other digestions. 2-5 Units of restriction enzyme were added to the reaction and the 
volume was adjusted to a total of 50 μL with ddH2O (or 80 μL for overnight digestions). 
The reaction was performed at 37°C for 2 h or overnight. 
3.2.6. Ligation of DNA 
Digested PCR products (inserts) were connected to the target vector by ligation of the 
sticky ends catalyzed by the T4 DNA ligase. In this ATP-dependent reaction a covalent 
phosphodiester bond is formed between the 3´ OH and the 5´ phosphate group of the 
deoxyriboses of vector and insert, respectively. The ligation was performed in a final 
volume of 20 μL using 1 μL of T4 DNA ligase in 1x reaction buffer at 4°C overnight. On 
the next day the product was transformed into E. coli using 10 μL of the ligation reaction. 
3.2.7. Subcloning 
In order to subclone DRR1 mutants into different vectors, inserts digested with XhoI and 
HindIII and purified from an agarose gel after restriction were ligated into the equally 
digested target vector. Prior to this step, the correct sequence of the insert was confirmed 
by Sanger sequencing. After transformation into bacteria the success of the subcloning was 
verified by digestion with XhoI-HindIII and PvuI, respectively.  
3.2.8. Measurement of DNA concentration 
The concentration of nucleic acids was determined in a spectrophotometer by measuring 
the absorbance of UV light at 260 nm in a quartz crystal cuvette. Usually the DNA 
solution was diluted 1:50 in ddH2O or higher if needed to measure OD260 in the range of 
0.1 to 1.0. Additionally, the absorbance at 280 nm was measured to check for possible 
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protein contaminations. At this, the ratio of OD260/OD280 was confirmed to be between 1.8 
and 2.0. 
3.2.9. Sequencing 
The coding sequence of successfully cloned plasmids was sequenced by Microsynth AG 
(Lindau). For this, the DNA was adjusted with ddH2O to a concentration of 80 ng/μL in a 
final volume of 10 µL. Primers were added in 20 pmol if needed. 
3.3. Cell culture 
3.3.1. Culturing of eukaryotic cell lines 
All cell lines used in this work were cultured as adherent cells in sterile tissue culture 
dishes or flasks at 37°C and 5% CO2 atmosphere in an incubator. High glucose DMEM 
was used as culture medium supplemented with 10% FCS, 1% sodium pyruvate, and 1% 
antibiotic-antimycotic (penicillin-streptomycin). The cells were passaged every 3-4 days 
after reaching a confluency of approximately 90%. For this, the adherent cells were 
carefully washed with ~10 mL PBS (for an T-75 flask), then detached by incubation with 
2 mL trypsin-EDTA for about 5 min at 37°C. Trypsin-EDTA was then inactivated by the 
addition of 3 mL DMEM. The detached cells were flushed from the surface and transferred 
to a sterile tube. To remove the trypsin-EDTA the cells were centrifuged (4 min, 
1,000 rpm) and resuspended in the appropriate amount of fresh medium for dilution in the 
desired ratio. Usually, this ratio was between 1:4 and 1:12 depending on the cell type and 
growth rate. The diluted cells were then placed in a new flask with fresh medium for 
further cultivation. 
3.3.2. Storage of cell lines 
For the long-term storage of cell lines, the cell pellet of a confluent T-75 flask was 
resuspended in 1 mL freezing medium, consisting of DMEM supplemented with 50% FCS 
and 10% DMSO. The cell suspension was transferred to a cryotube and frozen overnight 
at -80°C. The cells were placed in a liquid nitrogen tank for long term storage.  
In order to take frozen cells into culture, the cells were thawed rapidly by incubation at 
37°C, then the freezing medium was removed by centrifugation (4 min, 1,000 rpm) and the 
cell pellet was resuspended in fresh culture medium. Thereby, the DMSO was removed 
which might have a cytotoxic effect. The cells were then transferred to a T-75 flask, 
incubated at 37°C overnight and passaged on the next day. 
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3.3.3. Coating of glass coverslips/dishes and cell seeding 
The adherence of cells to the growth surface can be improved by coating the surface with 
different substrates. There is a variety possible of substrates all mimicking the natural 
interactions between the cells and the extracellular matrix (ECM). Different coatings were 
used in this work including fibronectin, gelatin, laminin and poly-D-lysine. Fibronectin is 
an ECM glycoprotein mediating adhesion by binding to integrins. Gelatin is derived from 
the major ECM component collagen and therefore a cheap and easy agent to coat culture 
flasks. Poly-D-lysine exhibits polycationic properties promoting effective attachment of 
cells to the growing surface and laminin is the most abundant non-collagen component of 
the basal lamina. Prior to coating the coverslips were sterilized with pure EtOH, air-dried 
and washed with PBS. Glass bottom dishes were directly coated. Gelatin, poly-D-lysine 
and laminin coatings were incubated at 37°C for > 3 h or overnight. Afterwards the 
coverslips/dishes were washed three times with PBS. Fibronectin was incubated for 
45 min at RT without washing the coverslips subsequently. For immunostainings, round 
12 mm coverslips were placed in 24-well plates and 10,000 – 20,000 cells were seeded on 
each coverslip. Transfection was performed 24 h after seeding. 
Fibronectin:   0.96 mg/mL stock solution, diluted 1:200 in DMEM. 
Gelatin:    0.1% gelatin in ddH2O, autoclaved. 
Laminin:  1 mg/mL in Ampuwa ddH2O, diluted 1:1000 in ddH2O prior 
to use. 
Poly-D-lysine:  10 mg/mL in Ampuwa ddH2O, diluted 1:100 in ddH2O prior 
to use. 
3.3.4. Transfection by electroporation 
Electric pulses increase the permeability of cell membranes without disrupting its 
structural integrity. This effect is used to introduce foreign plasmid DNA by diffusion 
through the small reversible gaps in the membrane (Chu et al., 1987). 
For each electroporation the cells of a confluent 10 cm dish (60 cm2) were washed with 
PBS and resuspended in 400 μL resuspension buffer. The cell suspension was transferred 
to an electroporation cuvette and the plasmid DNA was added (max. 20 μg per sample). 
Immediately prior to electroporating the cells, the suspension was carefully mixed by slow 
vortexing. The optimal electroporation conditions are dependent on the cell type. HEK-
293 cells were electroporated with a pulse of U = 350 V and T = 700 μF. After 
electroporation the cells were rapidly transferred into a new 10 cm dish with pre-warmed 
DMEM medium and incubated for 2-3 days. 
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MgSO4 buffer:   1 M MgSO4 · 7 H2O, adjust to pH 6.7 with NaOH. 
Electroporation buffer:  50 mM K2HPO4 · 3 H2O, 20 mM KAc, adjust to pH 7.35 
with acetic acid, sterile filtered. 
Resuspension buffer:   390 μL electroporation buffer, 10 μL MgSO4 buffer  
    for each electroporation (~60 m2 confluent cells). 
3.3.5. Transfection with TurboFect 
Adherent HeLa cells were transfected with TurboFect Transfection Reagent according to 
the manufacturer’s protocol. TurboFect is a cationic polymer forming compact, stable, 
positively charged complexes with the negatively charged DNA. Shortly, cells in a 24-well 
plate seeded on the day before transfection were transfected using 1 µg DNA, 2 µL 
TurboFect in 100 µL DMEM. In 35-mm dishes 4 µg DNA, 6 µL TurboFect and 400 µL 
DMEM were used. The DNA was diluted in DMEM, then TurboFect was added, mixed 
by vortexing and incubated at RT for 15-20 min. The transfection mixture was then 
added to the cells drop-by-drop. The medium was changed 24 h after transfection. 
3.3.6. Transfection with Lipofectamine 2000 
As an alternative to TurboFect, adherent HeLa cells were also transfected with 
Lipofectamine 2000, a transfection reagent based on liposomal complexes. In a 24-well 
plate, 0.5 µg DNA were diluted in 25 µL DMEM in one tube, and 2 µL 
Lipofectamine 2000 were diluted in another tube with 25 µL DMEM. After an incubation 
of 5 min, the first tube was added to the second, thoroughly mixed by vortexing and 
incubated for another 20 min at RT. Finally, the DNA-lipid complex was added to the 
cells. The medium was changed after 6 h. 
3.4. Primary hippocampal culture 
3.4.1. Preparation of primary mice hippocampal neurons 
Primary hippocampal neurons were prepared from mice by Dr. Sebastián Giusti, Research 
Group Dr. Damián Refojo, Max Planck Institute of Psychiatry, Munich (Dotti et al., 
1988). DIV0 (day in vitro) is defined as the day of preparation. Animals were handled 
according to the Guide for the Care and Use of Laboratory Animals of Government of 
Bavaria, Germany. 
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3.4.2. Culturing of hippocampal neurons 
Primary hippocampal neurons were seeded on coverslips (12 mm round) in a 24-well plate 
in a density of 50.000 cells per coverslip (250 cells/mm²) in 1 mL medium. Previously, 
coverslips were pre-treated with chloroform for 10 min followed by three washing steps 
(~10 min each) with absolute ethanol. After sterilization for 2-4 h at 180°C the coverslips 
were coated with poly-D-lysine (50 µg/mL, >3 h or overnight at 37°C) and laminin 
(1 µg/mL, > 3 h or overnight at 37°C). Neurobasal A supplemented with 2% B-27 and 
0.5 mM GlutaMax was used as a culture medium. The medium was not changed during 
cultivation at 37°C in the incubator. If needed, little amounts of fresh medium were added 
to the conditioned medium during transfection of the cells or above DIV10-14. 
3.4.3. Transfection with the calciumphosphate method 
Transfection of primary hippocampal neurons with the calciumphosphate method was 
performed on DIV7-14 and analysis was performed on the indicated time points in each 
experiment (Jiang and Chen, 2006). For four wells, 8 µg of endotoxin-free plasmid DNA 
were diluted in 37.5 µL Ampuwa ddH2O (subtracting the volume of the DNA) in a 1.5 mL 
Eppendorf tube. Then, 12.5 µL of CaCl2 were added and mixed by fast vortexing. For 
precipitation, the tube was placed on a vortexer and 50 µL BBS buffer were slowly added 
to the tube during slow vortexing followed by the addition of 900 µL pre-warmed 
Neurobasal A medium and fast vortexing. This mixture was incubated at RT for 15 min. 
The conditioned medium was then withdrawn from the neurons and 250 µL of the 
calciumphosphate-DNA precipitate were added. To avoid drying of the neurons and 
minimize exposure to oxygen, each well was processed separately working with two 
pipettes at a time. The neurons were then placed back in the incubator and incubated 
with the transfection mix for 1-2 h depending on the age of the neurons. 20-30% of fresh 
Neurobasal A was added to the conditioned medium which was then filtered sterile to 
remove any cell debris or contaminations. After incubation, the transfection mix was 
removed and the neurons were washed well-per-well 8x with warm HBSS working again 
with two pipettes. Finally 1 mL medium was added and the neurons were incubated at 
37°C. 
BBS buffer (2x):  50 mM BES, 280 mM NaCl, 1.5 mM Na2HPO4, 
    in Ampuwa ddH2O, adjust to pH 7.26, sterile filtered,  
    store at -20°C. 
CaCl2:    1 M CaCl2 ∙ 2 H2O, in Ampuwa ddH2O, sterile filtered,  
    store at -20°C. 
HBSS (1x):   for washing, supplement with 3 mL HEPES to adapt pH. 
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3.5. Proteinbiochemical methods 
3.5.1. SDS-Polyacrylamide gel electrophoresis 
In order to separate proteins depending on their molecular weight in an electric field a 
discontinuous SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was used (Fling and 
Gregerson, 1986). Protein samples were prepared with 1:5 volume of Laemmli sample 
buffer and heated to 95°C for 5 min. In doing this, proteins were denatured by β-
Mercaptoethanol and the anionic detergent SDS included in the sample buffer. SDS 
further applies a negative charge to the protein in proportion to its molecular weight. The 
gels were polymerized in a gel caster (Bio-Rad) with a thickness of 1 mm. The resolving 
gel was poured into the apparatus immediately after the addition of APS and TEMED 
and covered with a thin layer of isopropanol. After polymerizing for at least 30 min, the 
isopropanol was removed, the stacking gel was poured on the resolving gel and a comb 
with 10 or 15 wells was inserted. After polymerization for about 30 min the gel was either 
directly used or stored for up to week at 4°C wrapped in wet paper towels. For gel 
electrophoresis the comb was carefully removed under running water and the gel was 
placed into the electrophoresis apparatus. The buffer chamber was filled with SDS running 
buffer (1x). The protein samples were loaded on the stacking gel with a syringe 
(Hamilton) and 5 μL of peqGOLD Prestained-Protein marker IV were injected into the 
first well to estimate the molecular weight of the proteins. The electrophoresis was 
performed at 100 V for 15-20 min to allow the proteins to focus in the stacking gel and 
enter the resolving gel, then the voltage was increased to 120-150 V for about an hour for 
separation in the resolving gel. After SDS-PAGE the gels were either stained with 
Coomassie Brilliant Blue or transferred to a nitrocellulose membrane for Western Blotting. 
Stacking gel buffer (4x):  1 M Tris-HCl, pH 6.8. 
Resolving gel buffer (4x):  1.5 M Tris-HCl, pH 8.8. 
Laemmli sample buffer (5x):  5% SDS, 40% glycin, 160 mM Tris pH 6.8,  
5% β-Mercaptoethanol, bromophenol blue. 
Laemmli running buffer (10x): 25 mM Tris, 192 mM glycin, 0.5% SDS. 
APS:     10% w/v in ddH2O 
10% Resolving gel (2 gels):  4 mL ddH2O, 3.3 mL Acrylamide/Bis-Solution, 
2.5 mL Resolving gel buffer, 0.1 mL 10% SDS, 
add 100 μL APS and 10 μL TEMED for polymerization. 
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12% Resolving gel (2 gels):  3.3 mL ddH2O, 4 mL Acrylamide/Bis-Solution, 
2.5 mL Resolving gel buffer, 0.1 mL 10% SDS, 
add 100 μL APS and 10 μL TEMED for polymerization. 
15% Resolving gel (2 gels):  2.3 mL ddH2O, 5 mL Acrylamide/Bis-Solution, 
2.5 mL Resolving gel buffer, 0.1 mL 10% SDS, 
add 100 μL APS and 10 μL TEMED for polymerization. 
3.2% Stacking gel (2 gels):  3.1 mL ddH2O, 0.55 mL Acrylamide/Bis-Solution, 
1.25 mL Stacking gel buffer, 0.05 mL 10% SDS, add 50 μL 
APS and 7.5 μL TEMED for polymerization. 
3.5.2. Colloidal Coomassie staining of PAA gels 
Following the electrophoresis the gels were stained with colloidal Coomassie for 
visualization of all protein bands on the gel. For this, the gel was shortly washed in ddH2O 
after SDS-PAGE to remove SDS and fixed overnight in Colloidal fix (1x). On the next 
day, the gel was washed with ddH2O (3 x 10 min) and equilibrated in 10 mL Colloidal 
stain (1x) for 1 h. Finally, about 10 mg Brilliant blue G was added and the incubation 
was continued overnight or up to three days for staining. Prior to scanning the gel was 
washed with ddH2O. All incubation steps were performed on a shaker. 
Colloidal fix (3x):  90% EtOH, 6% Phosphoric acid 85%, in ddH2O. 
Colloidal stain (1x): 17% Ammonium sulfate, 2% Phosphoric acid 85%, 
34% methanol, in ddH2O. 
3.5.3. Western Blot 
Prior to Western blotting the proteins separated by SDS-PAGE were transferred from the 
polyacrylamide gel to a nitrocellulose membrane in a Wetblot. The transfer sandwich was 
carefully assembled avoiding the formation of air bubbles with the following components 
from cathode to anode: sponge (for isolation), 3x Whatman filter paper, gel, membrane, 3x 
Whatman paper, and sponge. All components were previously equilibrated in Wetblot 
buffer (1x) for 5-10 min. The entire stack was placed in the blotting chamber filled with 
Wetblot buffer (1x) and a cooling pack. The transfer was performed in the cold room at 
100 V for 90 min. 
In order to rapidly control the effectiveness of protein transfer from the gel to the 
nitrocellulose membrane, the membrane was stained with Ponceau S by incubation in the 
staining solution for about 5 min. Ponceau S is an azo dye reversibly binding to the 
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positively charged amino groups of the proteins. The proteins were destained with ddH2O 
and the dye was removed by washing with TBS-T. 
A Western Blot was performed for immunological detection of specific proteins. Usually 
two antibodies were used for this: the primary antibody binds specifically to the target 
protein, while the secondary antibody recognizes the constant region of the first and is 
coupled to the horseradish peroxidase (HRP) of fluorescent dyes. Some primary antibodies 
like anti-FLAG are already HRP-conjugated making the secondary antibody dispensable. 
The detection is based on the chemiluminescent reaction catalyzed by the HRP at which 
the substrate luminol is oxidized in the presence of H2O2 resulting in blue light emission or 
on the excitation of the fluorescent dye. These light emissions were detected in the 
ChemiDoc Imaging System (Bio-Rad, München). Since the membrane exerts a high 
capability of binding protein, all non-specific binding sites were blocked by incubation in 
5% milk powder in TBS-T (1x) for 1 h. Finally, the membrane was incubated with the 
primary antibody (1:500 – 1:5,000 in TBS-T with 2% milk, overnight at 4°C) followed by 
the secondary (1:10,000 in TBS-T with 2% milk, 2-3 h at RT). The Western Blot was 
developed according to the manufacturer of the luminescence reagents (Immobilon 
Western Chemiluminescent HRP Substrate, Merck Millipore, Darmstadt) if HRP was 
used. After each antibody incubation and prior to the detection the membrane was 
washed three times for 10 min with TBS-T. All incubation steps were performed on a 
shaker. 
Wetblot buffer (10x):  480 mM Tris, 390 mM glycin, 0.375% SDS. 
Wetblot buffer (1x):   10% Wetblot buffer (10x), 20% methanol. 
Ponceau solution:  2% Ponceau S, 30% trichloroacetic acid, 30% sulfosalicylic 
acid, diluted 1:10 in ddH2O. 
TBS-T (1x):    150 mM NaCl, 10 mM Tris-HCl, pH 7.6, 0.1% Tween 20. 
3.5.4. Measurement of protein concentration 
To measure the protein concentration of e.g. cell lysates the commercially available BCA 
Protein Assay Kit (Thermo Scientific, Rockford, USA) was used according to the 
manufacturer’s protocol. The reaction is based on the biuret reaction at which Cu2+ is 
reduced to Cu+ in the presence of protein in an alkaline solution followed by a highly 
specific detection for Cu+ with bicinchoninic acid (BCA). BCA reacts in a 1:1 
stoichiometry with Cu+ ions to a violet product with an absorbance maximum at 562 nm 
allowing for the sensitive quantification of the protein amount in the solution. Shortly, the 
samples were usually diluted 1:10 in ddH2O prior to the BCA reaction and then pipetted 
into a 96-microtiter plate in triplicates. The BCA reagent was then added according to the 
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manufacturer and incubated at 60°C for 20-30 min. The absorbance was measured at 
550 nm in a microplate reader. The protein concentration was calculated by comparison 
with a BSA calibration curve. 
3.5.5. Recombinant protein expression and purification 
Recombinant DRR1 proteins were expressed and purified as MBP fusion proteins in order 
to enhance stability and solubility (Fox and Waugh, 2003). DRR1 and the cloned mutants 
were subcloned into pMAL, an expression vector that leads to the expression of proteins 
attached to MBP at the N-terminus. Although MBP can be removed by cleavage with the 
specific protease factor Xa after purification, this resulted in denaturation of DRR1 which 
is why all further experiments were performed with MBP-fusion proteins. All experiments 
with recombinant proteins were performed with buffer only and MBP as controls, 
respectively. Since there were no detectable differences between buffer and MBP, the 
latter is shown in all figures as control. For expression of MBP-fusion proteins a 100 mL 
culture of BL21(DE3)pLysS E. coli bacteria was incubated overnight at 37°C in LB/Amp 
with 0.2% glucose. The following day 50 mL of the culture were transferred to 500 mL 
fresh medium and incubated at 37°C until the OD595 was between 0.4 and 0.6. The protein 
expression was induced by 0.3 mM IPTG (final concentration) and incubation at 37°C for 
2 h. Before and after induction, 1 mL of the bacterial suspension was centrifuged 
(4,000 rpm, 10 min) and resuspended in 50 μL and 100 μL 2x Laemmli sample buffer, 
respectively. After induction, the cells were centrifuged (4,000 rpm, 20 min, 4°C). The 
bacterial pellets were lysed by the freeze-thaw method in a dry-ice ethanol bath and then 
resuspended in 15 mL lysis buffer, incubated on ice 1 h and sonicated. Finally, the soluble 
proteins were separated from the cell debris by centrifugation (48,400x g, 45 min, 4°C). 
From this point on, all following steps were done at 4°C to avoid denaturation or 
aggregation of the protein. Prior to loading on the affinity column the cleared lysates were 
filtered through a 0.8 µm and a 0.22 µm filter. Protein purification was performed using 
the ÄKTApurifier system (GE Healthcare, Freiburg) with affinity chromatography 
(MBPTrap HP, 1 mL, GE Healthcare) followed by gel filtration (Superdex200 10/300 GL, 
GE Healthcare). All buffers for FPLC were filtered through a 0.22 µM filter and degassed. 
Cleared and filtered bacterial lysates were loaded on equilibrated MBPTrap at a constant 
flowrate of 0.5 mL/min with 15 mL binding buffer, washed by 5 mL binding buffer and 
eluted by 10 mL elution buffer. Samples containing recombinant protein as controlled by 
SDS-PAGE and Coomassie staining were pooled and concentrated with Vivaspin 20, 
molecular weight cut off (MWCO) 30 kDa. Then the buffer was exchanged to superdex 
running buffer. Gel filtration was performed on a Superdex200 10/300 GL column (GE 
Healthcare) at a constant flowrate of 0.5 mL/min and samples were analyzed subsequently 
on SDS-PAGE. Samples containing recombinant protein were pooled. The concentration 
was measured by UV absorbance at 280 nm and by densitometry with a protein standard 
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on colloidal Coomassie stained SDS-PAGE. Purified proteins were aliquoted and frozen in 
liquid N2. Freshly thawed aliquots of recombinant protein were used for all experiments. 
IPTG:    1 M, diluted in ddH2O. 
PMSF:    200 mM in EtOH 
Lysis buffer:    BB with PI (1:100), PMSF (1 mM), lysozyme (1 mg/mL). 
Binding buffer (BB): 20 mM Tris-HCl pH 7.4, 200 mM NaCl, 1 mM EDTA, 1 mM 
DTT. 
Elution buffer (EB):   10 mM maltose in CB. 
Superdex running buffer: 20 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM DTT 
3.5.6. Determination of protein concentration 
In order to determine protein concentration and to check the protein purity, an SDS-
PAGE was done loading 1, 2, 5, and 10 μL of protein, and a protein standard of 1, 2, and 
5 µg (protein on gel) BSA as a reference. In addition, a BCA test was performed with 1:5 
dilutions (see 3.4.5) and the absorbance of UV light at 260 nm of appropriate dilutions 
was measured. However, the latter two methods measure the total protein concentration 
including contaminations. Thus, the concentration of the MBP-fusion proteins was 
expected to be slightly lower depending on the purity of the sample. 
3.6. Cellular assays 
3.6.1. Dual-luciferase reporter gene assay 
For dual-luciferase reporter gene assays 10,000 HEK-293 cells/well were seeded in 96-well 
plates. The SRF reporter plasmid 3DA.luc and mDia1-dDAD plasmids were kind gifts 
from Robert Grosse (Universität Marburg, Germany). Simian virus 40 promoter-driven 
non-secretory gaussia luciferase expression vector (10 ng per well in a 96-well plate) was 
cotransfected with SRF reporter (25 ng) to correct for transfection efficiency. The 
indicated test plasmids (150 ng) were also cotransfected. Twenty-four hours after 
transfection, SRF activity was stimulated with 20% FBS or inhibited (0.5% FBS) for 16-
18 h until measurement. To measure reporter gene activity, cells were lysed in 50 µL 
passive lysis buffer for 30 min at RT under constant shaking. Firefly and gaussia luciferase 
activities were measured in the same aliquot using the TriStar LB941 Luminometer 
(Berthold Technologies, Bad Wildbad). Firefly activity was measured first by adding 
3. METHODS 
45 
 
50 µL firefly substrate solution to 10 µL lysate in white microtiter plates. By adding 50 µL 
gaussia substrate solution the firefly reaction was quenched and gaussia luminescence was 
measured after a 5 s delay. Firefly activity data represent the ratio of background (i.e. 
untransfected) corrected firefly to gaussia luminescence values. To compare different 
experiments, the SRF activity in the serum-stimulated control with pRK5 vector was set 
to 1. To verify protein expression, triplicate lysates were pooled, briefly sonicated and 
analyzed by SDS-PAGE followed by Western Blot. 
Passive lysis buffer:  0.2% Triton X-100, 100 mM K2HPO4/KH2PO4 pH 7.8 
Firefly substrate solution: 3 mM MgCl2, 2.4 mM ATP, 120 mM D-Luciferin 
Gaussia substrate solution: 1.1 M NaCl, 2.2 mM Na2EDTA, 0.22 M K2HPO4/KH2PO4, 
pH 5.1, 0.44 mg/mL BSA, Coelenterazine 3 µg/mL 
3.6.2. Co-immunoprecipitation with GFP-Trap 
For co-immunoprecipitation, agarose beads coupled to GFP-Trap (ChromoTek, Planegg-
Martinsried) were used. GFP-Trap is based on a single-domain antibody fragment derived 
from alpaca, a so-called nanobody, specifically binding to GFP or GFP-fusion proteins. 
HEK-293 cells were transfected by electroporation with 15 µg plasmid per sample of 
~60 cm² cells using plasmids expressing EGFP-fusion proteins. Lysis was performed with 
200 µL ice-cold lysis buffer. The extract was incubated for 1 h on ice, diluted with 700 µL 
dilution buffer and centrifuged for 10 min at 13,000 rpm to remove cell debris. Each lysate 
was incubated with 25 µL GFP-Trap agarose beads for 1 h at 4°C1. Beads were previously 
equilibrated in wash buffer as recommended by the manufacturer (centrifugation for 2 min 
at 2,500x g, 4°C). Then, the beads were washed two times with 1 mL wash buffer and 
samples were eluted by incubation for 10 min at 95°C in 50 µL Laemmli sample buffer 
(1x). The beads were then collected by centrifugation and eluates were transferred to a 
new tube. Lysates and eluates were analyzed by SDS-PAGE and Western blot. To analyze 
and compare actin binding, background corrected IP and Co-IP bands were quantified. 
The co-precipitated actin signal (if present) in the EGFP control was defined as 
background and subtracted from all other signals. Next, the ratio of co-precipitated actin 
and the corresponding precipitated protein was formed and defined as “actin binding”. The 
“mean actin binding” for each experiment using the same mutants (wt, dN, dC, dM and 
M) was calculated and actin binding of each mutant was normalized to the mean actin 
binding of the respective experiment. 
                                         
1 The incubation time was increased as recommended by the manufacturer, as GFP-Trap has a 
slightly lower affinity to C-terminal fusions than N-terminal fusion. 
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Lysis buffer:  10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 
0.5% NP-40, 1x PI cocktail (freshly added) 
Dilution & Wash buffer: 10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 
1x PI cocktail (freshly added) 
3.6.3. Chemical crosslinking 
Chemical crosslinking of HEK-293 cells transfected with DRR1 was performed with the 
membrane-permeable crosslinkers DSS, DSG and BMB. DSS (Disuccinimidyl suberate) 
and DSG (Disuccinimidyl glutarate) are NHS esters reacting with primary amines leading 
to crosslinking of lysine residues. DSS has a spacer arm of 11.4 Å, while DSG is slightly 
shorter with 7.7 Å. BMB (1,4-Bismaleimidobutane) is a maleimide with a spacer arm 
length of 10.9 Å generating chemical bonds between sulfhydryl groups, i.e. cysteine 
residues. HEK-293 cells were transfected with pRK5-DRR1 plasmids by electroporation 
and incubated for 2 days at 37°C. Cells were then detached by trypsinization and washed 
with PBS. Each 10 cm dish transfected with one plasmid was divided into two new tubes 
and resuspended in 5 mL of crosslinker conjugation buffer. Controls were performed by 
replacing the crosslinker with DMSO in the conjugation buffer. Cells were incubated on a 
shaker with DSS for 30 min at RT, then 2 h at 4°C, with DSG and BMB for 2 h at 4°C. 
After crosslinking, samples were quenched by incubation for 30 min at 4°C in 1 mL 
quenching buffer per sample. Finally, the cells were collected by centrifugation and lysed 
by resuspension in SDS-lysis buffer, short sonication and heating to 95°C for 5 min. 
Protein concentration was determined with the BCA method and 5-10 µg protein were 
loaded on SDS-PAGE for analysis in Western Blot. 
DSS stock (300x):  22.5 mM in DMSO (1 microtube), working conc. 75 µM 
DSG stock (100x):  200 mM in DMSO, working conc. 2 mM 
BMB stock (100x):  20 mM BMB in DMSO, working conc. 0.2 mM 
DSS/DSG conjugation buffer: DSS/DSG in PBS 
DSS/DSG quenching buffer: 50 mM Tris-HCl pH 7.5 
BMB conjugation buffer: 1:100 volume BMB stock, 5 mM EDTA in PBS 
BMB quenching buffer: 10 mM DTT in PBS 
SDS-lysis buffer (3x):  62.5 mM Tris-HCl pH 7.4, 10% sucrose, 2% SDS, 
    1x PI cocktail (freshly added) 
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3.6.4. Cell spreading 
In contrast to the active process of cellular migration, adhesion and early spreading of a 
cell in suspension to a substrate are more passive processes influenced by substrate 
stiffness and density, integrin-receptor diffusion to the adhesive patch, and mechanical 
properties of the cell (Cuvelier et al., 2007; Li et al., 2014; Yauch et al., 1997). Later 
stages of cell spreading include active processes like actin polymerization and myosin 
contraction (Chamaraux et al., 2005). For analysis of cell spreading with DRR1 
overexpression, HeLa cells in a 6-well-plate were transfected with EGFP fusion proteins 
using TurboFect as described above. On the next day, cells were harvested with PBS, 
diluted to about 20,000 cells/mL and replated on 12 mm round coverslips coated with 
50 µg/mL fibronectin placed in 24-well-plates (1 mL/well). For cell spreading analysis 
with antidepressants, HeLa cells were trypsinized from the culture dish and the medium 
was changed to antidepressant-containing medium immediately prior to replating on 
fibronectin. After 30 min spreading at 37°C, cells were washed once with PBS and fixed in 
4% paraformaldehyde (PFA) for 20 min at RT. Cells were then stained with 
Alexa Fluor 546-phalloidin and mounted on glass slides as described in chapter 3.7.5. 
Images were captured with the fluorescence (20x or 40x objective) or confocal microscope 
(10x/0.40 NA or 40x/1.15 NA objective). The cell size was determined from up to 10 
randomly selected fields with about 100-200 cells total using the open-access image 
processor ImageJ. Shortly, the images were scaled, the phalloidin-channel was thresholded 
(lower threshold level 250, upper threshold level 4095) and adjacent cells were separated 
by the “Watershed” algorithm. Correct cell separation was double-checked manually. By 
means of the thresholded phalloidin-channel, the mean gray value in the EGFP channel 
was measured and the cell size in the original phalloidin-channel using the “Analyze 
Particles” algorithm. Cells with a mean gray value of >500 were defined as transfected. In 
order to compare different conditions and experiments, the mean area of transfected cells 
was normalized with the mean area of untransfected cells in the same condition. In 
experiments with DRR1, the control refers to the EGFP-transfected sample, in 
experiments with antidepressants it refers to untransfected cells. 
3.6.5. Cellular fractionation 
In order to analyze nuclear and cytoplasmic localization of DRR1, HEK-293 cells were 
transfected with pRK5-DRR1 plasmids and after two days incubation a cytosolic-nuclear 
cell fractionation was performed. For this, cells were trypsinized, washed with PBS and 
resuspended in 250 µL hypotonic lysis buffer per 10 cm dish. After an incubation of 
10 min on ice, cells were briefly vortexed and disruption of the outer cell membrane was 
analyzed in the microscope. The samples were centrifuged (6,500 rpm, 30 s, 4°C) and the 
supernatant containing cytosolic proteins was transferred to a new tube. The pellet was 
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carefully washed three times with 500 µL hypotonic lysis buffer and finally the nuclei were 
lysed by incubating in 200 µL SDS-lysis buffer (1x) 5 min at 95°C and short sonication. 
After centrifugation (full speed, 1 min) the supernatant was transferred to a new tube. 
Concentration of cytosolic and nuclear fractions was determined by BCA and the samples 
were analyzed by SDS-PAGE and Western Blot. About 7-10 µg cytosolic fraction and the 
same volume of the corresponding nuclear fraction were loaded. 
Hypotonic lysis buffer: 10 mM HEPES pH 7.9, 10 mM KCl, 0.5 mM EDTA, 
0.1% NP-40, 10% glycerol, 1 mM DTT and PI (freshly 
added) 
SDS-lysis buffer (3x): 62.5 mM Tris-HCl pH 7.4, 10% sucrose, 2% SDS,  
1x PI cocktail (freshly added) 
3.6.6. 2D-Migration assay 
For 2D-Migration assays (also known as Wound Healing or Scratch assay) 30-50.000 HeLa 
cells were seeded in each well of a 24-well plate and cultured to confluency. The cellular 
monolayer was scratched with a P10 pipette tip mimicking a two-dimensional wound. 
After the scratch, the medium was changed to fresh medium containing antidepressants or 
the solvent (50% EtOH, 5 mM HCl) in the same volume as a control. Cell debris from the 
scratch was also removed with this medium change. The scratch was imaged after the 
medium change (t = 0) and after 24 h at 37°C with a bright field microscope (4x or 10x 
objective). Markings were made at the bottom of the well to image the same field of view 
each time. In order to quantify the migrated distance, the area of the scratch at t = 0 and 
24 h were measured in ImageJ. The difference of the area at t = 0 with the area at 24 h 
was normalized to the 0 h area to compare different conditions and experiments. 
3.6.7. Fluorescence recovery after photobleaching 
(FRAP) 
HeLa cells were seeded on 50 µg/mL fibronectin-coated 35 mm glass dishes (Greiner Bio 
One, Germany, 50,000 cells/dish). On the day after cell seeding, cells were cotransfected 
with GFP-Actin (1 µg) and pRK5 plasmids expressing DRR1 (or empty vector as a 
control, 3 µg) using TurboFect. The medium was changed 24 h post transfection. Time-
lapse images were acquired in the confocal microscope (20x/0.8 NA objective, 5x zoom, 
C.A. 200 µm, LSM FV-1000, 2% laser power) with 2 sec intervals for 5 min. Five frames 
were imaged pre-bleach. Bleaching was performed with the circular “TurboTool” for 
1000 msec at 100% 488-laser power at an image resolution of 320x320 px. Quantification 
of the acquired images was performed in ImageJ, by selecting the bleached area in frame 6 
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with the Wand tool (“legacy”, “tolerance” = 150), fitting a circle (ROI 1), and measuring 
the mean gray intensity. An equally sized area within the cell (ROI 2) was used to 
normalize the fluorescence intensity in each frame. The mean intensity of the first frame 
was set to 1 in order to compare different cells and conditions. In this experiment, “n” 
refers to the number of cells analyzed from 2-3 independent experiments. 
3.7. Cellular stainings 
3.7.1. Fixation, Permeabilization and blocking of cells 
For cellular stainings, cells were seeded on coated glass coverslips placed in 24-well-plates 
and transfected using Lipofectamine 2000 or TurboFect as described above. Cells were 
washed with PBS and fixed 24 h after transfection with 4% PFA in PBS for 20 min at 
RT. For permeabilization, the fixed cells were incubated with 0.1% Triton-X 100 (in PBS) 
for 10 min at RT. The non-ionic detergent Triton X-100 incorporates into the membrane 
thereby enabling the antibodies to penetrate the cell. After washing the cells again two 
times with PBS, unspecific binding sites were blocked by incubation in 10% goat serum for 
1 h at RT. After blocking, the cells were washed once with PBS. 
Triton-X 100:   10% v/v in PBS 
3.7.2. Immunostaining  
Immunostaining is an antibody-based method to specifically detect a protein target in 
intact cells. The detection is enabled by a primary antibody which specifically binds to the 
target and a fluorophore-coupled secondary antibody binding to the first one. By this, 
several targets can be simultaneously stained in one cell thereby allowing visualization of 
the sub-cellular localization of the target or potential interaction partners by 
colocalization. Primary antibodies were diluted 1:200 to 1:500 in 0.1% Triton X-100 in 
PBS and incubated overnight at 4°C. Secondary antibodies were added to the samples 
after 3x washing with PBS (10 min each) diluted 1:500 in 0.1% Triton X-100 in PBS and 
incubated for 2-3 h at RT. During this incubation and all following steps the samples were 
protected from light to avoid bleaching. 
3.7.3. F-actin staining with phalloidin 
Phallotoxins from the mushroom Amanita phalloides specifically bind to filamentous 
actin and therefore can be used for staining F-actin in fixed cells. For this, cells were 
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incubated with 165 nM Alexa Fluor 546-phalloidin in PBS for 20 min at RT. Subsequently 
the cells were 2x washed with PBS. 
3.7.4. DAPI staining of nuclei 
DAPI (4’-6-Diamidino-2-Phenylindol) is a fluorescent dye used to stain DNA as it 
incorporates into the minor grooves of AT-rich sequences. The DAPI stock solution was 
diluted 1:10,000 in PBS to a final concentration of 1 μg/mL. The cells were incubated for 
15 min at RT with DAPI staining (in the dark) and then washed three  
DAPI stock:   10 mg/mL in ddH2O 
3.7.5. Storage of stained cells 
Stained coverslips were mounted onto SUPER FROST microscope slides (Fisher Scientific, 
Schwerte) using a drop of approximately 10 µL ProLong Gold Antifade Medium. Mounted 
coverslips were dried overnight and slides were stored in the dark at 4°C or -20°C. Usually, 
imaging was performed very soon after mounting in order to avoid quality loss of the 
staining. 
3.7.6. Colocalization analysis 
Images for colocalization analysis were taken with the 40x/1.15 NA objective, 3x zoom, 
and a pinhole of 200 µm. According to the “Nyquist Calculator” of the Scientific Volume 
Imaging Website (http://www.svi.nl/), Nyquist sampling of 60/60/214 nm (x/y/z plane) 
and a point spread function (PSF) of 4.25 nm were calculated using the Alexa Fluor 546-
phalloidin channel for excitation/emission wavelengths. Using these parameters, 
colocalization analysis was performed in ImageJ with the plugin “Coloc 2”. ROIs 
containing one cell were generated by thresholding the DRR1 channel (lower limit: 300, 
upper limit: 4095 for a 16-bit image) and selecting individual cells with the “wand” tool. 
Pearson’s correlation coefficient R and Costes p value were calculated using 100 Costes 
Randomizations. Only R values with a corresponding Costes p of 1.0 were used. For each 
condition, 5-15 randomly selected cells from two independent experiments were analyzed. 
3.7.7. Quantification of mean cellular F-actin content 
Quantification of mean cellular F-actin content was performed in ImageJ. Shortly, the 
images were scaled, the phalloidin channel was thresholded (lower threshold level 150, 
upper threshold level 4095 for 16-bit images) and adjacent cells were separated by the 
“Watershed” algorithm. Correct cell separation was double-checked manually. By means of 
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the thresholded phalloidin channel, the mean gray value in the DRR1 channel was 
measured, while the cell size was measured in the thresholded phalloidin channel using the 
“Analyze Particles” algorithm. Cells with a mean gray value of >500 were defined as 
transfected. For each image, the mean gray value of F-actin in transfected cells was 
normalized to the mean value of all untransfected cells in the corresponding image in order 
to compare different images, conditions and experiments. The control refers to the mean 
cellular F-actin of untransfected cells and then set to 1. 
3.8. In vitro actin assays 
3.8.1. Preparation of purified G-actin from tissue 
α-G-actin was obtained from rabbit skeletal muscle actin and labeled with pyrene by 
technicians in the lab of Prof. Dr. Andreas R. Bausch, Technische Universität München, 
as previously described (Cooper et al., 1983; Schmoller et al., 2011). All in vitro actin 
experiments except the F-actin co-sedimentation were performed in the lab of Prof. Dr. 
Andreas R. Bausch. β-Actin from human platelets was prepared and used according to the 
manufacturer’s protocol (Cytoskeleton, Inc., Denver, USA). In all experiments, “R” refers 
to the molar ratio of DRR1 recombinant protein or antidepressant to actin. G-actin was 
stored in G-buffer and the polymerization was induced in all experiments by addition of 
1:10 volume of F-buffer (10x) and 1 mM ATP. Experiments were performed under 
reducing conditions with 1 mM DTT. 
G-buffer: 2 mM Tris-HCl pH 8.0, 0.2 mM ATP, 0.2 mM CaCl2, 
0.2 mM DTT, 0.005% NaN3. 
F-buffer (10x): 250 mM Tris-HCl pH 7.4, 250 mM KCl, 40 mM MgCl2, 
10 mM EGTA. 
ATP (100x): 100 mM in ddH2O. 
DTT (100x): 100 mM in ddH2O. 
3.8.2. Pyrene-actin polymerization 
The pyrene-actin polymerization assay is a quick method to analyze the function of a 
protein as an effector of actin polymerization and/or depolymerization. Fluorescence of 
pyrene-actin is enhanced two to twenty fold by the association of actin monomers into the 
polymer form (Kouyama and Mihashi, 1981) and can be measured by excitation at 365 nm 
and emission at 407 nm. Actin polymerization was monitored by the increase in 
3. METHODS 
52 
 
fluorescence of 20% pyrene-labeled actin at 407 nm (excitation at 365 nm) in a 
fluorescence spectrometer (Jasco FP-8500, Gross-Umstadt). The final concentration of 
actin in the reaction was 5 µM (1 µM pyrene-actin). Antidepressants or DRR1 proteins 
were added to G-actin in a constant volume and polymerization was induced by the 
addition of 1:10 volume of F-buffer (10x). The polymerization was monitored for 1-1.5 h at 
21°C with a cycle interval of 5.5 s. In experiments with antidepressants, the control was 
performed with the solvent 50% EtOH/5 mM HCl. The solvent itself did not affect actin 
polymerization (Supplementary Figure 1). 
3.8.3. Actin-filament elongation and nucleation assay 
For visualization of single filament polymerization in the confocal microscope samples 
containing F-buffer (1x) and antidepressants or recombinant proteins (in a constant 
volume) were prepared. In experiments with antidepressants, the control was performed 
with the solvent 50% EtOH/5 mM HCl. The solvent itself did not affect actin 
polymerization (Supplementary Figure 1). Polymerization was induced by the addition of 
1 µM G-actin. The sample was then immediately pipetted into a flow chamber consisting 
of two coverslips (60x24 mm and 20x20 mm) separated by vacuum grease and placed in 
the confocal microscope. To avoid unspecific surface interactions casein was added to the 
samples at 0.15 mg/mL. The larger coverslips were previously cleaned with a plasma 
cleaner (40-50 s at 4-6 mbar) and N-ethylmaleimide-modified heavy meromyosin (NEM-
HMM, 2.7 µg/mL diluted in F-buffer) was bound to the surface by incubation in the flow 
chamber for 3-5 min to keep actin filaments close to the surface during live visualization. 
The time between addition of actin to the sample and initiation of the visualization was 
2 min. Images in the confocal microscope were taken with a 63x/1.4 NA oil immersion 
objective and 5x optical zoom. Time-lapse images of polymerization were acquired for 
10 min every 3 s at a scan rate of 400 Hz.  
The image analysis for single filament elongation and nucleation rate was performed with 
ImageJ. In all images the background was subtracted (rolling ball radius: 10 px, with 
sliding paraboloid algorithm) and subsequently brightness and contrast was adjusted 
automatically to the last image of polymerization and applied to all slices in the stack. A 
segmented line was drawn along the filament and plotted time versus filament length (i.e. 
fluorescence intensity) using the plugin “Multiple Kymograph”. The graph shows time (i.e. 
frames) on the Y-axis and filament length on the X-axis, both displayed in µm. The 
obtained data in µm were recalculated to actin monomers (1 µm filament contains 370 
monomers, i.e. the length increase per monomer is 2.7 nm) and time in s (using the total 
number of frames and the frame interval of 3 s). The slope of this linear graph corresponds 
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to the filament elongation rate at the barbed end2 and was about 12 actin monomers per 
second for the controls (range from 9 to 14 actin monomers/s, containing superdex buffer 
or MBP recombinant protein) depending on the actin preparation. This is in accordance 
to values described in the literature for ATP-actin at similar buffer conditions (Pollard, 
1986). The filament elongation rate of the control was set to 100% in order to compare 
different experiments. For DRR1 experiments, ten filaments from three independent 
experiments with different actin preparations were measured for each condition.  
For nucleation analysis, filaments in 4-8 frames with 30 s intervals (during the first 5 min 
of polymerization) were counted manually in ImageJ from 3 to 5 independent experiments, 
respectively. The number of filaments was plotted versus time of polymerization and the 
slope of the resulting linear graph was defined as relative nucleation rate. The control was 
set to 1. 
3.8.4. Actin networks 
For visualization of in vitro actin networks, samples were prepared with 4 µM actin and 
recombinant proteins in a constant volume at 2 µM final concentration (R = 0.5, 
DRR1 wt also in R = 0.1 and 0.25) or antidepressants in different concentrations at 
constant volume (from different stock solutions). The control was performed with the 
solvent 50% EtOH/5 mM HCl. The solvent itself did not affect actin polymerization 
(Supplementary Figure 1). To avoid unspecific surface interactions, casein was added to 
the samples in 0.15 mg/mL. Actin filaments or bundles were visualized by addition of 
Alexa Fluor 488-phalloidin (0.08 µM) to the sample. The polymerization was induced by 
the addition of 1:10 volume of F-buffer (10x) and the samples were immediately placed 
into a flow chamber. After sealing the flow chamber with vacuum grease, the samples were 
polymerized at RT for 1.5 – 2 h protected from light. Polymerized networks were then 
visualized at steady state in the confocal microscope (63x/1.4 NA oil immersion objective, 
1x or 3x optical zoom). Z-stacks of each sample were taken with a 10 µM depth and slices 
with 0.38 µm step size. Maximum projections of the stacks were made in ImageJ, the 
background was subtracted (rolling ball radius 60 px) and brightness and contrast were 
adjusted automatically. 
3.8.5. Rheology 
Actin polymerization and viscoelastic properties of the actin network were analyzed by 
Rheology in a stress-controlled macrorheometer (Physica MCR301, Anton Paar, Graz, 
Austria). A sample of 470 µL was prepared with 10 µM actin and different concentrations 
                                         
2 Barbed and pointed ends could be easily distinguished in the graph resulting from the Fiji plug-in, 
as the elongation rate, i.e. the slope of fluorescence intensity, is much lower at the pointed end. 
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of antidepressants. The control was performed with the solvent 50% EtOH/5 mM HCl. 
Immediately after initiation of polymerization (addition of F-buffer) approximately 450 µL 
of the sample were loaded and polymerized on the rheometer using a 50 mm plate 
geometry with 160 µm plate separation. The polymerization was followed for 180 min by 
recording the elastic modulus G’ at 0.5 Hz applying small torques (0.5 µNm) to ensure a 
linear response. Then, G’ of the polymerized network was analyzed in a frequency scan of 
0.01 from 10.0 Hz (7 points per decade, 5% strain). The non-linear response curve was 
measured at a shear rate of 0.125 per second for 40 s. All measurements were performed at 
21°C. 
3.8.6. F-Actin co-sedimentation 
Polymerization of 1 µM G-Actin was induced by the addition of 1:10 volume of F-buffer 
(10x) for 1 h at RT. Freshly thawed recombinant DRR1 proteins were added at 0.5 µM to 
preformed F-actin (R = 0.5) and incubated on ice for 30 min to allow proteins to bind to 
F-actin. The samples of 100 µL total volume were then centrifuged at 150,000x g for 1 h 
at 21°C in an ultracentrifuge. A total protein sample was taken prior to centrifugation 
(“T” = total protein) and after centrifugation supernatant and pellet samples (“S” = 
supernatant, “P” = pellet). Supernatant samples contain G-actin and not sedimented 
protein, while F-actin and F-actin binding proteins are found in the pellet. All samples 
were loaded on SDS-PAGE, stained with colloidal Coomassie and subsequently analyzed 
by densitometry. Since the pellet fractions could be contaminated after removal of the 
supernatant, the fraction of co-sedimented protein was calculated by subtraction of the 
supernatant fraction from the total protein. In addition, each protein was centrifuged 
alone as a control, i.e. without the presence of F-actin. The amount of protein in the pellet 
calculated for these samples was defined as the background precipitation of the protein 
and subtracted from the co-sedimented protein amount. The co-sedimented protein was 
normalized to the amount of F-actin in the respective sample. This method turned out to 
be highly reproducible and consistent. 
3.9. Statistical analysis 
Statistical analysis was performed with the SigmaPlot 12.5 software. Comparison of two 
groups was done with a two-taled t-test. A one-way ANOVA with Bonferroni post hoc 
analysis was performed for multi-group comparisons. The level of significance was set at 
p < 0.05. All data is presented as mean + SEM (* p < 0.05, ** p < 0.01, *** p < 0.001). 
Grubb’s Test was run to identify significant outliers. 
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4. Results 
4.1. Clomipramine impacts on actin dynamics 
Three antidepressants were chosen in order to study their impact on actin dynamics: 
clomipramine (clomi), doxepin (dox), and citalopram (cital). Clomipramine is a tricyclic 
antidepressant (TCA) and was developed in the early 1960s. Besides major depressive 
disorder, it is also used to treat obsessive compulsive disorder and panic disorder, among 
others. Doxepin is another tricyclic antidepressant with a variation in the “classic” TCA 
chemical structure: it features an oxygen-atom in the tricyclic structure. Finally, 
citalopram is a representative of the selective-serotonin reuptake inhibitors, a newer and 
more specific class of antidepressants. Both of the latter are used in treatment of 
depression and anxiety. 
 
Figure 3. Chemical structures of antidepressants used in this study. 
4.1.1. Clomipramine slows down actin polymerization 
Inhibition of actin polymerization by clomipramine in the pyrene-assay 
A first approach to analyze the impact of any compound or protein on actin dynamics, is 
the so-called “pyrene-assay”. Being the fundamental step of actin dynamics, the 
polymerization from monomeric actin to filaments is analyzed in this experiment in vitro 
with purified components. α-Actin is isolated from rabbit skeletal muscle and labeled with 
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the polycyclic aromatic hydrocarbon pyrene. The increase in pyrene-fluorescence upon 
polymerization – through stacking of the pyrene molecule in the filament – enables 
fluorimetric monitoring of the polymerization reaction (Kouyama and Mihashi, 1981).  
The antidepressants clomipramine, doxepin, and citalopram were added to 5 µM globular 
20% pyrene-labeled actin and the polymerization reaction was initiated by the addition of 
F-buffer. Actin polymerization was monitored by the increase in fluorescence at 407 nm in 
a fluorescence spectrometer. Antidepressants were added to the sample in a constant 
volume from different stock solutions and the control was performed with the equivalent 
volume of the solvent (50% EtOH/5 mM HCl). The solvent itself did not affect actin 
polymerization (Supplementary Figure 1). 
While there were no effects on actin polymerization by the addition of doxepin and 
citalopram, clomipramine slowed down actin polymerization. This effect was already 
observable at a molar ratio of clomi with actin of R = 2, but became more pronounced at 
higher concentrations of R = 10 and 20 (Figure 4). 
 
Figure 4. Clomipramine inhibits in vitro polymerization of pyrene-labeled actin, 
while doxepin and citalopram have no effect. 20% Pyrene-labeled actin (5 µM total 
concentration) was polymerized at RT in the presence of antidepressants and polymerization 
was monitored by the increase in fluorescence at 407 nm. Representative curves are shown 
(value at 60 min was set to 100%). „R“ refers to the molar ratio of antidepressant:actin. 
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Since the predominant cytosolic isoform of actin is β-actin, the pyrene-assay was also 
performed with β-actin from human platelets, which is commercially available. For this, β-
actin was mixed with 20% pyrene-labeled α-actin and the experiment was performed as 
described above. At R = 20, the inhibitory effect of clomipramine on β-actin 
polymerization was similar to that on α-actin polymerization (Figure 5). At an even higher 
concentration of R = 200, the polymerization was very strongly slowed down with a 
notable extension of the nucleation phase (initial lag-phase). Nevertheless, it did reach the 
equilibrium state after approximately 60 min. 
 
Figure 5. Clomipramine inhibits in vitro polymerization of pyrene-labeled β-actin 
to a similar extent as α-actin. 20% Pyrene-labeled β-actin (5 µM total concentration) was 
polymerized at RT in the presence of clomipramine and polymerization was monitored by the 
increase in fluorescence at 407 nm. Representative curves are shown (value at 60 min was 
normalized to 100%). „R“ refers to the molar ratio of clomi:actin. 
Inhibition of actin polymerization by clomipramine in a label-free assay 
In order to verify whether the inhibitory effect of clomipramine on actin polymerization is 
indeed specific on actin and not unspecific e.g. by quenching pyrene fluorescence, 
macrorheological measurements were performed with label-free actin. Rheometry is 
another method to monitor actin polymerization by measuring the viscoelastic properties 
of the actin network. The polymerization takes place between the base of the rheometer 
and a plate and is started at the beginning of the measurement. During polymerization 
small torques of 0.5 µNm are applied to the sample. The elastic response of the network to 
the torques, monitored through the elastic modulus G’, increases with the progressing 
polymerization state of the sample. A diagram similar to the pyrene-assay is the result. 
Viscoelastic properties of the network are analyzed by measuring G’ (and G’’) in a 
frequency range from 0.01 to 10.0 Hz (only G’ is shown). At the measured intermediate 
frequencies, the elastic properties of the entangled actin network are dominant. Finally, 
the non-linear response of the network to shear stress is monitored at a shear rate of 0.125 
per second for 40 s. 
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Clomipramine was added to the sample at two concentrations (R = 2 and 20) and all 
three aspects were monitored: elastic response during polymerization (Figure 6A), elastic 
properties of the network over a frequency range at polymerization equilibrium (Figure 6B 
and C), and non-linear response to deformation, i.e. shear stress (Figure 6D). In order to 
characterize the stiffness of the network, an apparent plateau modulus G0 was defined at 
G‘ of 0.01 Hz (Figure 6C). 
 
Figure 6. Inhibition of polymerization by clomipramine was confirmed with 
rheology using label-free actin. Actin (10 µM) was polymerized in a rheometer in the 
presence of clomipramine. (A) Polymerization was monitored by measuring the elastic (storage) 
modulus G‘ at a constant frequency of 0.5 Hz at RT with a torque of 0.5 µNm. (B) Elastic 
properties of the actin network were monitored by measuring the elastic (storage) modulus G‘ at 
frequencies from 0.01 to 10 Hz with 5% strain. (C) In order to characterize the stiffness of the 
network, an apparent plateau modulus G0 was defined at G‘ of 0.01 Hz. (D) The non-linear 
response curve was measured at a shear rate of 0.125 per second for 40 s. „R“ refers to the molar 
ratio of clomi:actin. 
The polymerization was slowed down as observed before in the pyrene-assays with a 
stronger effect at R = 20. Interestingly, the initial lag-phase, in which actin nucleation 
happens, seemed to be extended in comparison to the control, suggesting a potential effect 
of clomipramine on nucleation. In the frequency scan of G’, the elastic modulus G’ seemed 
to be slightly increased at both concentrations over the entire frequency range. However, 
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when comparing the plateau modulus G0, the differences seem very small and thus 
insignificant. In the non-linear response to shear stress, clomipramine seems to have slight 
but likely negligible effect on the hardening of the networks. At the maximum point of the 
non-linear response curve, the network is disrupted. This point is reached at a lower strain 
by adding clomipramine, indicating a slight effect on strain hardening. 
Clomipramine has no effect on single filament elongation 
The pyrene-assay is a quick and easy analysis for effectors of actin dynamics. However, it 
is not possible to directly assign specific effects like nucleation or capping to the effectors, 
since the read-out of pyrene-fluorescence corresponds to the whole sample and cannot be 
attributed to single filaments or even actin monomers. I.e. inhibition of single filament 
elongation or nucleation cannot be distinguished.  
Therefore, polymerization of actin in the presence of clomipramine was visualized in the 
confocal microscope to enable single filament analysis. Samples containing clomipramine at 
different concentrations and phalloidin in F-buffer were prepared and polymerization was 
induced by the addition of 1 μM G-actin from rabbit skeletal muscle. In this experiment, 
less actin is used in comparison to the pyrene-assay, in order to enable single filament 
visualization. Antidepressants were added to the sample in a constant volume from 
different stock solutions and the control was performed with the equivalent volume of the 
solvent (50% EtOH/5 mM HCl). The solvent itself did not affect actin polymerization 
(Supplementary Figure 1). The sample was then immediately pipetted into a flow chamber 
and placed in the confocal microscope. The coverslips of the flow chamber were previously 
coated with heavy meromyosin. Thereby, actin filaments are bound to the surface via 
heavy meromyosin and maintained in one focal plane for visualization. The time-lapse 
recordings were started two minutes after induction of polymerization in the confocal 
microscope (63x/1.4 NA objective, 5x zoom) taking an image every 3 s for 10 min (Figure 
7A). The image analysis for single filament elongation and nucleation rate was performed 
with the open-access image processing program ImageJ. The single filament elongation 
rate was quantified as the slope of the plot filament length vs. time. For nucleation 
analysis, filaments in 4-8 frames with 30 s intervals (during the first 5 min of 
polymerization) were counted and the slope of the plot number of filaments vs. time was 
determined as the nucleation rate. 
Clomipramine did not affect single filament elongation rate (Figure 7B), but it seems to 
slightly reduce nucleation of filaments at R = 50, i.e. at 50 times excess of clomi (Figure 
7C). The effect was not statistically significant though. Such a reduction of the nucleation 
rate is in accordance with the results from the rheological measurements, indicating, that 
nucleation might indeed be reduced. 
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Figure 7. Clomipramine has no effect on single filament elongation while it 
slightly reduces nucleation. (A) Confocal time-lapse images of in vitro actin polymerization 
(1 µM actin) in the presence of clomipramine indicate inhibition of single filament elongation at 
the barbed end. Filaments were visualized by phalloidin-488. Scale bar denotes 10 µm. „R“ refers 
to the molar ratio of antidepressant:actin. (B) Quantification of filament elongation rate 
(control, clomi R = 5 and 50 n = 2, clomi R = 20 n = 1). (C) Nucleation rate defined as the 
slope of number of filaments per frame quantified in 3-5 frames (with 30 s intervals) normalized 
to the control (control n = 3, clomi R = 5 n = 2, clomi R = 50 n = 1). Bars represent 
means + SEM. No significant difference was found in comparison to control. Statistical analysis 
was performed with one-way ANOVA and Bonferroni post hoc. 
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4.1.2. Actin networks are not affected by antidepressants 
In order to further dissect the effect of clomipramine and other antidepressants on actin 
dynamics, an interesting question is whether higher order structures of actin filaments are 
altered. Actin networks can be reconstituted in vitro and analyzed with confocal 
microscopy. A common and easy method to label actin filaments uses the phallotoxins 
from Amanita phalloides, which specifically bind F-actin, but not actin monomers. 
Covalently linked to a fluorescent dye they are commercially available as phalloidin dyes. 
Samples containing 4 µM actin isolated from rabbit skeletal muscle and antidepressants in 
different concentrations were polymerized in a sealed flow chamber for > 2 h to ensure an 
equilibrium state of the network. Polymerization was initiated by the addition of F-buffer 
and Alexa Fluor 488-phalloidin was used for visualization. Antidepressants were added to 
the sample at a constant volume from different stock solutions and the control was 
performed with the equivalent volume of the solvent 50% EtOH/5 mM HCl. The solvent 
itself did not affect actin polymerization (Supplementary Figure 1). Polymerized networks 
were then visualized at steady state in the confocal microscope (63x/1.4 NA oil immersion 
objective). Maximum projections of z-stacks of each sample are shown.  
There were no effects on actin network structure by the addition of clomipramine, doxepin 
or citalopram at R = 5 or 50 (Figure 8). All samples showed pure filamentous networks 
lacking any alterations like bundled or crosslinked filaments. 
 
Figure 8. Antidepressants have no effect on actin network structure. Actin 
networks (4 µM actin) were polymerized in the presence of antidepressants at RT for > 2 h and 
visualized with phalloidin-488. Images were taken in a confocal microscope 
(63x/1.4 NA objective, 10 µm z-stacks). Scale bar denotes 50 µm. „R“ refers to the molar ratio of 
antidepressant:actin. 
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4.1.3. Actin-dependent effects of antidepressants in cells 
Overall F-actin structure of astrocytes is unaffected by antidepressants 
After characterization of the effect of clomipramine on actin dynamics in reconstituted in 
vitro systems, the actin network in cells was analyzed for possible structural alterations. 
Primary astrocytes from rat were chosen as a relevant cellular system, as they are crucial 
cells supporting and integrating brain function. Besides their structural and metabolic 
support of neurons, astrocytes are nowadays thought to be dynamic regulators of neural 
circuits in health and disease by controlling synapse formation and maturation (Clarke 
and Barres, 2013; Nedergaard et al., 2003). Thus, important actin-dependent processes in 
astrocytes impacting on synaptic function might be affected by clomipramine.  
Primary rat astrocytes were cultivated for three days and treated with clomipramine, 
doxepin and citalopram at 1, 10 or 100 µM final concentration for 90 min. The control was 
performed with the solvent 50% EtOH/5 mM HCl. After fixing, nuclei were stained with 
DAPI, the actin cytoskeleton was stained with phalloidin and cell morphology was 
analyzed in the fluorescence microscope (Figure 9). At 1 and 10 µM, none of the three 
antidepressants showed obvious changes in F-actin structure. While doxepin and 
citalopram had no effect even at 100 µM, astrocytes treated with 100 µM clomipramine 
showed severe alterations: many cells were detached, while most of the remaining cells 
were contracted and in some cases exhibited a breakdown of stress fibers. However, an 
unspecific effect of clomipramine on the actin structure due to general cellular toxicity at 
this concentration cannot be excluded. 
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Figure 9. The overall structure of actin filaments in astrocytes is largely 
unaffected by antidepressants. Primary rat astrocytes were treated with antidepressant at 
the indicated concentrations for 90 min and fixed. Nuclei were stained with DAPI (blue), actin 
filaments with phalloidin (red). Images were taken with a fluorescence microscope (40x 
objective). Only clomipramine affects cellular morphology at high concentrations. Scale bar 
denotes 50 µm. 
2D-Migration of HeLa cells is unaffected by clomipramine 
In a next step, the impact of clomipramine on two crucial actin-dependent aspects of 
cellular function was analyzed: cell spreading and migration. Adhesion and extension of 
protrusion during spreading rely on elongation of actin filaments, while migration is a 
complex process of F-actin reorganization involving protrusion at the leading edge of a cell 
and retraction at the rear part (Pollard and Borisy, 2003; Pollard and Cooper, 2009). In 
the CNS, the importance of these processes becomes obvious in regard of neuronal 
migration during development or neurite extension during wiring of the brain. 
For two-dimensional migration analysis, a classic “wound healing” or “scratch” assay was 
performed with HeLa cells. For this, a confluent cell layer was scratched with a pipette tip 
and the closing of the scratch or “wound” was monitored over time. Clomipramine was 
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added to the cells immediately after the scratch (10 and 20 µM wide) to assess its impact 
on migration. However, it did not show effects on migration of HeLa cells (Figure 10). 
 
Figure 10. Clomipramine does not affect migration of HeLa cells in a 
2D migration assay. A confluent HeLa cell layer in a 24-well plate was scratched with a 
pipette tip to mimic a wound in the presence or absence of clomipramine. (A) The cells were 
imaged immediately after the scratch (t = 0) and after 24 h. Images were taken with a bright 
field microscope (10x objective). Scale bar denotes 100 µm. (B) The migrated area was 
quantified in ImageJ as the normalized difference of the scratch area at t = 0 and t = 24 h. 
Bars represent means + SEM (control n = 6, clomi 10 µM n = 6, clomi 20 µM n = 2). There 
was no significant difference in comparison to control. Statistical analysis was performed with 
one-way ANOVA and Bonferroni post hoc. 
High concentrations of clomipramine reduce HeLa cell spreading 
While clomipramine had no effect on cellular migration, it significantly reduced spreading 
of HeLa cells (Figure 11). In this simple assay, HeLa cells were replated on a fibronectin-
coated surface and simultaneously treated with clomipramine at 15 or 50 µM during 
spreading for 30 min. As a positive control for decreased actin polymerization the drug 
Cytochalasin D (Cyto D) was added to the cells at a final concentration of 2 µM. 
Cytochalasins are natural occurring molecules that inhibit polymerization by capping the 
growing ends of the filaments and thereby reduce cell spreading (Domnina et al., 1982; 
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Sampath and Pollard, 1991). While clomipramine had no effect on spreading at 15 µM, it 
reduced the cell size after 30 min of spreading to approximately 50% of the control cell 
size at 50 µM (Figure 11B). Cyto D, however, was much more potent in reducing cell size: 
at only 2 µM cells reached only about 25% of the control cell size.  
 
Figure 11. Clomipramine reduces spreading of HeLa cells at high concentrations. 
HeLa cells were replated on fibronectin-coated coverslips in the presence of clomipramine or 
Cyto D. After 30 min of spreading, cells were fixed and F-actin was stained with phalloidin. 
(A) Images were taken in a fluorescence microscope. Scale bar denotes 50 µm. 
(B) Quantification of cells size was performed in ImageJ. Bars represent means + SEM (n = cell 
number from one experiment, control and clomi n = 100-200 cells, Cyto D n = 30 cells). 
*** p < 0.001 in comparison to control. Statistical analysis was performed with one-way 
ANOVA and Bonferroni post hoc. 
Taken together, clomipramine was the only of the three tested antidepressants to affect 
actin dynamics. It reduced actin polymerization in both, a label-based and a label-free 
approach, and this reduction can likely be attributed to decreased nucleation. Yet, in cells 
it only seems to affect actin-dependent processes at high concentrations (around 50 µM), 
while showing toxic effects at short treatments of 50-100 µM as evidenced by the 
unhealthy morphology of cells treated with this concentration (compare with Figure 9). 
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4.2. The stress-induced protein DRR1 
The aim of this study was to thoroughly analyze the molecular effect of DRR1 on actin 
dynamics as well as to embed these findings into the overall knowledge about actin 
dynamics at the synapse and to shed light on DRR1’s relevance for synaptic transmission 
and plasticity. 
4.2.1. DRR1 has a tripartite effect on in vitro actin-
dynamics 
DRR1 directly interacts with F-actin 
Initially, the actin binding ability of DRR1 was verified in cultured cells and in vitro with 
purified recombinant proteins. As a first step, actin binding of DRR1 ectopically expressed 
in HEK-293 cells was analyzed. DRR1 was overexpressed as a fusion protein with EGFP 
in HEK-293 and co-immunoprecipitated using GFP-Trap®. This Co-IP is based on 
agarose beads coupled to so-called nanobodies, recombinant single domain antibody 
fragments derived from alpaca, which feature high binding capacity and affinity. As 
expected and previously seen, DRR1 strongly bound actin in the Co-IP (Figure 12A) 
(Schmidt et al., 2011). The control was performed with EGFP protein and no actin 
binding could be detected. 
However, indirect binding of DRR1 to actin cannot be excluded with the Co-IP 
experiment. It is also impossible to deduce whether binding occurs at actin monomers or 
filaments. Thus, an in vitro binding assay specific for F-actin was performed with purified 
recombinant DRR1 and purified actin from rabbit skeletal muscle. Actin filaments can be 
separated from globular actin by centrifugation at ~150,000x g. While actin filaments 
sediment at this speed together with any F-actin binding proteins, G-actin remains in the 
supernatant. DRR1 was expressed in E. coli bacteria as a fusion protein with the maltose 
binding protein (MBP) in order enhance its solubility and stability as well as for affinity 
purification.  
For the co-sedimentation experiment, actin was polymerized at RT for 1 h to reach the 
equilibrium state. DRR1 was then added to the preformed filaments and after 30 min of 
incubation the sample was centrifuged to separate F- and G-actin. Samples of total 
protein (T) prior to centrifugation, supernatant (S) containing G-actin and non-F-actin 
binding protein, and pellet (P) samples with F-actin and F-actin binding protein were 
taken and analyzed by SDS-PAGE and colloidal Coomassie staining (Figure 12B). Actin 
and DRR1 were distinguished on the gel by their difference in molecular weight: actin has 
42 kDa and DRR1 (as a fusion protein with MBP) 60 kDa. The control was performed 
with the protein MBP. All experiments with recombinant proteins were performed with 
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buffer only and MBP as controls, respectively. Since there were no detectable differences 
between buffer and MBP, the latter is shown in all figures as control. MBP itself did not 
affect actin dynamics (Supplementary Figure 1). 
The amount of co-sedimented DRR1 (amount in P) was indirectly calculated as the 
difference before and after centrifugation (i.e. amount in S subtracted from the amount in 
T). A control without F-actin was made for each sample and subtracted from the co-
sedimentation value, i.e. DRR1 was centrifuged alone, to quantify background 
sedimentation. The background-corrected co-sedimented DRR1 was then normalized to 
the amount of F-actin in each corresponding sample, also indirectly calculated from the 
decrease of actin signal from the total sample to the supernatant sample. Samples from 
the total protein and the supernatant are more adequate for quantification, as they are 
clean from contaminations. The pellet sample on the other hand is contaminated with 
supernatant and was therefore only used as a visual reference on the protein gel. 
In spite of its complexity, this method of quantification was reliable and highly 
reproducible. In contrast, simply measuring the amount of protein in the pellet showed 
considerable variations derived from fluctuating amounts of residual supernatant. 
At a ratio of DRR1:actin of 1:10 about 60% of DRR1 is bound to F-actin, demonstrating 
direct binding of DRR1 to the filament (Figure 12C). With increase of DRR1, the 
percentage of co-sedimentation decreased slightly. At R = 0.25, roughly 58% of DRR1 
protein co-sedimented, while at a ratio of 1:2, about 50% of DRR1 was found in the pellet. 
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Figure 12. DRR1 binds actin in HEK-293 and F-actin in vitro in a concentration-
dependent manner. (A) Co-immunoprecipitation with GFP-Trap® of DRR1 fused to EGFP 
overexpressed in HEK-293 cells. Control was performed with EGFP alone. Lysate and eluate 
samples were analyzed by SDS-PAGE and Western Blot. A representative Western Blot is 
shown. (B) Co-sedimentation of DRR1 recombinant protein with preformed F-actin (1 µM) by 
ultracentrifugation. Coomassie-stained SDS-PAGE with total (T), supernatant (S) and pellet 
(P) fractions for controls and wt in different concentrations are shown. „R“ refers to the molar 
ratio of DRR1:actin. (C) Quantification of co-sedimented protein (DRR1 in R = 0.1, 0.25, 0.5) 
was calculated by subtracting background sedimentation (“- actin“ samples) and is shown as the 
fraction of total protein (n = 3). Bars represent means + SEM. *** p < 0.001 in comparison to 
control. Statistical analysis was performed with one-way ANOVA and Bonferroni post hoc. 
  
4. RESULTS 
69 
 
DRR1 slows down actin polymerization in the pyrene-assay 
The impact of DRR1 on actin polymerization was analyzed in a pyrene-assay as described 
before for antidepressants (chapter 4.1.1.). Shortly, the fluorescence of actin labeled with 
the aromatic hydrocarbon pyrene is strongly enhanced upon polymerization. This effect is 
used to monitor the polymerization reaction. DRR1 was added as a purified protein to 
5 µM 20% pyrene-labeled actin at different concentrations (1.5, 3 and 5 µM) and the 
polymerization reaction initiated by the addition of F-buffer. In a fluorescence 
spectrometer, the reaction was monitored by following the absorbance at 407 nm. 
At the lowest concentration (R = 0.3), DRR1 strongly slowed down the polymerization 
reaction. This effect was concentration-dependent and increased with more DRR1. While 
the control reached equilibrium after around 80 min, even with the lowest DRR1 
concentration of R = 0.3, it did not fully reach equilibrium after 90 min. The end-point 
fluorescence value in the pyrene-assay provides an estimate of the amount of F-actin in 
the sample if the sample consists of filamentous actin only. With DRR1, this apparent 
amount was remarkably reduced. However, certain factors can distort the final value, 
especially light scattering due to network or bundled actin structures. Without knowledge 
of the network structure, the end value of the pyrene-assay can therefore not directly be 
attributed to the amount of F-actin.  
 
Figure 13. DRR1 inhibits in vitro polymerization of pyrene-labeled actin. Actin 
filaments (c = 5 µM, 20% labeled with pyrene) were polymerized in the presence of DRR1. 
Increase in fluorescence of pyrene-actin during polymerization of G-actin to F-actin was 
monitored in 5 s intervals for 90 min. Representative curves are shown. „R“ refers to the molar 
ratio of DRR1:actin. 
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DRR1 generates thick bundles in F-actin networks 
In order to answer the question whether actin networks are altered by DRR1 and to verify 
its previously reported bundling activity, purified G-actin was polymerized in a sealed flow 
chamber in the presence of DRR1. Phalloidin was added coupled to a fluorophore to 
visualize actin filaments. Networks were polymerized > 2 h at RT to ensure an 
equilibrium state. Polymerized networks were then visualized at steady state in the 
confocal microscope (63x/1.4 NA oil immersion objective). Maximum projections of z-
stacks of each sample are shown. 
The polymerization in the absence of DRR1 (control) produced a purely entangled 
filamentous network, where single filaments can hardly be distinguished. In the presence of 
DRR1, thick actin bundles started to appear already at a ratio of 1:10, verifying the 
known bundling effect. At R 0.1, the network is composed of a mixture of filaments and 
bundles, with apparently more filaments. With increasing amount of DRR1, this pattern 
shifts towards more bundles resulting in a heavily bundled network at R = 0.5 (Figure 
14).  
Due to these bundles, the fluorescence of pyrene-actin in the previous assay is likely to be 
strongly reduced. Therefore, no conclusion about the amount of F-actin polymerized in the 
presence of DRR1 can be drawn from the pyrene-assay. 
 
Figure 14. DRR1 strongly bundles actin filaments in a polymerized network. Actin 
networks (4 µM actin) were polymerized in the presence of DRR1 at RT for > 2 h and 
visualized with phalloidin-488. Images were taken in a confocal microscope 
(63x/1.4 NA objective, 10 µm z-stacks). Scale bar denotes 50 µm. „R“ refers to the molar ratio of 
DRR1:actin. 
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DRR1 reduces single filament elongation and increases nucleation 
Finally, the polymerization reaction in the presence of DRR was also visualized in the 
confocal microscope, to analyze effects on single filament elongation and nucleation. In 
contrast to the networks above, where 10 µm thick z-stacks of the network were imaged, 
in this assay, actin filaments were bound to the surface via heavy meromyosin, which was 
adsorbed to the surface. Therefore, single filaments can be imaged and bundling of the 
filaments is likely to be strongly reduced.  
Samples were prepared containing F-buffer for polymerization and DRR1 at different 
concentrations and the polymerization was initiated by the addition of G-actin. The 
sample was then immediately pipetted into a flow chamber and placed in the confocal 
microscope. At 2 min after starting the polymerization, images of the growing filaments 
were recorded every 3 s for 10 min (63x/1.4 NA objective, 5x zoom).  
With this approach, a novel effect of DRR1 was revealed: the time-lapse images showed 
reduced elongation, while apparently more filaments were polymerizing in the captured 
field, suggesting enhanced nucleation (Figure 15A).  
The image analysis for single filament elongation and nucleation rate was performed with 
ImageJ. The single filament elongation rate was quantified as the slope of the plot 
filament length vs. time. For nucleation analysis, filaments in 4-8 frames with 30 s 
intervals (during the first 5 min of polymerization) were counted and the slope of the plot 
number of filaments vs. time was determined as the nucleation rate. The barbed and the 
pointed end of the filaments could clearly be distinguished because of the growth rate, 
indicating that the addition of new actin subunits at the barbed ends was heavily 
inhibited by DRR1. This effect is commonly described as filament capping. 
At R = 0.1, DRR1 reduced the single filament elongation rate to 30% of the control. At 
R = 0.25 the elongation rate was about 20% and at R = 0.1 less than 10%. These results 
present DRR1 as a potent capping protein, a function that was unknown before. 
Moreover, quantification of the nucleation rate showed enhanced nucleation concomitant 
with the novel capping effect. The nucleation was enhanced more than 3fold at R = 0.5. 
While this effect was significant and notable, it seems to be less significant than the 
capping effect. Furthermore, the enhanced nucleation could be an indirect effect in vitro 
dependent on the strong capping activity. With the strongly reduced growth of the 
filaments, the concentration of G-actin remains higher over time, allowing for a higher 
nucleation rate.  
Taken together, a tripartite effect of DRR1 on actin dynamics was revealed in vitro. In 
addition to the previously described bundling effect, a pronounced capping activity was 
identified concomitant with nucleation activity. Thereby DRR1 shifts the actin network 
towards more, shorter and strongly bundled filaments.  
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Figure 15. DRR1 strongly reduces single filament elongation and increases 
nucleation rate. (A) Confocal time-lapse images of in vitro actin polymerization (1 µM actin) 
in the presence of DRR1 indicates inhibition of single filament elongation at the barbed end. 
Filaments were visualized by phalloidin. Scale bar denotes 10 µm. „R“ refers to the molar ratio 
of DRR1:actin. (B) Quantification of filament elongation rate normalized to the control (n = 3, 
DRR1 in R = 0.1, 0.25, 0.5). (C) Nucleation rate defined as the slope of number of filaments per 
frame quantified in 3-5 frames (with 30 s intervals) normalized to the control (n = 3 – 4, DRR1 
in R = 0.1, 0.25, 0.5). Bars represent means + SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 in 
comparison to control. Statistical analysis was performed with one-way ANOVA and Bonferroni 
post hoc. 
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4.2.2. The functions of DRR1 are executed by two actin-
binding regions and a dimerization domain 
Domain analysis of DRR1 and design of truncation mutants 
In order to identify actin binding regions of DRR1, several truncation and point mutants 
were generated. As there is no crystal structure available for DRR1, a sequence 
conservation analysis and a secondary structure prediction were made to design the 
mutations. 
Murine DRR1 is a highly conserved protein with 144 amino acids containing the 
“conserved domain of unknown function 1151” (Figure 16A). Its paralog FAM107B lacks 
the first 15 N-terminal amino acids, but otherwise is highly conserved among most species 
from human, mice and rat to Xenopus and zebrafish. The secondary structure prediction 
revealed it to be a predominantly helical protein with three helices. The N-terminal 
domain is mostly unstructured loop region with a small helix, followed by the largest helix 
in the middle domain and a third C-terminal helix. A coiled coil motif was predicted from 
amino acids 66 to 93, i.e. within the central helical region, in the murine sequence. Coiled 
coils are protein motifs known to mediate protein-protein interactions and as such are 
interesting domains to be analyzed (Figure 16B). 
Based on the tripartite domain structure suggested by the secondary structure prediction, 
three mutants were cloned during previous work each lacking one domain: dN, dC and 
dM, as well as the isolated central helix M (Kretzschmar, 2010). In the present study, 
three further mutants were cloned: the N-terminal domain (N) and two point mutants 
dPEPE and C94A (Figure 16C). The mutant dPEPE was published by Le et al., 2010, as 
a mutant lacking the actin binding sites of DRR1 as concluded from colocalization 
analysis in cells. Two so-called “PE-motifs” at positions 65 and 122 were mutated to AA, a 
mutation that disrupted colocalization with actin in cells (Lee et al., 2010). DRR1 exerts 
only one cysteine residue at position 94. The previously described interaction with Prdx1 
(Schmidt et al., 2011) led to the speculation that C94 might have a potential redox-
regulated function. Thus, the C94A mutant was generated. 
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Figure 16. Domain structure and mutants of DRR1. (A) Murine DRR1 has 144 amino 
acids and contains the „domain of unknown function 1151“ from amino acid 16-133. 
(B) Sequence conservation of DRR1 with the closely related protein FAM107B from human, rat 
and mouse is shown. Secondary structure prediction was performed with the „Predict Protein 
Server“ (green: loop, red: helix). Coiled coil prediction was performed with the online tool „Coils“ 
(window: 21). (C) Truncation and point mutants of DRR1 used in this work. dPEPE was 
published by Le et al., 2010, as a mutant lacking the actin binding sites of DRR1 as concluded 
from colocalization analysis in cells. 
Identification of two actin binding regions in DRR1 
Using the same two approaches as for the wild type DRR1 (wt), the actin binding abilities 
of the mutants were analyzed with a Co-IP experiment in HEK-293 cells and in an F-actin 
co-sedimentation assay (described in chapter 4.2.1.). 
The Co-IP using GFP-Trap showed that all mutants except M are able of co-precipitating 
actin from HEK-293 cells (Figure 17A). The finding that both the mutants dN and dC 
bound actin, while the M mutant didn’t, indicates the presence of two separate actin 
binding regions in DRR1. Likely, the first and the third helix bind actin, while the central 
helix containing the coiled coil motif mediates protein-protein interactions. The series of 
Co-IPs, however, showed some variations from experiment to experiment. For 
quantification of the relative actin binding, the “mean actin binding” in each experiment 
was calculated from the amount of (background corrected) actin in the eluates of wt, dN, 
dC, dM and M, and the binding of each DRR1 mutant was related to this mean. While 
the wt, dN and dM mutants showed statistically significant actin binding, this was not the 
case for dC, M and N. It was remarkable that dPEPE showed actin binding similar to 
DRR1 wt, in spite of being previously described as non-actin binding mutant. 
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Figure 17. DRR1 shows two actin binding regions separated by a central non-
binding region. (A) Co-immunoprecipitation with GFP-Trap® of DRR1 wt and mutants fused 
to EGFP overexpressed in HEK-293 cells. The control was performed with untagged EGFP 
instead of the DRR1-EGFP fusions. Lysate and eluate samples were analyzed by SDS-PAGE 
and Western Blot. A representative Western Blot is shown. (B) Quantification of Co-
immunoprecipitation (n = 8, dN and M n = 7, N n = 4). Background corrected actin binding 
was normalized to mean actin binding for each experiment. Bars represent means + SEM. 
*** p < 0.001 in comparison to control. Statistical analysis was performed with one-way 
ANOVA and Bonferroni post hoc. 
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Figure 18. Both actin binding regions bind F-actin in vitro. (A) Co-sedimentation of 
DRR1 wt and mutants recombinant protein with preformed F-actin (1 µM) by 
ultracentrifugation (R = 0.5). Coomassie-stained SDS-PAGE with total (T), supernatant (S) 
and pellet (P) fractions for mutants are shown. (B) Quantification of co-sedimented protein was 
calculated by subtracting background sedimentation (“- actin“ samples) and is shown as the 
fraction of total protein normalized to the respective amount of F-actin (n = 3).„R“ refers to the 
molar ratio of DRR1:actin. Bars represent means + SEM. * p < 0.05, *** p < 0.001 in 
comparison to control. Statistical analysis was performed with one-way ANOVA and Bonferroni 
post hoc. 
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The co-sedimentation experiment as an indicator of F-actin binding in vitro appeared to 
be more reliable and reproducible than the Co-IP. According to the results from the Co-
IP, there was highly significant binding to F-actin for DRR1 wt and the mutants dN, dM, 
and C94A. The mutants dC and N showed some binding, but the level of significance was 
not reached (Figure 18). The control (with untagged MBP), M and dPEPE did not co-
sediment with F-actin. Two findings diverged from the Co-IP. First, dPEPE did not bind 
F-actin, suggesting that the binding found with the Co-IP might be derived from 
interaction with G-actin. Second, dC showed stronger binding to F-actin than dN, 
although in the Co-IP dN co-precipitated more actin than dC. Presumably, the two-actin 
binding sites diverge in their affinities towards G- and F-actin. 
Slowdown of actin polymerization in the pyrene-assay by the mutants dM and 
C94A 
The DRR1 mutants were also assessed in the pyrene-assay. Only two mutants slowed 
down polymerization to a similar extent as DRR1 wt: dM and C94A. While dN and M 
showed virtually no difference to the control, dC and dPEPE appeared to alter the shape 
of the polymerization curve slightly ending up with less F-actin (Figure 19). As outlined 
above (see chapter 4.2.1.), this might be influenced by scattering of the light caused by 
the actin network structure or to slight variations in the amount of G-actin in the sample 
(derived from pipetting inaccuracy). 
 
Figure 19. In vitro polymerization of pyrene-labeled actin is inhibited by 
DRR1 wt, dM and C94A. Actin filaments (5 µM, 20% labeled with pyrene) were 
polymerized in the presence of DRR1 proteins (R = 0.5). Increase in fluorescence of pyrene-actin 
during polymerization of G-actin to F-actin was monitored in 5 s intervals for 90 min. Purified 
MBP instead of the MBP-DRR1 fusion proteins served as control. Representative curves are 
shown. 
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Effects of DRR1 mutants on single filament elongation and nucleation 
In order to analyze the effects of the mutants on single filament elongation and nucleation, 
polymerization was visualized by confocal microscopy as before (for DRR1 wt, see Figure 
15). The prevailing reduction of filament elongation rate concomitant with enhanced 
nucleation found for DRR1 wt was also observed for the mutants dM and C94A. 
Therefore, the reduction of polymerization in the pyrene-assay can clearly be attributed to 
reduced single filament elongation, i.e. capping. This capping effect is only effective with 
both actin binding regions of DRR1, as only the mutants featuring both regions, i.e. dM 
and C94A, displayed this effect.  
Intriguingly, the mutant dPEPE showed a slight, albeit not significant reduction of the 
polymerization rate, but enhanced nucleation comparable to the wt. Again, this might 
suggest a certain activity of dPEPE in binding to G-actin or even in stabilizing actin 
nuclei, but the capping effect at the filament is lacking as the mutant is unable to bind to 
F-actin. Moreover, this result suggests nucleation as an independent effect of capping.  
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Figure 20. Single filament polymerization is inhibited by DRR1 wt, dM and 
C94A, while nucleation is enhanced by DRR1 wt, dM, dPEPE and C94A. 
(A) Confocal time-lapse images of in vitro actin polymerization (1 µM actin) in the presence of 
DRR1 mutants (R = 0.5) indicates inhibition of single filament elongation only for wt, dM and 
C94A. Images at 5 min after induction of polymerization are shown. Filaments were visualized 
by phalloidin-488. Scale bar denotes 10 µm. (B) Quantification of filament elongation rate 
normalized to the control (MBP instead of the DRR1-MBP fusion proteins, n = 3). 
(C) Nucleation rate defined as the slope of number of filaments per frame quantified in 3-5 
frames (with 30 s intervals) normalized to the control (dN, N, dPEPE and C94A n = 3, wt and 
N n = 4, control, dC and dM n = 5). „R“ refers to the molar ratio of DRR1:actin. Bars 
represent means + SEM. *** p < 0.001 in comparison to control. Statistical analysis was 
performed with one-way ANOVA and Bonferroni post hoc. 
  
4. RESULTS 
80 
 
Effects of DRR1 mutants on actin bundling 
There are several ways in which a protein can crosslink or bundle actin filaments: either 
the protein exerts (at least) two actin binding sites mediating direct crosslinking, or it 
exerts one binding site and is able to dimerize, generating crosslinks as a dimer (or 
multimer). In order to dissect this aspect of DRR1’s molecular mechanism, actin networks 
polymerized in presence of each mutant were visualized in the confocal microscope as 
described above (chapter 4.2.1). 
 
Figure 21. All DRR1 mutants show deficits in actin bundling. Actin networks (4 µM 
actin) were polymerized in the presence of DRR1 wt or mutants at RT for > 2 h and visualized 
with phalloidin-488 (R = 0.5 each protein, „R“ refers to the molar ratio of DRR1:actin). Images 
were taken in a confocal microscope (63x/1.4 NA objective, 3x zoom, 10 µm z-stacks). Scale bar 
denotes 20 µm. 
In spite of exerting two actin binding sites, the mutant dM did only show amorphous 
bundle “aggregates”, but no proper actin bundling activity, suggesting that the central 
region is necessary as a spacer for accurate positioning of the two actin binding regions. 
Surprisingly, the mutants dN and dC both had an impact on actin networks, although 
exerting only one actin binding region each. While dC showed bundle-like aggregates, dN 
generated nicely bundled actin similar to the wt in a lower concentration (see Figure 14, 
wt R = 0.1). The presence of these bundles and aggregates with these two mutants is 
likely allegeable to homodimerization of DRR1. The mutants M, N and dPEPE had no 
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effect on the actin networks and appeared similar to the control. This was expected in all 
three cases: for M and dPEPE due to the missing F-actin binding ability, and in the case 
of N due to exerting only one actin binding site. C94A showed a strong bundling activity 
as expected. However, the bundles appeared to be less stiff and narrow than the ones of 
the wt as their visual appearance was longer, less straight and more diffuse (Figure 21). 
Analysis of homo-dimerization of DRR1 
To evaluate dimerization of DRR1 more directly, HEK-293 cells ectopically expressing 
DRR1 were treated with chemical crosslinkers. Two crosslinkers were selected: DSS 
(Disuccinimidyl suberate), a lysine-lysine crosslinker and BMB (1,4-Bismaleimido-butan), 
a cysteine-cysteine crosslinker. While DRR1 features many lysine residues, it only has one 
cysteine at position 94. In addition, with a spacer arm length of 11.4 Å, DSS is slightly 
longer than BMB with 10.9 Å. Both crosslinkers are membrane-permeable allowing for 
intracellular crosslinking. 
Cells were detached from the surface, intracellular crosslinking was performed in 
suspension and the cells were lysed after quenching the reaction. The lysates were 
analyzed with SDS-PAGE and Western Blot. With DSS, about half of DRR1 wt was 
crosslinked into a dimer. Both mutants dN and dC still were crosslinked to a dimer, but 
significantly less than the wt. The mutant dM, having both actin binding regions but 
lacking the central spacer, still showed some dimerization, roughly about 1/4 of the 
protein. Finally, there is also evidence for dimerization of the mutant M, but much less 
than all other mutants (Figure 22B). These results suggest that dimerization is brought 
about the central region presumably containing the coiled coil although it might depend 
on F-actin binding. In addition, binding to F-actin likely increases and stabilizes 
dimerization. Furthermore, the possibility cannot be excluded that the dimer-sized band 
after crosslinking is not only derived from a dimerized DRR1, but is also due to its dense 
packing within the bundle. 
With the cysteine-cysteine crosslinker BMB similar results were obtained (Figure 22C). 
Neither the mutant dM nor C94A were dimerized as they are lacking the cysteine residue. 
dN and dC showed stronger dimer bands than with DSS and dPEPE was strongly 
dimerized as well. Only the potential dimer bands below 15 kDa of the mutant M 
appeared to be much weaker, if present. Nevertheless, the crosslinking of dN, dC and M 
mediated by cysteine at position 94 further suggest dimerization of DRR1 via the central 
coiled coil motif. As also dPEPE, which lacks F-actin binding ability, is crosslinked into a 
dimer, it is likely that DRR1 is dimerized independently of the position at the actin 
filament. 
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Figure 22. DRR1 is crosslinked by the chemical crosslinkers DSS and BMB in 
HEK-293 cells. (A) Expected molecular weight (MW) for DRR1 monomers and dimers in 
kDa. HEK-293 cells transfected with DRR1 wt or mutants were incubated with the lysine-lysine 
crosslinker DSS (B) or the cysteine-cysteine crosslinker BMB (C). Lysates were analyzed by 
SDS-PAGE and Western Blot. Representative Western Blots are shown. 
The model of DRR1 homodimerization via the central helix in the M domain and 
presumably via the coiled coil was further tested with actin networks polymerized in the 
presence of a mixture of DRR1 wt and the mutant M in a 1:1 molar ratio and visualized 
in the confocal microscope with phalloidin as indicated above. Indeed, M interfered with 
the wt-induced bundling, as the actin network appeared less bundled and showed F-actin 
clusters when M was added to DRR1 wt (Figure 23, compare the second and the fourth 
panel). This is consistent with the mutant M being able to dimerize with DRR1 wt and 
since it misses F-actin binding regions it reduces bundling. 
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Figure 23. The middle domain interferes with actin bundling of full length DRR1 
(wt). Actin networks (4 µM actin) were polymerized at RT for > 2 h and visualized with 
phalloidin-488 (R = 0.5 each protein, „R“ refers to the molar ratio of DRR1:actin). Images were 
taken in a confocal microscope (63x/1.4 NA objective, 10 µm z-stacks). Scale bar denotes 50 µm. 
4.2.3. DRR1 localizes to both the cytosol and the nucleus 
Wang et al. described a nuclear localization for ectopic DRR1 in the cell line HTB-46 
derived from renal cell cancer using MYC-based detection of tagged DRR1 and propidium 
iodide counterstaining of nuclei. Moreover, a nuclear localization signal (NLS) was 
predicted for the central region from amino acids 90 to 106 in the human DRR1 sequence 
(Wang et al., 2000). However, using the freely available secondary structure prediction 
tool “Predict protein server” (https://www.predictprotein.org/) for the mouse DRR1 
sequence no NLS was predicted. A nuclear localization was also confirmed in the lung 
cancer cell line A549, as about 76% of cells ectopically expressing a DRR1-EGFP fusion 
showed a signal in the nucleus (Zhao et al., 2007).  
In order to verify these findings as well as to analyze the subcellular localization of all 
DRR1 mutants used in this work, a biochemical fractionation of the cytosol and nucleus 
was performed. For this, the outer membrane of HEK-293 cells ectopically expressing 
DRR1 wt or mutants was lysed with a hypotonic lysis buffer without disrupting the 
nuclear membrane. Cytosolic fractions were separated by centrifugation and nuclei were 
lysed after repeated washing with an SDS-containing lysis buffer. Equivalent protein 
amounts from cytosolic and nuclear fractions were loaded on SDS-PAGE gels and 
analyzed with Western Blot. To ensure correct cellular fractionation in the Western Blot, 
the kinase AKT was used as a cytosolic and the acetyl-histone-H4 as a nuclear control. 
These showed a slight contamination of the nuclear samples with cytosolic protein, but 
cytosolic samples appeared very clean of nuclear proteins. 
For DRR1 wt more than half of the protein signal was detected in the nuclear sample. 
The mutants dPEPE and C94A showed a similar distribution pattern between cytosol and 
nucleus. In contrast, dN, dM and M mutants showed a lower signal in the nucleus and a 
stronger signal in the cytosol. The biggest divergence in comparison to the wt was found 
for the mutant dC: the nuclear signal was strongly reduced and about 90% of the protein 
appeared to be localized in the cytosol (Figure 24). All mutants include the putative 
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nuclear localization signal from human DRR1, except for the dM mutant which lacks the 
region from amino acid 64 to 94 and therefore would miss the first five amino acids of the 
NLS. However, this putative NLS does not seem to be decisive for nuclear localization of 
ectopic DRR1 in HEK-293 cells. 
 
Figure 24. DRR1 wt and all mutants localize to the nucleus in HEK-293 cells. 
Cytosolic and nuclear fractions of cells expressing ectopic DRR1 wt or mutants were analyzed 
by SDS-PAGE and Western Blot. Clean fractionation of cytosol I and nucleus (N) was 
confirmed with antibodies against the cytosolic kinase AKT and the nuclear acetyl-histone H4. 
Representative Western Blots are shown. 
4.2.4. DRR1 binds and increases F-actin in cells 
Colocalization of DRR1 and F-actin in HeLa cells 
Functionally interacting proteins are often organized in cellular clusters. For DRR1, 
localization along stress fibers, membrane ruffles and other actin-rich structures had been 
shown previously (Le et al., 2010; Schmidt et al., 2011). The colocalization of DRR1 with 
actin in cultured HeLa cells was therefore analyzed and quantified for each mutant. 
HeLa cells ectopically expressing DRR1 for 24 h were fixed and nuclei stained with DAPI, 
F-actin was stained with phalloidin and DRR1 with specific antibody. Quantification of 
colocalization was performed using whole cells as regions of interest (ROI) and Pearson’s 
correlation coefficient (PCC) was calculated in ImageJ with the plugin “Coloc2”. The PCC 
is a standard and well-established procedure for measuring the degree of overlap (Adler 
and Parmryd, 2010; Manders et al., 1992). The test of significance of the PCC was 
performed by randomization of the image (Costes et al., 2004). In contrast to other 
colocalization measures, the PCC is independent of the gain and offset of the image and 
measures correlation. Thereby, it reflects direct or indirect dependency of the two 
intensities. 
Representative HeLa cells are shown in Figure 25. The PCC with the number of cells used 
for quantification (n, from two independent experiments), the standard error of the mean 
(SEM) and the squared PCC (PCC²) are shown in Table 1. In this table, the mutants 
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were ordered by descending PCCs for easier estimation of the relative colocalization. 
Although the interpretation of the PCC is not straight forward, as a rule of thumb, a 
PCC > 0.4 can be regarded as a strong positive correlation. DRR1 wt, dN, dC, dM, 
dPEPE and C94A had PCCs above 0.4. This colocalization was mainly derived from stress 
fibers and filopodia as visually assessed. The non-actin binding mutant M was the only 
one to show a weak correlation with a PCC < 0.3.  
The coefficient is the ratio between the covariance of the channels and the product of their 
standard deviations. Hence, the squared value of the PCC is the percentage variance in 
the actin channel that can be explained by alterations in the DRR1 channel, and vice 
versa (Dunn et al., 2011). For DRR1 wt, the PCC² indicates about 30% of covariance 
between F-actin and DRR1. 
DRR1 PCC N SEM PCC² ± SEM (%) 
wt 0.543 14 0.0432 29.5 ± 4.32 
C94A 0.561 7 0.0904 31.5 ± 9.04 
dM 0.52 10 0.0376 28.3 ± 3.76 
dN 0.500 14 0.0335 25.0 ± 3.35 
dC 0.453 15 0.0462 20.6 ± 4.62 
dPEPE 0.446 12 0.0856 19.9 ± 8.56 
M 0.268 7 0.0813 7.2 ± 8.13 
Table 16. Colocalization parameters of DRR1 and actin. 
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Figure 25. DRR1 wt and dN localize along actin stress fibers in HeLa cells 
(continued from previous page). HeLa cells were transfected with DRR1 plasmids or empty 
vector as a control and fixed 24 h after transfection. Nuclei were stained with DAPI (blue), F-
actin with phalloidin (red) and DRR1 with specific antibody (green). Images were taken with a 
confocal microscope (40x/1.15 NA objective, 3x zoom). Representative cells are shown. Scale bar 
denotes 20 µm. 
Increase of mean cellular F-actin in DRR1-expressing cells 
HeLa cells ectopically expressing DRR1 could in fact be identified within the actin 
fluorescence channel, as they often showed a stronger phalloidin staining indicating a 
higher amount of cellular F-actin. This observation led to the quantification of the mean 
F-actin per cell. HeLa cells were transfected with DRR1 plasmids (or empty vector 
control) and fixed after 24 h. F-actin was stained with fluorophore-labeled phalloidin and 
DRR1 with a specific antibody. Images were taken with a confocal microscope (Figure 
26A). Quantification was performed in ImageJ by measuring the mean gray value of each 
cell in both channels, actin and DRR1. Transfected cells were defined with a gray value of 
> 500 (in a 16-bit image), and the mean gray value in the actin channel of transfected 
cells was normalized to the mean gray actin value in control cells. For each condition, 30-
200 cells from 5-10 images were analyzed.  
The amount of F-actin per cell in DRR1 wt-transfected cells was more than three times 
higher than in the control. The mutants dM and C94A increased the amount of F-actin 
about three times, while dN increased F-actin about two times in comparison to the 
control. The other mutants, dC, M and dPEPE showed no significant increase of F-actin 
(Figure 26B). Together with the data from in vitro experiments this leads to the 
suggestion that all three molecular effects of DRR1 contribute to the higher amount of F-
actin in cells with DRR1 overexpression: bundling, capping and nucleation. The mutant 
dM shows the second highest increase in F-actin after the wt, in spite of lacking bundling 
activity. Thus, the increase is likely mediated by enhanced nucleation and capping. The 
C94A mutant exerts the same tripartite effect as the wt although less pronounced, and 
consequently the F-actin in the cell is increased to a slightly lower extent than in the case 
of DRR1 wt overexpression. Finally, the mutant dN still increased F-actin two-fold, 
although it does neither cap nor nucleate, indicating that the bundling activity of dN is 
stabilizing F-actin, and results in an increase of cellular F-actin. The mutants M and 
dPEPE had no effect on actin network structure and didn’t alter F-actin as expected, 
while the mutant dC only generated amorphous bundles that didn’t result in stabilization 
of F-actin within the cell. 
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Figure 26. Mean F-actin per cell is increased with DRR1 wt, dN, dM and C94A 
overexpression. (continued from previous page). HeLa cells were transfected with DRR1 
plasmids or empty vector as a control and fixed 24 h after transfection. (A) F-actin was stained 
with phalloidin (red) and DRR1 with a specific antibody (green). Images were taken with a 
confocal microscope (20x/0.4 NA objective). Scale bar denotes 100 µm. White arrows indicate 
exemplary cells with increased F-actin correlating with high DRR1 wt or mutant expression. 
(B) Quantification of mean cellular F-actin was performed in ImageJ and values of transfected 
cells were normalized to untransfected cells in the same image (n = number of cells in one 
experiment, control n = 200, wt n = 102, dN n = 93, dC n = 38, dM n = 54, M n = 52, 
dPEPE n = 35, C94A n = 85). Bars represent means + SEM. *** p < 0.001 in comparison to 
control. Statistical analysis was performed with one-way ANOVA and Bonferroni post hoc. 
Activation of the serum-response factor upon DRR1 overexpression 
To explore the consequences of DRR1’s effect on actin dynamics further, we made use of 
the fact that the transcription factor serum response factor (SRF) is activated or 
inactivated via its cofactor MAL in response to alterations of the G-/F-actin equilibrium 
(Posern and Treisman, 2006). Bound to G-actin, MAL-translocation to the nucleus is 
inhibited and SRF consequently not activated. With increasing amounts of F-actin, 
however, MAL detaches from G-actin and activates SRF after translocation. In order to 
verify the increased amount of F-actin in DRR1 overexpressing cells, we chose SRF as a 
reliable and functionally relevant read-out. 
Dual-luciferase reporter gene assays were performed with the SRF reporter plasmid 
3DA.luc and gaussia luciferase for normalization of transfection efficiency. HEK-293 cells 
were transfected with the two reporter plasmids and the plasmids expressing DRR1, 
mutants or empty vector. The nucleator mDia lacking its autoinhibitory “DAD”-region 
was used as a positive control for SRF activation. Stimulation of SRF was performed with 
20% serum for 16-18 h.  
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The results of the SRF reporter gene assays reflect the increase in F-actin quantified from 
cellular stainings (Figure 27). In serum-stimulated cells, DRR1 wt increased SRF activity 
about 10fold in comparison to control cells and similarly to the effect of mDia. In the 
absence of serum the stimulation was still about 8fold above the serum-stimulated control 
sample and similar to the unstimulated mDia sample, indicating strong SRF activation by 
DRR1 independently of serum. The mutant dN also strongly increased SRF activity in a 
similar way as the wt, indicating that bundling does indeed have a strong effect on F-actin 
stabilization. And finally, the mutants dM and C94A showed an increase in SRF activity, 
although not as pronounced. Nevertheless, the analogous results from cellular stainings 
and SRF reporter gene assays strongly support the stabilization of F-actin in the cell by 
the tripartite effect of DRR1 by capping, nucleating and bundling. 
 
Figure 27. DRR1-dependent increase in cellular F-actin leads to a strong 
activation of the serum response factor (SRF). SRF reporter gene assays in HEK-293 
cells show 8-10fold enhanced SRF activity after overexpression of DRR1 wt, dN or C94A with 
and without serum (n = 5). Cells were transfected with the SRF reporter 3DA.luc, the gaussia 
luciferase vector for normalization of the luciferase signal and the indicated plasmids or empty 
vector as a control. Serum stimulation or withdrawal was performed for 16-20 h. Luciferase 
activity is shown as the fold-increase of serum-stimulated control samples. Bars represent 
means + SEM. *** p < 0.001 in comparison to control. Statistical analysis was performed with 
one-way ANOVA and Bonferroni post hoc. 
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Effects of Cytochalasin D on DRR1-overexpressing cells 
Several compounds can alter the actin structure in the cell, including depolymerizing 
agents like cytochalasins. As explained in chapter 4.1.3., cytochalasins are a class of 
organic molecules originally isolated from fungi, with Cyto D being the most potent one. 
Cyto D triggers depolymerization of F-actin by capping, cleaving barbed ends and 
acceleration of the actin assembly kinetics (Sampath and Pollard, 1991; Urbanik and 
Ware, 1989). In the model of DRR1’s molecular mechanism DRR1 is assumed to bind to 
the side of the filaments for bundling, but also to the barbed ends thereby inhibiting the 
addition of new monomers. Thus, Cyto D and DRR1 could have competing or partially 
overlapping binding sites on the filament’s barbed ends. 
To test this scenario, HeLa cells were transfected with DRR1-expressing plasmids for 24 h 
and treated with 2 µM Cyto D for 2 h prior to fixation. After staining with DAPI, 
phalloidin and DRR1 antibody, the cells were analyzed with the same two approaches as 
used above: the PCC to quantify colocalization of F-actin and DRR1, and the mean F-
actin content in transfected cells (normalized to untransfected cells) via the mean gray 
values in the respective channel. 
Prior to Cyto D treatment, the colocalization of DRR1 was reflected by a PCC of 0.543 
(see Table 16). After Cyto D treatment, the F-actin structure in HeLa cells was 
dramatically altered: no actin stress fibers were left, the cells started to round up and the 
phalloidin-staining showed a punctuate pattern. The distribution of DRR1 within the cell 
was changed in a similar way resulting in a punctuate pattern throughout the cytosol 
(Figure 28A). Interestingly, the PCC for DRR1 wt and F-actin in Cyto D-treated cells 
was significantly increased in comparison to untreated cells overexpressing DRR1 (Figure 
28B). Although no conclusion can be drawn about G-actin binding of DRR1, the 
concurrent alteration of the cellular distribution pattern of DRR1 and actin upon 
depolymerization of F-actin corroborates a preferential binding of DRR1 to F-actin within 
the cell. 
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Figure 28. DRR1 colocalization with F-actin is increased in HeLa cells treated 
with Cytochalasin D. HeLa transfected with DRR1 for 24 h were treated with 2 µM Cyto D 
for 1 h before fixation. The cells were stained with DAPI (blue), phalloidin (red) and DRR1-
antibody (green). (A) Images were taken with a confocal microscope (40x/1.15 NA objective, 3x 
zoom). After treatment with Cyto D, DRR1‘s cellular distribution appears similar to the 
punctuate pattern of F-actin. Representative cells are shown. Scale bar denotes 20 µm. 
(B) Quantification of colocalization with Pearson‘s correlation coefficient. Pearson‘s correlation 
coefficient (no threshold) was calculated in ImageJ using a PSF of 4.25 and running 100 Costes 
randomizations (untreated n = 14 cells, Cyto D n = 9 cells). Bars represent means + SEM. 
* p < 0.05 in comparison to untreated control. Statistical analysis was performed with a two-
tailed t-test. 
As a next step we measured the mean cellular F-actin in cells treated with Cyto D in the 
same way as described above. Indeed, the amount of F-actin in cells ectopically expressing 
DRR1 was still higher than in control cells after Cyto D treatment. Moreover, there was 
about three times more F-actin in ectopic DRR1 expressing cells than in untransfected 
cells within the same sample (used as control), according to the results from untreated 
HeLa cells (Figure 29, compare with Figure 27). A very strong positive correlation was 
found between the amount of F-actin and the amount of overexpressed DRR1 with a 
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correlation factor of r > 0.8 (Figure 29C). Altogether, these data support the model of 
DRR1 binding to barbed ends and thereby protecting the filaments against Cyto D-
induced depolymerization. Presumably, DRR1 might compete with Cyto D at the barbed 
end. 
 
Figure 29. DRR1 stabilizes F-actin in HeLa cells treated with Cytochalasin D. 
HeLa transfected with DRR1 wt for 24 h were treated with 2 µM Cyto D for 1 h before fixation. 
(A) The cells were stained with DAPI (blue), phalloidin (red) and DRR1-antibody (green). 
Images were taken with a confocal microscope (20x/0.4 NA objective). Scale bar denotes 
100 µm. White arrows indicate exemplary cells with increased F-actin correlating with high 
DRR1 expression. (B) Mean F-actin content in DRR1 expressing cells vs. untransfected cells is 
increased, suggesting a protection of F-actin against Cyto D-induced depolymerization by 
DRR1. Quantification of mean cellular F-actin was performed in ImageJ and values of 
transfected cells were normalized to untransfected cells in the same image (n = number of cells 
in one experiment, untransfected n = 118, DRR1 n = 138). Bars represent means + SEM. 
*** p < 0.001 in comparison to untransfected control. Statistical analysis was performed with a 
two-tailed t-test. (C) The amount of F-actin per cell correlates with DRR1-expression. Values 
for mean cellular F-actin (phalloidin fluorescence) and DRR1 expression (antibody fluorescence) 
correspond to the gray scale of a 16-bit image. For DRR1-transfected cells, Pearson‘s correlation 
indicates a strong positive correlation with cellular F-actin (r = 0.813, p = 9.862E-34). 
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4.2.5. DRR1 modulates actin-dependent processes in cells 
DRR1 reduces HeLa cell spreading 
The results obtained from fixed cells clearly indicated a functional impact of DRR1 on 
actin dynamics. In order to deepen these findings, experiments with living HeLa cells were 
performed to analyze actin-dependent processes. 
As a first approach, cell spreading on fibronectin-coated surface was chosen as a simple 
read-out for changes in actin dynamics. Cell spreading is a relevant aspect in many 
cellular functions, such as migration or wound healing. During the initial phase of cell 
adhesion to the substrate, the cell shows a round morphology analogous to a drop of oil 
falling onto a surface. During this phase, the stiffness or viscosity of the cell has a major 
impact on the speed of spreading, meaning that for example a heavily bundled actin 
network will slow down spreading in contrast to a more filamentous network. After 
attachment of the cell to the surface, the second and longer phase of spreading is 
characterized by the extension of protrusions and eventually cell polarization. Thereby, 
filament elongation is the predominant effect together with integrin-mediated adhesion 
(Berrier and LaFlamme, 2005; Chamaraux et al., 2005; Yauch et al., 1997). 
Spreading of HeLa cells on fibronectin was analyzed by transfecting them with DRR1 
fused to EGFP for 24 h, replating on a fibronectin-coated surface and fixation after 30 min 
of spreading. In order to analyze the actin structure and quantify the cell area, F-actin 
was stained with phalloidin. Representative cells of the spreading assay are shown in 
Figure 30A. The experiment was reproduced with untagged DRR1 leading to the same 
results. Quantification was performed in ImageJ measuring 50-200 cells from four 
independent experiments (including the one with untagged DRR1). The control was 
performed with untransfected and EGFP-transfected cells. EGFP transfection did not 
alter spreading in comparison to untransfected cells. 
DRR1 wt strongly reduced spreading of HeLa cells: while control cells showed a mean size 
of about 700 µm², DRR1 wt expressing cells had a mean cell size below 500 µm². In 
addition, control cells expressing EGFP showed extension of filopodial protrusions after 
30 min of spreading, while DRR1 wt expressing cells were still rounded up lacking any 
protrusions. Together with the observed colocalization of DRR1 wt and F-actin at the 
edge of the cells, where the filaments barbed ends are orientated, the conclusion can be 
drawn that DRR1 indeed caps filaments thereby inhibiting extension of protrusions during 
spreading. All mutants except M also inhibited cell spreading, indicating that both, 
bundling and capping by DRR1, reduce spreading. Interestingly, the mutant dC had a 
pronounced effect in this assay similar to the wild type. Taken the results of the in vitro 
assays into consideration, the inhibition of cell spreading by the mutants dN and dC can 
likely be attributed to bundling, while for dM it is the capping effect. As both mutants 
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reduced spreading in a very similar way, it is likely that both effects contribute about 
equally to the spreading process. 
 
Figure 30. DRR1 wt and all mutants except M reduce spreading of HeLa cells on 
fibronectin. Cells were transfected with constructs expressing DRR1 wt or mutants fused to 
EGFP and replated on fibronectin. After 30 min of spreading, cells were fixed and F-actin was 
stained with phalloidin. (A) Representative cells are shown (DRR1: green, F-actin: red). 
(B) Quantification of cells size was performed in ImageJ (n = 4, 50-200 cells in each 
experiment). Scale bar denotes 20 µm. Bars represent means + SEM. * p < 0.05, ** p < 0.01, 
*** p < 0.001 in comparison to control. Statistical analysis was performed with one-way 
ANOVA and Bonferroni post hoc. 
Fluorescence recovery after photobleaching of GFP-actin is reduced in  
DRR1-overexpressing cells 
DRR1 slowed down actin polymerization in vitro and stabilized F-actin, suggesting these 
functions to have an effect on actin treadmilling in cells. In order to prove this hypothesis, 
fluorescence recovery after photobleaching (FRAP) of GFP-labeled actin was measured in 
HeLa cells co-expressing DRR1 (or empty vector as a control) for 24 h. Time-lapse images 
were acquired with a confocal microscope during 5 min (5 frames were recorded pre-
bleach). Recovery was quantified in ImageJ. 
After 5 min, the recovery in control cells (co-expressing empty vector) reached about 80% 
of the pre-bleach fluorescence. In DRR1 wt overexpressing cells, however, the recovery 
reached less than 60%. None of the mutants analyzed had an effect on FRAP, except dN, 
which had an only slightly higher recovery than the wt. These findings indicated that 
DRR1 slows down actin treadmilling in cells mainly by bundling actin filaments. 
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Figure 31. DRR1 wt and the mutant dN slow down actin treadmilling in HeLa 
cells. Fluorescence recovery after photobleaching (FRAP) in HeLa cells co-transfected with 
GFP-actin and DRR1 wt, dN, dC, dM and M was analyzed. Representative cells are shown. 
Quantification was performed in ImageJ (n = 25-30 cells from 2-3 independent experiments). 
Scale bar denotes 20 µm. Scales of the graphs are all similar to the upper one (Y axis: 
fluorescence [A.U.], X axis: time [s]). 
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4.2.6. DRR1 is located at post-synaptic spines 
As a first step to characterize the function of DRR1 in neurons, the localization of ectopic 
DRR1 in mature primary hippocampal neurons from mice was analyzed. Transfection of 
neurons was performed on DIV10, and on DIV21 neurons were fixed and immunostained 
with antibodies directed against DRR1. Images were acquired on a confocal microscope. 
DRR1 showed a pronounced location in axons and dendrites of mature neurons, with a 
particular accumulation at spine heads. Moreover, many enlarged dendritic spines showed 
a very strong DRR1 signal within the head, while the necks appeared to lack DRR1 
(Figure 32). These findings suggest a role of DRR1 in regulating the actin structure and 
related processes in mature dendritic spines, although an additional role in presynaptic 
mechanisms cannot be excluded. 
 
Figure 32. DRR1 localizes to dendrites and dendritic spine heads. Mouse 
hippocampal neurons show a strong localization of DRR1 along dendritic shafts and spines, with 
a remarkable accumulation at the spine heads (marked with white arrows). Neurons were 
cotransfected with EGFP and DRR1 on DIV10, fixed on DIV21 and immunostained with 
DRR1. Images were taken with a confocal microscope (60x/1.2 NA objective). Scale bars denote 
5 µm. 
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5. Discussion 
It has become evident, that actin dynamics are a major player in synaptic transmission 
and plasticity. The stress-inducible gene DRR1 has emerged as a novel molecular 
candidate translating the stress response to changes on the actin cytoskeleton and 
behavior. On the other side, antidepressants have been shown to impact on the 
cytoskeleton and a “disturbed cytoskeletal theory” of mood disorders has been proposed. In 
this study, a two-pronged approach was taken to analyze the modulation of actin 
dynamics during stress and upon treatment with antidepressants. Three antidepressants  
– clomipramine, doxepin, and citalopram – were assessed in various in vitro assays of actin 
dynamics, showing that only clomipramine had a slight effect in slowing down 
polymerization. On the other hand, the molecular mechanism of DRR1 was revealed to be 
tripartite, hence raising interesting further questions about its specific effect at the 
synapse. 
5.1. Antidepressants effect on actin dynamics 
Of the three antidepressants tested in this study – clomipramine, doxepin, and 
citalopram – only clomipramine was shown to impact on actin dynamics. It moderately 
slowed down actin polymerization, presumably by reducing nucleation, but without 
affecting single filament elongation. The slowdown of polymerization was found for α- and 
β-actin in the pyrene-assay, and reproduced for α-actin in a label-free approach with 
macrorheology. Thus, an unspecific interaction with pyrene or quenching of its 
fluorescence can be excluded. For this effect, at least a two-fold excess of clomipramine 
over actin was required in vitro and became pronounced at a ten- or twenty-fold excess. 
While neither single filament elongation nor nucleation were reduced at a two-fold excess 
of clomipramine over actin, at a fifty-fold excess nucleation appeared to be reduced to 
roughly 60% of the control. Further indication for an effect of clomipramine on nucleation 
was derived from the observed prolongation of the initial lag-phase of the polymerization 
monitored in the macrorheology.  
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The amphiphilic clomipramine and other tricyclic antidepressants have been previously 
shown to interact with human serum albumin in the blood albeit with high interindividual 
differences (Braithwaite, 1980; Taboada et al., 2004). Moreover, physiologic concentrations 
of small cations, polycations or basic polypeptides have been shown to promote actin 
filament bundling based on the negative charge of G- and F-actin at physiological pH and 
thus without the need for specific binding sites (Tang and Janmey, 1996). These findings 
suggest that clomipramine could be electrostatically bound to G-actin or to short 
filaments, thereby interfering with either the nucleation or the addition of new monomers 
to the barbed end. However, this hypothesis remains to be tested further. 
Clomipramine did not appear to have an effect on the structure or elastic properties of 
reconstituted actin networks. Neither the rheological measurements of the elastic 
modulus G’ over a frequency range nor the confocal images of actin networks showed 
significant differences upon addition of clomipramine even at high concentrations. A slight 
increase of G0 (G’ of 0.01 Hz) was observed, although it seems to be negligible in 
comparison to known effects of ABPs. For example, for a filamin/actin network, the 
increase of G0 from R = 0 to 0.1 raises over almost one order of magnitude (Schmoller et 
al., 2009). For fascin, the increase in G0 is even higher (Lieleg et al., 2009). 
Whether the concentrations at which clomipramine exerts an in vitro effect on actin 
assembly are relevant for cellular processes, is yet to be analyzed. Concentrations of above 
20 µM and even up to 40 µM have been estimated in the brain after 5 weeks of treatment 
with the antidepressant fluoxetine, and the tricyclic antidepressant amitriptyline was 
found in the brain of mice in a concentration range of 10-20 µM (Bolo et al., 2004; Henry 
et al., 2005; Uhr et al., 2007). Clomipramine did not show any effects on actin-dependent 
cellular processes at the commonly used 10 µM concentration or even at up to 20 µM. The 
overall F-actin structure of astrocytes and two-dimensional migration of HeLa cells were 
unaffected by clomipramine at 15 µM. It strongly reduced HeLa cell spreading at 50 µM 
similar to the actin depolymerizing agent Cyto D. However, this effect was exerted only at 
this very high concentration and must therefore be interpreted with caution, as unspecific 
toxic effects – as observed in cellular F-actin stainings at high concentrations – might be 
involved. 
5.2. Molecular effect of DRR1 on actin dynamics 
Domain mapping is a frequently followed approach to better understand the mechanism of 
action of proteins. Here, several in vitro experiments with full-length and truncated 
mutants helped to elucidate the molecular mechanism of DRR1. Two actin binding regions 
were identified separated by a central non-binding region. Given the known conservation 
of DRR1 among species, these binding regions can consequently be narrowed down within 
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the “conserved domain of unknown function”. Thus, the N-terminal binding region is 
contained in amino acids 16 to 60, while the C-terminal one lies within amino acids 113 to 
133. The identified actin binding regions in DRR1 lack any homology with known actin 
binding motifs.  
 BINDING CAPPING NUCLEATION BUNDLING 
DRR1 wt + + + + + + + + + + + + 
dN + + + 0 0 + 
dC + 0 0 + 
dM + + + + + + + + 
M 0 0 0 0 
N + 0 0 0 
dPEPE + 0 + + + 0 
C94A + + + + + + + + + 
+ enhancement, – decrease, 0 no effect 
Table 17. Schematic overview of DRR1’s molecular effects on actin dynamics. 
The central region (amino acids 61 to 112) contains a predicted coiled coil (amino acids 
66-93) and presumably mediates homodimerization of DRR1 at the actin filament. 
Interactions with other proteins could possibly also be mediated by this region. An 
overview of the results of in vitro actin dynamics with the mutants of DRR1 is shown in 
Table 17. 
It was demonstrated that actin bundling by DRR1 is mediated via the two actin binding 
regions both as a monomer and potentially as a dimer with four actin binding regions. 
Dimerization of DRR1 through the middle domain (M) is essentially supported by the 
observation that the N-terminally truncated DRR1 with only one actin binding domain 
(dN) forms proper bundles in actin networks. Conversely, addition of the non-actin 
binding middle domain interferes with proper bundling by full-length DRR1. The actin 
bundles formed in the presence of DRR1 appear to be similar to bundles formed by  
α-actinin with respect to bundle thickness and length, and mesh size of the bundled 
network (Falzone et al., 2012). Comparing the data on assembly kinetics of bundled 
networks reveals that at ratios of α-actinin:actin around 1:1 the bundle structure appears 
highly similar to the bundles by DRR1 at a ratio of 1:2 (Falzone et al., 2012 and this 
work). This comparison suggests DRR1’s bundling activity to be at least as strong as the 
respective effect of α-actinin, presumably even more efficient. Meanwhile, actin bundling 
proteins have been demonstrated to inhibit depolymerization of actin in vitro at similar 
concentrations as used in this study (Schmoller et al., 2011). Accordingly, DRR1 has also 
been shown to inhibit dilution-induced actin depolymerization at a DRR1:actin ratio 
of 0.7, very likely through actin bundling (Schmidt et al., 2011). 
5. DISCUSSION 
101 
 
Both actin binding sites of DRR1 are necessary for capping actin filaments, as only 
mutants retaining both actin binding regions (wt, dM and C94A) were able to inhibit 
single filament elongation. Most capping proteins seem to cap at a nanomolar range, and 
both the binding regions and capping mechanisms are not conserved (Hertzog et al., 2010). 
For example, gelsolin caps actin filament at gelsolin:actin ratios of 1:20 to 1:80 (Gremm 
and Wegner, 2000). Capping protein, which is the dominant capping protein in vivo, caps 
with very high affinity and is effective at ratios of 1:1,000 (Schirenbeck et al., 2005). While 
the precise KD of actin capping by DRR1 remains to be analyzed, it seems to have a 
similar potency as other capping proteins, as estimated by the notable capping effect of 
DRR1 at a ratio with actin of 1:10. However, it is by far not as effective as capping 
protein. 
Further experiments are required to determine whether the three effects of DRR1  
– bundling, capping, and nucleation – are independent of each other. All evidence suggests 
bundling and capping to be independent. The comparison of actin networks at a 
DRR1:actin ratio of 1:10 with the respective capping effect shows that there are only few 
bundles visible, but filament elongation rate is strongly reduced to about 30% of the 
control. In addition, the mutant dM shows strong capping ability similar to the wt, while 
it hardly generates any bundles or even clusters of F-actin in the networks. Moreover, due 
to the experimental setting of actin filaments bound to the surface via heavy mero-myosin 
when visualizing polymerization by confocal microscopy, bundling is supposed to be 
strongly reduced. An interesting experiment to further support barbed end capping as a 
novel, independent effect would be to analyze the impact of DRR1 wt (capping and 
bundling) and the mutant dM (only capping) in the pyrene-assay with actin and profilin. 
Profilin sequesters G-actin and inhibits pointed end elongation, i.e. an inhibitory effect of 
DRR1 on profilin-actin polymerization could only be derived from barbed end capping.  
In contrast, nucleation could be a concentration-dependent effect of capping. For capping 
protein, a concentration-dependent nucleation activity has been demonstrated: it inhibits 
elongation of actin at low concentration by blocking the barbed end, while at higher 
concentration it promotes nucleation by mimicking a nondissociable actin dimer (Cooper 
and Pollard, 1985). All DRR1 mutants showing the capping effect also enhanced 
nucleation, with the exception of dPEPE, which enhanced nucleation but had no 
significant impact on filament elongation. This result suggests nucleation as an effect 
dependent on F-actin binding of DRR1. To further address this aspect, nucleation activity 
of all mutants should be further analyzed dependent on their concentration in both the 
pyrene-assay and the confocal polymerization. 
Taken together, the exact mechanism of actin nucleation by DRR1 is unclear so far, but 
due to its two actin binding sites, it is conceivable that DRR1 stabilizes actin dimers (or 
even trimers and tetramers when dimerized) and thereby directly enhances nucleation in a 
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similar way to capping protein. All actin nucleators except formins exhibit the actin-
binding motif WASP-homology 2 domain often organized in tandem repeats. Formins 
nucleate and promote barbed end elongation through their formin-homology domains 
(Dominguez, 2010). However, DRR1 lacks homology with these domains, suggesting a 
different mechanism of nucleation. In comparison to the formin mDia1, the nucleation 
capacity of DRR1 appears much weaker (Harris and Higgs, 2006). However, they both 
lead to a similar activation of SRF, indicating that the bundling and capping effects of 
DRR1 lead to a strong stabilization of F-actin in the cells. 
The tripartite effect of DRR1 on actin dynamics is schematically depicted in Figure 33. 
 
Figure 33. Model of DRR1’s effects on actin dynamics. (A) Scheme of DRR1 protein 
(144 amino acids) containing the highly conserved domain of unknown function 1151 and 
domains analyzed in this work. N: N-terminal actin binding region, M: middle region containing 
a predicted coiled coil and potentially mediating homo-dimerization, C: C-terminal actin binding 
region. (B) Scheme of the molecular mechanism of DRR1 as a monomer and dimer on actin 
dynamics (capping, nucleation, and bundling).  
Meanwhile, there are additional features worth to mention among the effects of the DRR1 
mutants. First, the cysteine residue in the center of the coiled coil does not appear to have 
a crucial impact on any of the molecular effects. Due to the known interaction of DRR1 
with Prdx1, it is tempting to speculate that this cysteine residue might be important for 
regulation of DRR1’s functions under certain redox conditions (Schmidt et al., 2011).  
For the mutant dPEPE, some results seem contradictory: it showed actin binding in the 
Co-IP experiment (Figure 17), but no binding in the co-sedimentation assay (Figure 18). 
The latter result excludes specific binding to F-actin, which is in agreement with the 
original publication, in which the mutant dPEPE lacked colocalization with phalloidin in 
cells (Le et al., 2010). In the Co-IP, however, one cannot differentiate between F- and  
G-actin binding, therefore suggesting the ability of this mutant to bind to G-actin. This 
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interpretation is further supported by the finding that the mutant dPEPE enhances 
nucleation potentially through interaction with G-actin, while it obviously does not inhibit 
filament elongation due to the lacking F-actin binding.  
In a similar way, the apparent actin binding capacities of the mutants dN and dC differ 
somewhat between the Co-IP and the Cosedimentation experiments, although the 
differences are not significant (compare Figure 17 and 18). While dN shows higher actin 
binding than dC in the Co-IP, dC exerts higher F-actin binding in the co-sedimentation. 
Yet, in the presence of dN proper actin bundles are generated, while dC (same as dM) 
only leads to the formation of aggregate-like crosslinks. Moreover, the mutant dC shows a 
trend to enhance nucleation and slightly reducing elongation. These results indicate that 
the two actin binding regions differ in F-actin binding affinity and likely also in their G-
actin binding ability. Nevertheless, additional data are required to address the specific 
function of each binding region. 
Taken together, DRR1 shifts the equilibrium of actin polymers towards more, thicker and 
shorter actin bundles. The importance of these alterations for cellular mechanisms is 
discussed in the following chapter.  
5.3. Cellular effects of DRR1 
Increasing evidence supports the view that many ABPs are multifunctional, rather than 
exhibiting one exclusive effect on actin dynamics. For example, the protein Epidermal 
growth factor receptor pathway substrate 8 (Eps8), is the founding and so far unique 
member of a family of capping proteins, capable of filament side-binding and bundling 
(Croce et al., 2004; Hertzog et al., 2010). DRR1 adds to this class of multifunctional ABPs 
by exhibiting a tripartite effect in vitro: bundling, capping, and nucleation. These three 
effects are likely to be regulated further for example by the relative abundance of other 
ABPs that might compete with DRR1 for access to actin structures. 
Moreover, DRR1’s cytosolic and nuclear localization suggests an additional impact on 
nuclear actin dynamics. While the role of nuclear actin is just beginning to be understood, 
it has been shown to be involved in chromatin remodeling, gene transcription and 
cytosolic-nuclear shuttling (Castano et al., 2010). The question whether DRR1’s effect on 
actin in the nucleus is similar or divergent from the one in the cytosol as well as its 
functional consequences will be a quite interesting issue for future research. 
Table 18 shows an overview of DRR1 effects on actin-dependent cellular processes. 
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 F-ACTIN 
COLOCALIZATION 
CELLULAR  
F-ACTIN 
SRF 
ACTIVATION 
CELL  
SPREADING 
ACTIN 
TURNOVER 
DRR1 wt + + + + + + + + + – – – – – 
dN + + + + + + – – – – 
dC + 0 0 – – – 0 
dM + + + + + – 0 
M 0 0 0 0 0 
N   0   
dPEPE +  0 0   
C94A + + + + + +   
+ enhancement, – decrease, 0 no effect 
Table 18. Schematic overview of DRR1 effects on actin-dependent cellular processes. 
The correlation coefficients of F-actin and the DRR1 mutants reflect the respective F-
actin binding abilities. There is no colocalization of the central region M with F-actin, in 
line with the lack of actin binding. In contrast, the mutants dN, dC, dM, dPEPE, and 
C94A all exhibit colocalization with F-actin, owing to the existence of two actin binding 
regions separated by the central, presumably dimerizing region. Although the mutant dC 
showed slightly more cosedimentation with F-actin than dN in vitro, this is not reflected 
by increased F-actin colocalization in cells. 
Transfection of DRR1 produced a remarkably stronger F-actin staining than the 
untransfected control cells, which was quantified to be about three times more. 
Intriguingly, for the mutants dM and C94A this effect was almost as pronounced as for 
the wt, while dN showed an approximately two-fold increase of cellular F-actin. These 
findings, together with the respective molecular effects of each mutant, suggest all three 
effects of DRR1 – bundling, capping, and nucleation – to contribute to the increased 
amount of cellular F-actin. 
The experiments of HeLa cells treated with Cyto D indicated a preferred binding of DRR1 
to F-actin versus G-actin, as the colocalization analysis revealed that the DRR1 staining 
essentially followed the remaining and reorganized F-actin strucutres upon Cyto D-
induced depolymerization of actin. On the other hand, cells expressing DRR1 still featured 
more F-actin after Cyto D treatment than untransfected cells. These findings indicate that 
bundled F-actin is less sensitive towards Cyto D-induced depolymerization, and that actin 
binding sites of DRR1 might overlap with Cyto D, thereby protecting the filaments 
against Cyto D-induced depolymerization by DRR1-binding. 
The increase in cellular F-actin caused by ectopic DRR1 was paralleled by increased 
activation of the serum response factor SRF, comparable to the activation of the formin 
mDia1. Virus-mediated overexpression of DRR1 in the hippocampus reduced spine density 
and LTP, while SRF was described to promote spine morphogenesis and axonal outgrowth 
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(Kalita et al., 2012; Schmidt et al., 2011). This seeming contradiction might be explicable 
by a compensatory effect of SRF in reaction to the upregulation of DRR1. In addition, 
SRF-dependent effects on gene-transcription might be slower than the direct and 
immediate impact of DRR1 on synaptic actin dynamics and thus balance DRR1’s action. 
HeLa cells expressing ectopic DRR1 wt reduced cell spreading to about 70% of the 
controls. All mutants capable of actin binding, i.e. dN, dC, and dM, showed a comparable 
effect. Cell spreading is a complex process affected by different parameters: substrate 
stiffness and density, diffusion of integrin-receptors to the adhesion patch, and actin 
polymerization (Chamaraux et al., 2005; Li et al., 2014; Yauch et al., 1997). Furthermore, 
early spreading was proposed to follow a universal law depending on the mechanical 
properties of the cell and predominantly the actin cortex (Cuvelier et al., 2007). The 
results of the mutants indicate that both, inhibition of filament elongation (by wt and 
dM), as well as bundling (by wt, dN, and dC, see Table 17 and 18) contribute to 
inhibition of cell spreading. While bundling presumably inhibits the early phase of 
spreading during cell-substrate contact initiation by increasing cell stiffness, capping of F-
actin is likely to interfere with extension of the lamella during the later phase. 
Experiments of fluorescence recovery after photobleaching with HeLa cells revealed a 
reduced recovery of GFP-actin in the presence of ectopic DRR1 wt or dN. It is reasonable 
to assume that the recovery rate of GFP-fluorescence upon photobleaching reflects the 
actin turnover or treadmilling rate, as the free diffusion of monomeric G-actin is by far 
quicker (Frost et al., 2010; Honkura et al., 2008; Star et al., 2002). In accordance with 
previous studies, these findings indicate a significant slowdown of actin turnover by 
DRR1’s bundling activity (Falzone et al., 2012; Okamoto et al., 2007). Although the 
relevance of this effect for the stress response remains to be elucidated, it strongly 
implicates a considerable increase in ATP supply for the cell. Actin treadmilling was 
shown to be a major energy drain in the brain and estimated to consume about 50% of a 
neurons’ ATP (Bernstein and Bamburg, 2003). Such an increase in available ATP through 
slowdown of actin turnover could be necessary for other vital processes of the cell like 
protein synthesis. 
Up to date, most studies are using fibroblasts for FRAP experiments. Nevertheless, there 
is increasing interest in FRAP experiments analyzing dendritic spines, as these highly 
dynamic structures play a central role in learning and memory (Koskinen and Hotulainen, 
2014; Yuste and Bonhoeffer, 2001). For DRR1, such an approach dissecting its function in 
dendritic spine shape and synaptic transmission would be highly interesting. 
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5.4. Effects of DRR1 on synaptic plasticity 
Previous results from electrophysiology indicated a pre-synaptic effect of DRR1, by 
increasing paired-pulse facilitation likely through preventing the recruitment of synaptic 
vesicles to the ready-releasable pool. Moreover, while LTP was inhibited by DRR1, its F-
actin stabilizing activity appeared to be important for memory retrieval and consolidation 
(Schmidt et al., 2011). On the other hand, DRR1 also appears to have an impact on 
dendritic processes and post-synaptic function, as indicated by its localization along 
dendrites and its strong accumulation in enlarged spine heads. 
A knockdown of capping proteins in fibroblasts caused a massive increase of filopodia, 
while DRR1 overexpression reduced neurite outgrowth and spine density (Mejillano et al., 
2004; Schmidt et al., 2011). Therefore, it is likely that DRR1’s capping activity rather 
than actin bundling would result in the observed reduction of protrusions. Further support 
for this hypothesis comes from the bifunctional actin capping and bundling protein Eps8, 
which was shown to control dendritic spine density through its capping activity (Menna et 
al., 2013). However, capping activity has also been shown to be essential for enlargement 
of dendritic spine heads during maturation: Eps8 is recruited to the spine head during 
LTP to mediate spine enlargement (Menna et al., 2013). While the major driver of spine 
enlargement is assumed to be the branching activity of Arp2/3, a coordinated capping 
activity appears to be essential as well (Fan et al., 2011; Korobova and Svitkina, 2010; 
Wegner et al., 2008). Actin filaments in mature dendritic spines have been shown to be 
quite short (< 200 nm), highly crosslinked and bundled, in line with DRR1’s capping and 
bundling effects (Frost et al., 2010; Ivanov et al., 2009; Okamoto et al., 2007; Terry-
Lorenzo et al., 2005). 
Altogether, a model is proposed in which DRR1 on the one hand inhibits the outgrowth of 
new spines, but on the other hand contributes to the stabilization and maturation of 
existing spines (Figure 34). It might therefore enhance structural stability concomitant 
with a loss in plasticity. According to the current knowledge on synaptic actin dynamics, 
all three molecular effects of DRR1 are in agreement with such a model (Cingolani and 
Goda, 2008; Hotulainen and Hoogenraad, 2010). 
Moreover, hippocampal LTP is accompanied by elevated F-actin content in dendritic 
spines, and ongoing actin polymerization was shown to be essential for LTP induction and 
maintenance (Fukazawa et al., 2003). The previously described inhibition of LTP by 
DRR1 (Schmidt et al., 2011) could thus be explained by reduced actin turnover, as found 
here in the FRAP experiments of this study. Interestingly, Ca2+-calmodulin-dependent 
protein kinase II (CaMKII) is another multifaceted effector of spine structure which was 
shown to bundle F-actin and to slow down actin turnover in resting spines, while synaptic 
activity induced detaching of CaMKII from actin and functioning as a signaling molecule 
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upon Ca2+ influx. In this way, it was proposed to mediate spine stability and enable 
remodeling necessary for LTP in response to activity (Okamoto et al., 2007). Taken 
together, this study provides further support for the model of DRR1’s function in 
mediating stability of spines, but rendering them less dynamic for LTP at the same time. 
 
Figure 34. Hypothetical effect of DRR1 on dendritic spine maturation. During 
initiation of dendritic spines and extension of filopodial structures prior to maturation, 
elongation of actin filaments from the tip of the spines is necessary. This process would 
presumably be inhibited by DRR1. However, increased content of short actin filaments is 
necessary for spine head enlargement, mainly mediated by Arp2/3 branching activity in 
coordination with actin cappers. In mature mushroom spines, short filaments are highly bundled 
to provide stability. It is therefore likely that DRR1 could support the both spine head 
enlargement and the actin structure in mature mushroom spines by nucleating, capping and 
bundling filaments. 
Another interesting notion is that DRR1 could link actin fibers with microtubules in 
dendritic spines. Microtubules have been proposed to enter dendritic spines and DRR1 
was shown to also bind to the microtubule associated protein MAP1A (Jaworski et al., 
2009; Le et al., 2010).  
While molecular data acquired from this work, together with the current knowledge on 
spine actin dynamics, allow developing a model of DRR1’s impact on dendritic spine 
maturation, it is essential to further test this model with additional experiments. Ideally, 
the tripartite effect of DRR1 should be analyzed in regard to the function of each effect 
for synaptic plasticity and the respective functional consequences. The implication of spine 
malformations in many psychiatric and neurological disorders calls for broadening the 
current knowledge on molecular players linking actin dynamics with synaptic transmission 
and behavior (Spronsen and Hoogenraad, 2010). 
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5.5. The function of DRR1 during stress response 
DRR1 has been proposed to counteract adverse stress effects and promote coping 
behavior. In the adult mouse, its virus-mediated overexpression in the hippocampus 
improved cognitive function, while in the septum it specifically enhanced social behavior 
(Masana et al., 2014; Schmidt et al., 2011). This study provides further molecular 
indications that are in agreement with a function in promoting stress resilience. 
Glucocorticoids have been shown to stabilize and bundle actin filaments through 
upregulation of the actin binding protein caldesmon. This in turn prevented the release of 
ACTH in the pituitary tumor cell line AtT-20, thus presenting a negative feedback loop of 
glucocorticoids on HPA axis activity (Castellino et al., 1992). The bundling effect of 
DRR1 on actin dynamics appears similar and it appears to be expressed in the pituitary 
gland (www.genecards.org), therefore suggesting a possible influence on hormone release. 
The serum response factor, which was found to be activated by DRR1 in this study, was 
previously described as a significant mediator of activity-dependent gene expression and 
synaptic plasticity, and consequently to promote learning and memory (Etkin et al., 2006; 
Ramanan et al., 2005). The brain-derived neurotrophic factor BDNF has lately received 
increased attention in psychiatric research, given its positive impact on neurogenesis, 
synapse formation and maturation, and memory formation, together with its 
downregulation upon stress exposure and in many mood disorders, including schizophrenia 
and depression (Brunoni et al., 2008; Vicario-Abejón et al., 2002; Xiu et al., 2009). 
Moreover, BDNF stimulation led to the activation of the serum-response factor SRF 
facilitating synaptic activity (Kalita et al., 2006). This convergence of mechanisms 
between DRR1 and BDNF support DRR1’s function in promoting stress coping.  
Interestingly, a shift of the G-/F-actin equilibrium in depression and bipolar disorder 
towards depolymerization and fragmentation of F-actin was suggested, as a result of cap1 
downregulation, upregulation of cofilin and profilin, and downregulation of the cofilin-
inactivating kinase LIMK1 in animal models and postmortem patient brains (Nakatani et 
al., 2004, 2007). The observed effects of DRR1 in this study generate a counteracting shift: 
increased F-actin and reduced turnover. Assuming a function of DRR1 in mediating 
coping and adaptation to stress by stabilization of F-actin is in accordance with the view 
of the opposite effects (depolymerization and F-actin fragmentation) promoting the 
development of mood disorders. Furthermore, the major susceptibility gene in 
schizophrenia, DISC1, was shown to interact with microtubule-associated proteins 
(including MAP1A) and actin-related proteins among others, further suggesting a role of 
cytoskeletal disturbance in this disease (Ishizuka et al., 2006; Millar et al., 2000).  
Altogether, increasing evidence suggests a crucial involvement of the cytoskeleton in the 
etiology of stress-related mood disorders. However, conventional tricyclic antidepressants 
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appear not to target expression of actin-related genes (Nakatani et al., 2007). Although 
extensive studies are required in the future to dissect in more detail the function of actin 
during stress response and adaptation, these pathways might open up novel therapeutic 
approaches in the future. 
5.6. Outlook 
While this study provides important evidence in elucidating the molecular and cellular 
function of DRR1, it also raised interesting questions to be addressed in future research. 
The known interaction of DRR1 and Prdx1 together with the finding that the unique 
cysteine residue of DRR1 is not significant for any particular function in the tests so far, 
could point to its potential role as a regulatory site for Prdx1. Prdx1 has been shown to 
regulate the activity of cytosolic proteins by reducing their intramolecular disulfide bond, 
raising the question whether covalent dimerization of DRR1 could be mediated through 
enzymatic activity of Prdx1 (Yan et al., 2009). Furthermore, DRR1’s interaction partner 
MAP1A has been described as a stabilizer of microtubules, implying a role of DRR1 not 
only in F-actin stabilization, but also an involvement in microtubule stability (Halpain 
and Dehmelt, 2006; Le et al., 2010). Both interactions and their relevance for cellular 
processes would be interesting targets for future research. 
With actin being the major driver of cell locomotion and given the effect of DRR1 on cell 
spreading together with its proposed function as tumor suppressor, an impact of DRR1 on 
cell migration is expected. Accordingly, progression through the cell cycle could be altered 
by DRR1. Analysis of both of these effects will further enlighten its intriguing role in 
tumor development and progression. 
Finally, a detailed analysis of its function at the synapse would be highly interesting, to 
further support the novel link from stress through alterations of actin dynamics to 
synaptic transmission and behavior. Eventually, the aim would be to correlate each 
molecular effect of DRR1 – bundling, nucleation, and capping – with the respective 
functional alterations on pre- or postsynaptic transmission.  
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Appendix 
Supplementary Movies 
The time-lapse images acquired from confocal polymerization of phalloidin-labeled actin 
shown in Figure 7, Figure 15, and Figure 19 are provided on the enclosed CD as “.avi” 
movie files. 
FILENAME SAMPLE R 
01 control ddH2O.avi ddH2O - 
02 control EtOH-HCl.avi 50% EtOH/5 mM HCl - 
03 control MBP R05.avi MBP 0.5 
04 clomi R5.avi Clomipramine 5 
05 clomi R50.avi Clomipramine 50 
06 DRR1 wt R01.avi DRR1 wt 0.1 
07 DRR1 wt R025.avi DRR1 wt 0.25 
08 DRR1 wt R05.avi DRR1 wt 0.5 
09 DRR1 dN R05.avi DRR1 dN 0.5 
10 DRR1 dC R05.avi DRR1 dC 0.5 
11 DRR1 dM R05.avi DRR1 dM 0.5 
12 DRR1 M R05.avi DRR1 M 0.5 
13 DRR1 N R05.avi DRR1 N 0.5 
14 DRR1 dPEPE R05.avi DRR1 dPEPE 0.5 
15 DRR1 dC94A R05.avi DRR1 C94A 0.5 
Table 19. List of supplementary movies (on CD). 
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Supplementary Figure 
 
Supplementary Figure 1. Overview of the controls used in all in vitro actin 
assays: ddH2O, the solvent of the antidepressants 50% EtOH/5 mM HCl, and 
purified MBP protein. The controls ddH2O and EtOH/HCl were added in a constant 
volume, MBP was added in R = 0.5. (A) Pyrene-polymerization assay. Actin filaments (5 μM, 
20% pyrene-labeled) were polymerized and increase in fluorescence of pyrene-actin during 
polymerization was monitored for 60 min. Representative curves are shown. (B) Confocal time-
lapse images of in vitro actin polymerization (1 μM actin). Filaments were visualized by 
phalloidin. Scale bar denotes 10 μm. Quantification of filament elongation and nucleation rate. 
Bars represent means + SEM. No significant differences were found. Statistical analysis was 
performed with one-way ANOVA and Bonferroni post hoc. (C) Actin networks (4 µM) were 
polymerized at RT for > 2 h and visualized with phalloidin-488. Images were taken in a confocal 
microscope (63x/1.4 NA objective, 10 μm z-stacks). Scale bar denotes 50 μm. 
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Abbreviations 
ABPs Actin binding proteins 
ADF/cofilin Actin depolymerizing factor/cofilin 
Amp Ampicillin 
AMPA receptor α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid r. 
ANOVA Analysis of variance 
APS Ammonium persulfate 
ATP Adenosine triphosphate 
BCA Bicinchoninic acid 
BMB 1,4-Bismaleimidobutane 
BSA Bovine serum albumin 
Cdc42 Cell division control protein 42 
Cital Citalopram 
Clomi Clomipramine 
CoIP Coimmunoprecipitation 
DAD Diaphanous autoregulatory domain 
DAPI 4’,6-diamidino-2-phenylindole 
DID Diaphanous inhibitory domain 
ddH2O Double distilled water 
DMEM Dulbecco’s modified eagle medium 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
Dox Doxepin 
dNTPs Deoxyribonucletide triphosphates 
DRR1 Down-regulated in renal cell carcinoma 1 
DSG Disuccinimidyl glutarate 
DSS Disuccinimidyl suberate 
DTT Dithiothreitol 
E. coli Escherichia coli 
EDTA Ethylenediamine tetraacetic acid 
EGTA Ethyleneglycol tetraacetic acid 
Eps8 Epidermal growth factor receptor pathway substrate 8 
EtOH Ethanol  
F Flag-tag 
F-actin Filamentous actin 
FAM107A family with sequence similarity 107, member A 
FBS / FCS Fetal bovine/calf serum 
G-actin Globular actin 
GR Glucocorticoid receptor 
GS Goat serum 
h hours 
HBSS Hank’s balanced salt solution 
HEK-293 cells Human embryonic kidney-293 cells 
HeLa cells Henrietta Lacks cells 
HPA axis Hypothalamic-pituitary-adrenal axis 
HPC Hippocampus 
HRP Horseradish peroxidase 
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IB Immunoblot 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
Kan Kanamycin 
LTP / LTD Long term potentiation / depression 
MBP Maltose binding protein 
min minute 
MR Mineralocorticoid receptor 
mRNA Messenger RNA 
MWCO Molecular weight cut off 
NBA Neurobasal A 
NEM-HMM N-ethylmaleimide-modified heavy meromyosin 
NLS Nuclear localization signal 
NMDA receptor N-Methyl-D-aspartic acid receptor 
(N-)WASP (neuronal) Wiskott-Aldrich syndrome protein 
OD Optical density 
PAA Polyacrylamide 
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline 
PCC Pearson’s correlation coefficient 
PCR Polymerase chain reaction 
PI Protease inhibitor 
PFA Paraformaldehyde 
PMSF Phenylmethanesulfonylfluoride 
Rac1 Ras-related C3 botulinum toxin substrate 1 
RhoA Ras homolog gene family, member A 
R Ratio of antidepressant of DRR1 protein : actin 
RNA Ribonucleic acid 
ROCK Rho-associated protein kinase 
ROI Region of interest 
rpm Rounds per minute 
RT RT 
s Second 
SEM Standard error of the mean 
SDS Sodium dodecyl sulfate 
SSRI Selective serotonin reuptake inhibitor 
TBS-T Tris-buffered saline tween 20 
TEMED Tetramethylethylenediamine 
TRIS Tris-(hydroxymethyl)-aminomethan 
TU3A Tohoku University cDNA clone A on chromosome 3 
wt wild type 
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